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Summary
This thesis reports a study of effects of bacterial 
1ipopolysaccharides (LPS) on morphological polarization, 
locomotion and chemiluminescence of human neutrcphi 
1eukocytes (po1ymorphonuc1ear 1eukocyt es:PMN).
Change from a spherical to a polarized morphology 
by a cell is the initial event in cell locomotion. PMN 
in suspension were shown to change shape even in the 
presence of small amounts of LPS (> 100 ng/ml) in the 
medium. Exposing PMN to LPS from rough strains of 
bacteria resulted in slow shape change (60-90 minutes), 
unlike chemotactic factors which cause shape change 
within a few minutes. This suggests an indirect effect. 
Rough strains were more active than the smooth 
chemotypes in inducing polarization of PMN. The number 
of polarized cells increased as the period of incubation 
increased implying the possible presence of a second 
(non-LPS) agonist that promoted further polarizing 
activity. Polymyxin B sulfate (10 pg/ml) was added to 
the cells prior to challenging with LPS (10 jug/ml) in 
order to inhibit this biological effect. However, 
polymyxin in this system did not reduce the number of 
polarized PMN to a statistically significant extent. To 
test if a chemotact. ic-type factor might have been 
released by the cells, supernatant was prepared from PMN 
(106 cells/ml) which had been incubated with LPS for 90 
minutes. The supernatant (but not LPS alone) was shown
XV
to cause the shape change within 10 minutes in a short­
term polarization assay on a new batch of PMN. By 
reducing the cell density in the presence of constant 
amounts of LPS (10 Mg/ml), it could be shown that 
polarizing activity of the supernatant was reduced.
To assess the relationship of shape change to that 
of locomotory ability, three additional leukocyte 
locomotion assays were employed. With a micropore filter 
assay, migration of the cells in different concentration 
gradients of the factor showed that the released 
material behaved like a chemotactic factor as analyzed 
by the checkerboard system. A collagen gel assay was 
used to study detailed cell locomotion quantitatively 
(population of cells migrating) and also qualitatively 
(morphological changes during locomotion). Detailed 
behavioural analysis of the PMN response to LPS was 
obtained from visual studies. Quantitative measurements 
of shape change showed a slowly developing increase in 
elongation of the cells exposed to LPS for up to 90 
minutes, in contrast to rapid elongation of cells 
exposed to the chemotactic peptide, formyl-methionyl- 
1eucy1-pheny1a 1an i ne (FMLP).
One of the ways a neutrophil might release a 
stimulant is through arachidonic acid metabolism. 
Steroidal and non-steroidal antiinflammatory drugs used 
to modulate the shape change process of the leukocytes 
displayed varied effects. Two drugs, with reported
XVI
inhibitory effects on lipoxygenase activity, BW755C and 
Revlon 5901A reduced the number of PMN polarized by LPS. 
Conversely, neither indomethacin nor dexamethasone had 
any effect. Preliminary characterization of the cell 
released factor was also conducted. The factor was heat 
stable and non-dialyzable. Hexane extraction, thin layer 
chromatography and column gel filtration suggested that 
the released material was heterogenous. A low molecular 
weight factor (about 2000 kD) was identified by gel 
filtration on Sephadex G-25.
Monoclonal antibodies against the CD11/CD18 family 
of cell surface receptors (shown by other researchers to 
be responsible for the binding of LPS to PMN) were used 
as inhibitors of LPS binding to PMN. Some antibodies 
were relatively effective in inhibiting LPS-induced PMN 
polarization particularly those against CDllb/CD18. 
Combinations of monoclonals against three antigens 
(CDlla, b and c) were more effective than any one alone. 
The study using these antibodies unexpectedly showed 
that the binding site of LPS to the phagocyte is highly 
affected by antibodies to the ar-chain and not the 6- 
chain as reported by previous investigators. Competitive 
inhibitory binding of LPS to PMN was observed with 
synthetic peptides containing an RGD-sequence. The 
observation points to a probable involvement of the 
sequence in LPS-induced neutrophil polarization.
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Chemi luminescence was used an additional test of 
LPS activation of PMN. On addition of LPS (10 /ig/ml) , 
slow but progressive light emission was noted. Normal 
peaking time ranged from 30 to 60 minutes with different 
intensities from different donors. Addition of platelet 
activating factor (PAF) as a primer did not enhance the 
response but instead slightly depressed the activity. 
LPS on its own can also act as a priming agent . 
Preexposing cells to LPS for 30 minutes at 37° C 
followed by adding PMA gave enhanced chemiluminescence. 
Similar priming but using opsonized zymosan as a second 
stimulus however depressed the activity. Comparison of 
the priming effect with PAF shows that PAF potentiates 
both responses to soluble and particulate stimulus. The 
degree of chemiluminescence differs between the two 
primers with the different stimulus used.
Results obtained from normal individuals were used 
as standards to compare with diabetic patients both in 
po1ar i zat i on and chem i1um i nescence stud i es . D i abet i c PMN 
showed poor responses in a polarization assay. With the 
addition of PAF as a potentiator, the response 
increased. Chemiluminescence using LPS alone, opsonized 
zymosan and PMA was comparatively lower in diabetics 
than in normals. The presence of LPS or PAF as primers
XVIII
for the responses towards opsonized zymosan and PMA 
increased the activity. There was no positive 
correlation between the response to LPS and levels of 
blood glucose, fructosamine or glycosylated haemoglobin 
in individual patients.
CHAPTER 1  
INTRODUCTION
2The ini iamma t orv process can be triggered by bacterial 
invasion or by physiological changes in the body such 
as physical trauma or immunological reactions. The 
inflammatory process is manifested by three distinct 
features which generally lead to an end result of 
restoration of normal function . Nevertheless, there are 
instances whereby severe injury can be initiated as a 
consequence of the inflammation. The three main features 
of inflammation can be summarised as follows:-
A) the enlargement or dilatation of the elastic blood
vessels hence allowing a large volume of blood flow 
to the injured area.
B) the increased permeability of the vessel walls to
plasma proteins which are normally .. retained
in the blood vessel.
C) the migration of polymorphonuclear leukocytes
(neutrophils) and monocytes into the extravascular
space. The process usually involves certain
systematic characteristics. Leukocytes initially
adhere to the endothelial cell lining. Having
adhered, the ceils traverse the vessel vs.
actively. using an amoeboid pat i: era  ^  op Ted-d :
towards t, he i nf i ammat ory st i nui 1 us .
The latter feature in inflammation has been the subject
of intensive research for the past twenty years.
Substantial evidence has thus far emerged in
understanding the emigration and accumulation of
1eukocytes in vivo. Endot ox i ns , 1i popo1ysacchar i des
derived from the Gram- negative bacteria are among the 
important mediators which cause c _ , leukocytes to 
accumulate at the site of injury (Issekutz and Bhimji, 
1982; Issekutz and Megyeri, 1987). Bacterial
1ipopolysaccharides (LPS) elicit local inflammation when 
injected into an animal , but the role of
1ipopolysaccharide in inducing the infiltration of
leukocytes into the inflammatory lesion has received
much more attention than its other inflammatory effects. 
Leukocyte membrane proteins which mediate adhesion to 
endothelium have recently being discovered to contribute 
to the extravasation of these inflammatory cells to the 
extravascular space. Lipopolysaccharide is known to 
enhance this adhesion as discussed later. Information to 
support this notion is presented by the discovery of 
patients with leukocyte adhesion deficiency (LAD) 
lacking adhesion glycoproteins on the cell surface of 
neutrophils (Springer et a l , 1984; Arnout et a l , 1984).
With the availability of quantitative assay to 
assess the mechanisms and kinetics of leukocyte
migratory behaviour, a better picture of the actual
situation in the.inflammatoryprocess should be displayed
soon. It is therefore hoped that the work in this thesis
will be of help in solving the puzzle of leukocyte
1ocomot i on and accumu1at i o n .
4Sect i on 1
Early studies of inflammatory cells in inflammation
Inflammation was clearly recognised in ancient 
Egypt as recorded by the historians. During the 
nineteenth century, extensive work was conducted to 
better understand the process. Of particular interest 
was the phenomenal involvement of leukocytes sticking to 
the blood vessels following injury. Dutrochet in 1824 
was recorded as the first who observed leukocyte 
sticking to the vessel wall and their emigration 
thereafter (Grant, 1974), but Addison and Waller were 
widely accepted to be among the pioneers who documented 
the event clearly (Movat, 1985). Some twenty to thirty
years later other investigators made considerable 
progress in their initial work. Among those forefront 
figure was Cohnheim, in .iS_89, whose contribution to the 
study of cellular emigration was extensive. He is 
quoted as mentioning that the veins were filled with 
: Innumerably: colourless corpuscles that did not remain 
entirely motionless but advanced. slowly. These 
observations were noted i n the mesentery and tongue of 
the frog. The movement of these leukocytes through a 
vessel wall was however considered by Cohnheim to be a 
pass i vc u.oL i oic:ana ru: referred to ,i t as a f i ltrat ion process 
(Cohnheim, 1889). This was countered by later workers 
particulary Elie Metchnikoff (Metchnikoff, 1893) who
strongly believed in the active participation of the 
leukocytes. By the turn of the century, it was generally 
known that iciikuc vies marginate, adhere to the 
endothelium and eventually emigrate. The precise events 
during migration of the leukocytes were elucidated with 
the advent of electron microscopy and the in vitro 
studies of leukocyte locomotion and chemotaxis.
Chemotaxis was first described in leukocytes by 
Leber in 1888 (Movat, 1985) when he injected Aspergillus 
fumigatus in the cornea of rabbits. Leber described the 
directional movement of leukocytes outside vessels as 
due to the differences in concentration of the substance 
with which these cells come into contact. The term 
"chemotaxis" was used by Bloch in his 1896 publication
Interpretations of the earlier findings on chemotaxis 
were later well understood when chemoattract ion of PMN 
was shown to be. .i as i spsnsabie ..in the Arthus reaction (Ward 
and Cochrane, 1965) due to complement activation by 
immune complexes. However, chemotaxis as the principal 
mechanism in in vivo leukocyte accumulation was not 
fully recognised until after the in vitro experiments of 
Boyden (Boyden, 1962). Thus the study of leukocyte
6chemotaxis received a considerable impetus with the 
description of a chamber by Boyden. A new field of 
"chemot act i c movement s" was consequent 1y exp1ored t o 
further strengthen the understanding of leukocyte 
accumulation at the site of inflammation.
7Section 2 
Polymorphonuclear leukocytes
In the early days of microscopic anatomy, it was 
discovered that blood and tissues of animals contained 
large numbers of cells that were capable of locomotion 
and showed a tendency to engulf foreign materials from 
their environment. These cells were thought to function 
as scavengers but also rQ responsible for spreading 
infections by engulfing and transporting microbes in the 
tissues. In the late 1890s, Metchnikoff discovered that 
these cells, phagocytes as he called them, were not just 
scavengers but would engulf and Kill the most common 
bacteria. Hence, he had shown that the phagocytes 
constituted one of the principal agencies of defense 
against microbial invaders. Phagocytes may be divided 
into two general classes depending on their nuclear 
structures:-
(i) polymorphonuclear cells witha,segmented nucleus 
of two or more lobes
(ii) mononuclear cells possessing a single kidney­
shaped nucleus.
The former class forms the subject of the whole 
dissertation. The designation, polymorphonuclear 
leukocytes or granulocytes, is not specific to the cells 
under discussion since it includes basophils, 
neutrophils, and eosinophils. The accepted term in
dealing with the specific cell type discussed in this 
project is the neutrophil leukocyte. It is the most 
common gr anu 1 ocy t e accoun tjngfo r approx i mat e 1 y two-thi rds 
of the white cells in human blood.
Morphology
The cell is well identified in Wright-stained blood 
smears as having a mult i lobulated ,dark-stainingnucleus 
and a pinkish cytoplasm filled with small granules. The 
cell diameter is 10 micrometer and the lobes are 
connected to one another by very thin strands of nuclear 
material . One of the most unusual features of these 
cells is the striking nuclear shape. The molecular 
mechanism for the development and maintenance of the 
divided nucleus is still completely unknown. Metchnikoff 
suggested that the unique structure of the nucleus would 
facilitate the passage of these cells through the 
capillary walls. A notable feature of neutrophil 
ultrastructure is the rarity of organised cytoplasmic 
structures other than the granules. The cells seem to 
lack a nucleolus or ribosomal aggregates and have little 
or no smooth or rough endoplasmic reticulum, .a small,.,,.- 
Golgi apparatus and few small sized mitochondria 
(Thompson, 1977; Laszlo and Rundles, 1986).
Granules
As lias: been mentioned, one of the ___
distinguishing features of neutrophils is the abundance
of cytoplasmic granules that are usually centered in the 
cell. Two types of granules have been identified in man: 
azurophil or primary granules and specific or secondary 
granules (Bainton et al, 1971). The former comprise
one-third of the population displaying primarily 
intracellular lysosomal contents while the latter are 
more accessible to extracellular release. Primary 
granules appear first about the promyelocyte stage. They 
store the majority of the neutrophil's potent 
antimicrobial components, hence fulfilling the 
requirements of the cell's role in host defense. 
Myeloperoxidase is the protein that is responsible for 
t he perox i dase act i v i t y , charact er i st i c of azuroph i1i c 
granules. In the presence of hydrogen peroxide and 
halide, together they function as the cidal mechanism cf 
the target cells (Klebanoff, 1980). Lysozyme is a 
cationic enzyme that has been shown to kill certain 
Gram-negative and Gram-positive microorganisms via 
enzymatically hydrolysing the bacterial cell wall and 
also by a non-enzymat ic mechanism; - .though for several 
years it has been proposed that the primary bactericidal 
spectrum of lysozyme is limited to saprophytic gram- 
positive organisms such as Micrococcus and Bacillus 
species (Salton, 1957; Selsted and Martinez, 1978). 
Bactericidal/ permeability-increasing protein, a 
cationic bactericidal protein, exerts selective 
bactericidal action against gram-negative bacteria non-
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enzymatically (Elsbach and Weiss, 1985). The polypeptide 
isoenzyme cathepsin G, one of the neutral serine 
proteinases,exhibits chymotrypsin-1 ike esterase activity 
and has a broad antimicrobial spectrum of act!onon gram- 
positive and gram-negative bacteria which is independent 
of enzymatic function (Odeberg and Olsson, 1975; Odeberg 
and Olsson, 1976; Shafer et al, 1986). The major
constituent of primary granules, representing 5% to 7% of 
total cellular protein in neutrophils, -s the
antimicrobial peptides, defensins (Ganz et al , 1985;
Selsted et a l , 1985). These structurally and
functionally homologous peptides are small (Mr 3500- 
4000), cysteine-rich, moderately cationic and identical 
except at their amino terminal residues. Recently, three 
carbohydrate-free defensins have been identified (Rice
et al , 1987). The proposed mechanism of antimicrobial
actions is._ by per meabi 1 i zing the inner and outer 
membranes of the bacteria (Lehrer et al , 1989). The
spectrum is broad including gram-positive and gram- 
negative bacteria, certain viruses and fungi (Daher et 
al, 1986; Lehrer et al, 1988). Most of the primary
granule products are released late in inflammation from 
dead and dying neutrophils and may have important role 
in inhibiting the extent of inflammation. Thus, in 
addition to amplifying inflammation, primary granule
secreted products may be vital in   turning off
the inflammatory response (Gall in, 1984).
11
Later in maturation, the synthesis of primary 
granules is checked (Bainton, 1973). The secondary 
granules rich in glycoprotein then develop and 
predominate in the matured cells. Even though specific 
granules contain lysozyme as do azurophilic granules,
they also contain characteristic components such as 
lactoferrin and vitamin Bi2 -binding proteins. Specific 
granules are readily mobilised during neutrophil 
activation appearing to fuse with phagosomes before the 
azurophil granules do (Bainton et al , 1971). During the 
migration of neutrophils to sites of inflammation, 
fusion of specific granules with the plasma membrane, 
accompan i ed by re 1 eas i ng of cont ent s {- or he ext race 11 u 1 ar 
environment, t.akes place. Lactoferrin is an iron-binding 
protein which may block bacterial growth : recur i uy; j
free-iron concentration to below the required level 
needed by all bacteria to proliferate (Oram and Reiter, 
1968). The protein has also being observed to facilitate 
production of hydroxyl radicals (Ambruso and Johnston, 
1981) and may regulate myelopoiesis (Broxmeyer et al, 
1980). The role of vitamin Bi 2 -binding protein is not 
known.
Origin and development of neutrophils
Neutrophils are produced mainly in the bone marrow 
at a rate of 2.5 billion cells per hour from the 
-precursor _    cells. These stem cells are capable
12
' 1 ' - a  ' , , i ng to several cell 1 ineages and in vitro
were termed spleen colony forming units (CFU-S) 
(Quesenberry et al , G,'/? d Different < .r <• - i the CFU-S
leads to the gene m  of the precursors of matured 
neutrophi Is , Rep Rj.i' ,i of pz d < ' f ■ ative act i W ;  of 
these stem * I 1 . n o _d to several growth factors
v "V nJ, '.r lei a 3 whilst the production of 
neutro driven by growth factors known as
granulocyte macrophage . o i o j.y ; t, ' e <d,<, »,< . r-d.tor or GM-
Mve iodI ast s i This is the earliest morpl» f o a i y 
recognise cell.., of ' the series, It occurs in
normal bone marrow co,-( t - < ud to 5% o* < {<* tfitr
; o-md in u z  o r  Iri in
ifocc.V' rfatnu. d ,/< • b < ■ I <j >,«< - . unnd vjiHna-, tear
n z h  g  Di - ! ,s f" iwD'j *i - nir o die nu> Jz a,'., in In vdrs
stain smears. The cyt yd w r«»nln i *« nrrrrr 1 i n
structures that have staining a m  id tj as true l <n ; i 
char act er i st i cs o f azun > p i d ) gra "die, The 
iiyo » o{ >! a st firr old o r  < i es into a promyelocyte,
! y  .igndf yt,< >o, Mo. ? , | i 1 n ?ff , ,inge are larger
  wvm J id j I a. v(. m/ {; , numerous azuroj «n < I i r granules
«n i he cvl op boom and ; m (ho region overlaying the
nucleus, However, these granules are quite distinct 
from the spec n e u t r o p hi1ic granu1es.
MY,§,1.9,§.: The succeed the promyelocytes,
Spec t  t ' hiue-brown neutropfaillc granules that 
with peroxidase appear during this stage. 
Myelocyte maturation can be subdivided, into several 
stages. The two known stages are metamyelocyte 
( n Juven: if'”) and band (stab) fo the latter
stage, the nr .cos begin; < - jgate, icl,, , * jd
1 ' f ; i t * * * <> terogenous nuclear form thai pc es the 
'band ce; 1 its name. Thus, this is the first of a 
neutrophilie line that can be regularly identified 
in normal circ sd .
  ,C,§,§,Sll§Iih.§d).   nejitx,op»h. iil s : These
cells are the end product of the granulocytic
The nuclei
are segment' > ’ < ’ * *'o or c , n  r,p f / r - ad a, ,n 
reveals great numbers of oj -or 5 « * >. "lanulco slot
fully mature £ uric > j. "ko'*'d > ? '• s eoOy f
ho m i cake the task of corn ho* h o ,
hr 1 » ' * , (< - body.
' f a * ■ at ion and i»do o/ war ore neutron fr ' *1
To » prolif? i d iv* ' n >,m of bone inarrow contains a
k»MO' n-forve poof < h c.f o  r r,. b r#b,s kfii , nn pe­
rn *!. i ( j o , < m ' H / ocf n> oo > c diji • oo f he s' on c of ,* h > r
or Ui infection. Or * mat a o iruilMjphi Pr euror < hr
fn » irherai biond, It ?)1 < d t bo piwuf ii \< n ws j I be j n
cir< m[ ,f '',i • ,c vother half adhering to the endot f*o: im
small vessels, marginal ion (Cartwright et al , 1964),
As morpho1 matured neutrophils move from the
narrow reserve pool to the circulating pool and 
equilibrate with the marginal pool . they acquire then:'
q t; res t f unc 11, ona 1 capac i t y , 'Hie na 11 - i 1 1 e u i i.
neutrcphiiic granulocytes in the blood stream is about 6 
to 7 hoars (Athens et al, 1961). sheen the ceiis icicive 
r 6e vasculait space? they migi'ate in no tissues ceoi e ifo.y 
perform their phagocyt ic biiiict: ion oi tb In a ,t i i  ££.It
..... Generally it has been accepted that exhausted
neutrophils meet thfo t (c c  in situ since there is 
1 vidence of their returning to the blood stream
from the inflame or that the lymphatics provide a
major disposal ro-m ■. (FI iedner et al , 1984; H'o-o/t
i'*P ; > , Recent 1 ' ?. o? oup of inves* i >, [ o/ s bo,, cfioou r n i s
with time, o- ceasing numbers * h u •<< < oiiu i r \ g* •
characteristic fiorptr * P v »« r » ; cy • , \ o }' r * * *o ' d «,
progu <i d f 1 P or apoptcvo < vre orocess leads to
reo 7 11 ,ou Pa fMic rophages of senescent but structural ly
and functionally oo.ct neutro>> ’ ' ,9 P  et al ,
J t , Their o'o r /.m »- / s nay therefore represent a 
M' o 6 (Uism of rwuojJds removal that * o s,w 1 < /ely
iirtf,o f. ,fP if f 6 i i ,icl‘i‘ ion of inf lemma > i n a/of 
I urn: i ,, k, i C-! a „ injury in acute odd ummcAo/ v'
reactions ,
M e t  a b o i l  i *> > , m t r o p v  * hr
<> i i ,ay, glucose as an energy source and
store glycogen as a reserve supply in the cytoplasm, 
dr, colysis is the icoo energy production p u fu-iy as for 
e o o, ,, in phagocytosis (Sbarra and Karnovsky, r oi
f d iae, ; 9 / *> . The phagocytes do function \* f [ in an 
anerobic environment t bus enab1ing t hem t o contro1
b . ' * f 1 7 u ( - " 1 \ * )< w  cle m i  u p  dele • , o < , crot ic
. Jury < t I ' i o; \ > j  O , ipply > >' i < » -  ■ , 1984). Dill" Cl.'
phagocyte o tt i f o ygen uptake is increased
along '* i , i " acid production. k i • s > ' ( of MADE
oxidase ; - o » ,** largely respon s r j •- for the increased
al - i < of O2 (Stossel f > ' o Produ- r . » of
hydrogen peroxide ensues in the course id neutn ■ • > n  > • >  
metabolic act - < > ^ i h  f r u  t o/i a/ jo i • > < u
0 1 ; fa < /C pho rtf '* A * ro' ; a morn *0 . A ut et-'-r-'v
product ion;
11 f ' ' < cr o ' ci us i! 0  < ’>< > < i 1 <) , . ‘on- »h' '1 b 5f.
6"'”'a ! illy 1 P ' I'' < /1 c at/’ •>/(chccp a, i-f
:o., r yfopinr ii on f I* .m •/ 000 oVe , "/rfi h* ro , *1,0 / do,
however* € oi- f «* < ' r-cio' i s  and rapid turnover of
( t{ 1 J < *'p ■ 5 P ' s  l l > , i fur piupox y I cro , ■ iv 1 1 >0 ; cl. cl .
I ngp 1 ,
Ad - , #VO p 1 < n it ail ropy / .
In in fj uMiu.ut ocv roi/i J one neul ror * i 1 f imtd ions 
ffwolvs* 0 secy nrurn of sicro os i i sled ’ -
A) 1 >> rence of  to capij. j.ary endo} - ■ -ex
is physi o1og i c i nt eraction ex ists between 
PMN and the vessel wall in which about one-tenth of the 
' f ' a PMN pool emigrate from the ' odstream every
hour by adhering -ede j ,cross the endotI < » *m
h * .s et a!, >< I /. hr • ; r?ing local ir Pi^y cells
adhere . * < he side of vessel wall near^c ' o ' , c a
f c ./ but n i - se undamaged endothelium in the 
vessc' • or i ' cm when they are occasional - r> r , Iged
a * „ ' These obser c ; * n.s suggest etc
endothelium adjacent to tl becomes more
adhesive. There is a posf 1 > ' * mctiona 1 alter"- >■ in
endothelium that promotes adhesion even though sp* 
morp 'i j r n  rat ioi r n c c not apparc ' r- > >rey 
a**'1 <'t ,, ■' On treatment » *' ' »cb • ' ^ t. ;i 1
or tumour necrosis factor, V£ - Or : >*, ,» j c in d , < ,
more • * " ' y for leukocytes ,4.c c ,u> t c • » ' o . -o
aiotnr ' 'T i - >, molecules such < > > > , * 1 j 1 a
ach^’ 1 f c - 1 *'.ule 1 o o » or ends c > _, / -< j c ,r vs «• 
adiiucion o " - 1 1 r • c,_i id by several
invest igat*. ' • 11 c - < > ' > 11 •' • , 'ice s ? 1986;
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> 7 , / * ' < al have to a certain extent
shown that membran j , <: ' . ojcw; '< ' deed
PMN adherence and extravasation in vivo
(Arfors et al , 1937), In their experime , monoclonal
i ,i , w dies; recog # v.py were injected intravenously
. *' r ' <' ch n  i ' j ging the y j , . - >'• response towards
chemotact ic factors that were injected i o \ t  aderro > * \ y .
Cell accumu< w -on  ^•»* PMN-dependent plasma leakage were
r * « / ' i in the inflammatory skin lesion. 1 *' < ' r
liicroscc.;*/ -d «abbit muse 1 e reveal' - . ic! '• • *< of
adherenc' - * " u*< les and vigftd i v . i * * ling
the aj ! 1 *- *' of leukotriene B4» FMLP and zymosan
activated serum. Rolling of PMN along the venular.
endoth' » t '-as found / un& * -'' /‘. Basal expression
,e 1 ' ' , ’ < n on the neutrophil surface ? y
import  ^ neutrop • ' attachmeid 1 tv < ih't 7*
■ 7 ' ■ < - i» 7 ‘ ( ' s , : ' ' , ;v etc, /». ' 1 7 .
I V 1/' .
* V { IU 1 C ' V C  V C ' !' 1 V' ' ’'
Once ad' t, PMN will undergo shape changes and 
act i ve i y from the vesse 1 £5 through t he
gaps be* w ' ,i c mith if. i ?,, f ' 1 *. rchesi and Florey,
p /' f ) , s»r' *> I 1 <it! *, V I f j «) 4;X ,f n 1 ‘ *!"> *, f V I: / '! i) fh •
1 ame 111 pod I. n t he? d i rect i on of 1 ocomot i on so t hat t he
cel 1 becomes elongated with its long axis parallel to
» r , f r' > i u >/ 1 v '!* i ,'4i F ' - - ( 9 * >' i f • u ; m |'f .P v v ;
1 1 1 ' <1 ' ' >5 by the f ' MKOcytes have been
' umented in vb so where the cells were in
suspension w * s f Dut any effect of a contact v ' t! s.bivr 
substratum ' if- et ai, ",T . H  o - and Has ton, 
h';,c>, } ; is known that neutropt r- in suspension can
become polarized and that they are capable of pe< io; rning 
the same crawling-type movements as cells diapedesing
0 i >m the of > >d vessels into the injured tissues (Smith
<, >1 * ' 1 t r and Cottier, 1981), The d 'ect s on of
iiigi r c m  can be determined by a gradi o (« x imotact ic
factors . This mode of direct ionai
r cl ’ oq accounts for the accumu 1 at icr - * 4-  ^ » tt*
source of gradient, Besides the presence of cherootact ic
1 t ' ‘S , other meet -n ' rms nay be operative in the 
accumu r d son of PMN at id p-t minatory sites. The
polarir r * m, response 1 PMN c rC v-sed if' more detail
' / , o n /is ; p » uis between leukocyte behc, , i. u i 1
suspension r - / 1 puent >' > i l r a, r ,coni •* ' - j- o
5 i, , t( < < f r, .u i>f t( ; -vs accurate pre j i' i »- «u of
tlv • note' ' i » I ' . ‘comotor responses of the leukocyte.
Havi or ^rrivec, o ' ; invasion .' * * , agocytes must
recognise wk it 111 »J « K <' td demon'. ' rema t m-
s,. y , ? i / v of, n stvu mu *, i'. r n i, < r fk c oh, » f , r < / b
as } /  . <• ,i I C , (it j< *P < I , \ ' in i,i f | y P
,,,-u r i < < • |o ch c' s •< \ o; ; • < < n to v* j c k rP . u>h m< or'
on ins on the surface of object 55 that they
' f' t* osse 1 , 1974). The consequer*- ' < recogi j c  on
O- r • ' coated with IgG and/or C3b via th- . b s d
G3b receptors is the i n i t i at i on cl .or, * / 0 nt by the
phagocyte. When tfc b comes into contact with the
* a sin a membrane the hy I * > ectool -i,m extends to form
pseudopod i a . The 1 1 G aids of the pseudopods / , 1 illy 
seem to fuse so that the object is inter ed by
« 1 v ag i nat i on and a phagocyt ic vacu< c '• ,,, ' b y e  vie is
1/ -ted, Interaction between opsonized par r * <  , ..-id
r ' ; sma membrane ai so causes activation of e ,e
in of the cell whereby a variety of oxygen
rr . 1 hich have strong b ' » tivity are
formed , 1978).
jranujat.ion
Concoiri ' ,m ' , the membrane of cytoplasmic gram7 o
come o-'* m  t ,• f m d  fuses wi: h / 1 m  phagof o.*s< *
} /sos* »<•' - ' 'he corite r ' * m  armies, most ly
pr ot eo 1 y t i c eim / v " wo,* 1 ct er i c 1 da 1 act i v 11 y> are
I* ! i * t into the phagosome mi the surroundings
rp ..'.Pi (Sit os' ' >, ' » < • Uf proce, 1 , . known as
degi f r ! since granules are no longer " -3
do ;creto st r ur-t.ii res in the cvtoplasm o  < 1 sdi and Cohn, 
I960). A, ) m  i »i M  'd m  lab a ' ' 1 G  m/ and <.r Id j5 '•. m
t „ I CO> f 1 ' < b • ' id , *) K -i I 1 II gl i!< l|! j f d t I'd f 1 f 1 ! i a ■ . the
V j, Ij.t i(,i, , G * a e ) f‘ie! { ft * o G M m m *  , 0 <jf d
S 1, / e j j -1, > [ , 1 i, 1 * , f ' »i , I ' > /i > t on 11 |ijr i f y u f I G~ ee> d
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probes .have been .. . 0 there is no clear
consensus concern, i rig pH changes in phagolysosomes, 
i , 'o' «' it that the pH rises v a ' ast 8.0
w minutes after phagolysosome format ion and
it 6.5 within. 30 minutes (Segal, et al , 
St ! ; f ✓ « ; 1 , 1984), Subsequent i d * (O', , primary
II fuse with phagosome and release their content .
■ * ' 1 j nr and '< < » - - 1 take >>t e within, the
phagolysosome.
E )   bact er i c I act on
Coil*. d ;? • > * >• aese dynamic events, a series of
>' ,r > changes occur that result i< ' -i 1 < ..g of
if '» r.ed nicroo- r * uc'S, Mfr.r < - i • < y can be
divided into two major categories;
(!) oxygen d t m. • !<"'* * '-a * • tat rely on . i >' ''
1 < \ \ <‘ < ’, 1 < ' - - of ’U" m . ales w d , u * , t the
r burst,
(ii) oxy ' u o.'! ' ■" - 1 mechanisms rssponr d /;o
kilf f c ; i > ‘ ’ o . -' t or iit - it where the
o >2r - mechanism is itr *, u ;t or -d-sent. 
Lysozyme, defensins, ar. f t >,,3 are the
main weapons in 1 u r ' * - a - o  c  < ,
The respiratory burs to an abrupt increase in
oxygen >< ' t >o;a ;'h \ ' v < , • wd << rb(4 in- :d »mu bn ><i
( ' j 1 11 i vt y ' j t,' O <4 f 41 t 'W) 14 > ; j f / '* ' ! C , t' 1 '11
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' ? - i "> , - ' . Within seconds - r <■ , ,, o ' . -, oxygen
uptake increases and large qua: es of hydrogen
,<>>>'' f -> c , ) and superoxide (0“2) ares release >,< _ 
the surround! 3d imi, At the same time large amounts
' f h- »< < c , r ,f f '/ the hexosemonophosph "t “ ♦
p > f • a ", O2 i" ■« si re"d* from the
enzymatic act in n of respiratory burst oxidase.
Through the foregoing sequent m  , •r ' 1 -a, re'-, o 1 it 0123/
burst oxidase a « ' utes r • i. , ; < ;ts apart from
- t' " 0**2 or H2O2 which are products - further
reactions involving these two compounds. Two 
reactants are formed by oxidation of 
o,, 2 ,, < 1 as radi  ^ H2O2 + Cl- n o d  +
01“ in the presence of it 1 . se (Andrews and
Krinsky, 1981). Hypochlorous a - ' d  n o - med 5 i(
' ' * ’ ' , ♦ / , mi r*r ,V , * ! <A ; , - r but U d  O-, Cv ‘ , ,
a> i or s o in the .r ,'ny - ,r r ’ o' *- •,,<» r. oc t ..
f' , m • a v/c c ; . * n , .<•<> > ;*» i d  it \ o r ,- , <■ .0
r r : - i Coir ;'! - .ib( 4 ,r t o f • * a- ‘ n 1 * 02, s *-t >*
p, i <r . f ' ■ ; ' ai.o ' 2 1 0,0 . n< r , * t ' r : r.rt to
o J , ! o /J i ) t > ' > 4 r  f ' r , , p. r  » . iO i'h < r o j 1 0
,0 < • /o . . Ammon i um ' to < ro ,* /, ■, o- fr, o.,• • p, *• on.
it< r [ * /1 ' '' ' (O'1!;!. 0 * 'hi- -(J < O, m ( . , , , ,,
tu< 'os!;; > 11 s f s no 1 o 1' 0 •'» 11 1 f i r ' f ' *< o < - 3 i * Oft, i*r r, t . r .
14t y 1 1
O' * o *1, H !'M / ' 0 ? i|i 1 "! » / ' !*i# •) in jU I SOS (Hi f it. •
, H 1 o | fl.u, in- Oof O' ( 1 v - ^ 1 ' - oi I vcr; *0 ; , ( ’
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other hydrolytic enzymes, and proteins and peptides that
bind to microorganisms and disrupt essential processes
or structural components (Thomas et al , 1988). If PMNs
are successful in engulfing microorganisms they are
usually able to eliminate them shortly after the
ingestion via oxygen-dependent and -independent K i l l i n g  
pathways.
Neutrophil functions
The main functions of polymorphonuclear leukocytes 
in the host include resistance to infectious diseases or 
immunity, and production of inflammation, necrosis and 
fever.
For the first role, clinical observations indicate that 
neutrophil maintains control of the "frontier outposts" 
which interface with the microbial population. A steady 
flow of neutrophils into the areas is necessary to 
sustain this control although at times the host appears 
to be able to tolerate prolonged periods of markedly 
diminished rates in this flow (in neutropenia where 
blood neutrophil concentration is below the normal range) 
(Dale et a l , 1979; Kyle, 1980). The action of the
neutrophil as an essential agency for protection of the 
host is best evidenced by an enormous increase in 
susceptibility u  sepsis of persons afflicted with 
agranulocytosis, a clinical condition in which 
neutrophils are conspicuously absent, and chronic 
granulomatous disease (Bodey et al , 1966; Quie et al ,
1967; Malech and Gail in, 1987).
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serve some functions in which 
- ■* i> ( it;-,- m' t < , < - f > not primarily involved, In
inf 1 ami/ ■ y reaction , r' * »■ • c h-'ermine the
severity or the production of i \ or- j >n itr, = ,'i , The 
same o *' ' ' &  mid non-or i /1 -» yo processes that are so
important in clearing up ©organisms can act on.
a - i I . i  be inipcr ' r . , r ' r. *. pathogenesis of
a number of non-infectious as reviewed by Malech
a ‘ 1 - > < "y , ft ’ > , , - ' , gents which are known
'< » 3 - , us to neutrop' emselves may leak out
closed phagosomes or even be secreted
iii actly into the ; y - > :vironment resulting in tissue
destru ; .» \ uehner < ; © , 1977; It ; *c, " . Pyrogen
production is activated by phagocytosing bacteria or
endotoxins eventually giving 
- - t <, d ex' ' ' ' wi n , j » r , > , .
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Section 3
Loukoc ot i on
One of the most < * 'king property'- 1 < - 4kocytes
their ability to crawl about on oi • «d vessels, in 
tissues arid on foreign surfaces, Emigrat ion of 
leukocytes into inf lam,a.-; " ry arc r  'r of the most
fundamental e ' > r < patt'u I cgy. Tin- ' o i  ? goal ly begin 
movement by sending out a new pseudopod. The rate of 
Promotion varies depending on the ph;": .'■=*» and chemical 
nature of the environment. A response to an 
environmental st im»-; .<«} takes the form <ih o ’ racted 
oi H'/o.m f it ' ills') or undirected in* v 5 ot. (kin 1 1
1ocomot1on i s a process invo1v i ng
cooi m u  , >n of a large number -3 mechanochemical
events.
• * that leave i b blood and accumn rb ' »«*
-o' m .is-' »,*y C' . must have locon ** capacity.
Leukoc * > - ' f  ' < **s may be , *-!• • ;  , <  . <>i , ' o . but
' ' <h f .''O' it dur *' 4 ?ii.f vration process
o . a ‘O '> A !tf 1 , f > y with the :iv sc i *ph s '•
‘ t- m (p rinsic l<> -u'< \ ■ $ i< ! is observed to be
 ^ f)u' w A dui * p > <.,,({ u ion * « ! m bone? marrow before
leaving for the bloodstream. Fontana and ' im i.u'tv
report' <f c f f nre -r1 f P  i om
normal bone marrow acquiring an incr; »,vd uf
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c as they proceed with the
/ - ", '• » ' < , ■ / ' , 1980). The promyelocyte
line HL-60 which is non-mo , acquired locomotor 
i as shown. by the increased numbers of
chemotactic r , s r-< * r , .riticed to maturation
(hiede j. et al , 1980).
Mam €icm
T < o 'in of mot ion is random . section along a 
p.'' n - the a: * o c the / *c '  ^i1 is not oriented
towards a stimulus. .kocyte is tracked,
the r; walk is not typical Brownian movement but the
p <; b i r smoothly cure ' * - c - I f 3 . • ,,nd
Wilkinson, To , , , > p, . , - rounds up and
starts off again in a different direction.
Chemokinesis : A 
random s omotion. It includes 1 *• » .u ,o-‘ c a ,
cues t ...... ... .
but not
The kinesis response nay be of two types with different
< - p  a- c *, 1 -t - ! i' < < * m j 1 c p a  . -I . (11 i , , / . . ; poan i ng
that the speed or frequency of locomotion is determined 
by the magnitude of stimulus. The reaction is simple as
! 1 -1; a .,' 1 1 b ' 1 > ' h <'; c 1. ■ w . . j , 1 ( . , , 1 ( 1 r , / ( |, |
« 1 \ij> « • fd i Of < - ,• ( y < ,)> .'\i \ A <' • >p < c ''ii\ i i 'Apdf o
> <1 1 bop j , / • u . in , ‘ O ; ; . » ' cy , j r ,, t snf.;; j j, ( ,{, , |nr - < >„,
1 t o  1,0 , As H*/i! of speed ' A D  * 0, ;om < u n I J w? p ; .
KliJ i i r  ' i in the frequency or
( (i riing r irmined by the magnitude of
; ! - i s v  ' - : ,f 1 , r r i!
it seems 1 i ke 1 y t! / a - - , * > , i cws a random path
with plenty of tut
c:nan once: oi ceils following more pei. si stent paths;
uui:re::cL cis ana haston, 19 Bo), Changes in both speed and in
t oreri rig are n°i restricted to chemical stimuli only but
13 a b . ts e 1 n cl. u. c i D 1 e b y t ii e e n v i r o m  e n t: a I d h v s i c a I. 
proper!: ics .
When present at uni form concentration, leukocyte 
u' } " ' - ■/ , can stific ,r y, oinof ion. Leukocytes show a
’ M  * ent f . a y^ffii walk1 under these condit ioic ""I
and Wilkinson, » /oe„ The speed of loco® ^ ' is 
dependent on the con c1 ; u,b® of at: tract ant, thus 
. !' ’C f ' ' L 'c Miotor rei.' > '< a to lo, > b ••3 I ; •<: a:
orthokinesis. Klino) , >u m-- * o be 'mo*' 2 b I.’-
y * > c,-c ' - , erved lay K-. h 5 -c , , : ; t '»«,< ;•. o /. n '
1 ' f > d' * , , ' , - J - « < , _ j c j t1 I fj'O
- ..a • ' ' can . \ \ t t. ' / « ’ " 3 < c:i»f
V m t • nJ ! ' 1 > ty > <1 •<, - »4 -) , ( ' I / c,>/ ?c c c i * »< I ' >
< / 1 \ < ‘I >'*,'> e " y C  *c l!C< 1 f I »g Cm C » ' - C i I*/'
it® r ' ! M- * ) i < ' ' \ A c > / h f * ; t (;.;f
i < > * f !i cf ® ' < ' ■?m a f *i id b - *1 h . ‘i ; ,y * > : , i c, h > i i ■ * m
« ' i i c' /' * < ' t : i > i j : : ' c ’ > < - > i c ' i ' ) - i ; a *»I 11 u | f l / !| a * * *
c ! I ' O y , ; 1 {, / f U < / ' J ! » ' «U I * ‘i ji> i ' ! I? '-at . M M  (
i > f ( iu um i <i< '< (. ■ :> > cl , j. < ucm r i! O >c < i! -'all copy j.i M  aa
\> l ; ! Jh h t (' ® * M  Ml - f'.i i , f » S' or* « 'O UI 1 1 CVi f, I i, 11,
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of chemotactio cues provided that the 
r r v '• of cfaemokinet ic agent is anisotropic 
(Wilkinson et al, 1984),
f i > ' ' / / *n it ion
Is l . mode of m > „ i denotes a preference for or
a •" once of particular ' rs, Two responses to
environment are; knowi - cause » jctional locomotion in 
1 -icytes; chem / 1 . contact guidance (Wilkinson,
1985).
t'- r t  - - » . Thu is a spe< . form o, locomotor
r i the respond! list
cell becomes oriented in, moves tip a concentration
if. In isotropic concent rat i on 
the same ' . ' , wi ' , • ' r' 1 acorn*'f c a through
similar bn /■ , „ , athways but the novt >»• r is random
in h ‘ '1 , '' r-'ond, i , . . Leukocytes most 1 i* r 1 *,
will not move nr; . < , , ' < L p < n ‘ f <(l <=*vt prnal
signal. Blood neutrophils if carefully purified remain 
? 1 * 9  * i 5 i ' » < • ' ' r ,, ,♦ ( .«f i j tor .i- /J
than 95% of
'9 ' m! ■ up ♦ of <f r i ; ’*1 locomotor morphology
vHffin if r riii't ,* • , - urn »•.< ’ •< ■»! , 1981; » <9 1 and
If Cl • ' I f J U,V> i , t. | if* , a . f ho-"' t f
a *'•» o> th* a ; , / i i ; • -n i mined lay the ant > >•> *' ' e „
p /I n is r f c / * us /i;i and sr9:,c.jo "9 , *,« > <o n * on
therefore cannot be the responses '*> , ^fohrfd pci se.
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A v  oi the event then is that the?
e- :> 'osponds by polarising in the no or; ; vi of the
f i rst J, • by 1 i gand on cond i t i on t hat f j ' nd
concen i > 'o>< ; <' <w enough for cell to ; ’ A , e 1 »
between the first and the subsequent A t  b 1 varsh
c is isotropic, the f irst ligand hit on
•ent ' ' * , c- , o will be random in
r - *n and so will the polar i , - i ^ . reaction, In a 
gradient however there is a greater chance that the
n the side of t;he ce 11 facing the 
gradient source. As the gradient gets steeper, the
. . higher- the occupancy of i eceptors by iigandr..
presenting - o ‘ '-her chanc. ' - , < t and
m o v i n g  t o  w a r  < - ■ o.ree of g r a d i e n t ,  O'ce t h e
m a j o r i t y  of t h e  r e c e p t o r s  a r e  n o w  i front
p o r t i o n  of t h e  cell, the ' a i n c r e a s e d  c h a v  <2
f u r t h e r  s i g n a l s  b e i n g  r e c o g n i z e d  cell to
cont i*'"' - ' ' r v  f o , - r . » ' i h< sotr - ' n* j , f , n, ,s. ?*
ai'/r " ,v, c v  , ' I" v. i j is n o  A uui ,n ' •« ' ; b a,
behci / o .:!)•( ! '<'U' ‘ on/ for cel 1 o< ' c o o  r o r rc v  - b v
l b ' 1 " ' » i » i ' a } , , i o r  In > h i out F' v'n , os! -,
to- h I fvia d','/ : i «
Ho, f r I g>!VV<; - ♦ ) ( v  i O h M ,,fV  'v rb'*f,o*P rtf? fl
1 oc' mi* h ' r i ( ' :c>f no- o: et i h ' <,r- d h o> * ox; i>i h « m.h! hhi
f, a > , i o ( o o ir < fjo • I' g < n O'l" < he.i *,i o, s i»* - a <* I
the oh t r<, * sio vo ! A tin h w  v  / , hi o o t ■ c h (i t v
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The mechanism of io«n of directional
0 comot 1 on is not well understood. , r > ostuv; A  to
he depe ; on physical features of the environment
without requiring any socialised sensory systems. Cells
1 / ' T ■ _n gels are constrained '< , move only in 
o> , , iis (the a: r , ' .ment of the v ' ; t free to
move in bo> I; -,o -ctions in that axis (Wilkinson et n 
' ' ' . T‘r- ii.nii r 1 « ; oving t h r o w * r  , y. ed * » ,
: ■ otactic grad i ents is inf1uenced by
t merit . Better responses are seen if the axis
- »i * i" or ' ,1 .3nt is . -  I to to t
cheer t .i ' r ' <. ,r -i Ikinson and Lackie, 19 , : r is is
a - ’*i * > ' -1 - r '* i > * < - tissue patterning on
the dire? ' lo< » „• « <:i . More complex t issue
, ' ' • f *e wi 1 ; - ose constraints on '
1ocomotion in vivo.
'■ , i1!/1 /> i si r, //, -o - V' >,wot ion
Leukoc " crawl
Host
are rounded up with a uniformly ruffled
fv i,it !i • ; v , ' v *, :e of an o<( u •,'<?<? r ,, When
’ t-f ur»! f oj n < , •>;.). ui o- v,- • «" i perturbed,
pr ot r h ; v«i • -1 of a h • < * f , e.. ».. . <-> 5 ( ve i 1 or 1 ane 111 pod i um >
can 1ocomotion (Ramsey,
1 ' - . !dti ‘ 11 i 1 ;p-, > irs to be pushing
forward remainder of the cell seems to be
p1’ i > - } forward bellind the advau' < io>, w m k is in this
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region i that the cell is most adherent to the
substratum, Thin-sect ion actron micrographs have
revi ' the absence of cyt- t * srnic granules in the
hro i ne ' - , , - . of 1 ocomot ing leukocytes (Fukushima et
' , •1 tb) . Instead, th ' a <>,< structure of the veil
ro.de up of r >  , r 5 * > rents and changes in their
a ' i 1 ture account for the i:m' , « < ,1 shape changes of
s rear of the
moving cell meant* :is a knob-like projection
1 i f < ,i the uropod or * rtiere capping takes pI.ace
(Fukusn. , ! A , * . a). . . " , ' j.
A variety 1 rids v r ; t 3 ' ich to receptors on the
external su t^e of the cell stimn - hese receptors
f. 1 ' • - rue , v ’ * f u , a phenomenon known
4 • 'U »mi , and Berlin, rj--u /.
Mot 1
rdies have
- ' ' ' > d - i ‘"ffi’ " o
t r  O '  l . f i O  p O t  " ,  U  H  I j K  I
I p rrn r r - f  ; I omen ce
CBoyles and Bainton, a - ; '< > r,* *.r and /numond,
1983)
O'
ular protein ,
, U of
cy
chemotaxi
p s e 11 d o p o d
Or
1 bought t o be 
out , , u • o the polymerized 
I in large quantities in 
:s , Cvt ocha 1 as i 11 li , a
1 O r ! ’ I 0 f C i r , * . b , j 
'f 0 I'.i!) of I if ' ov n  < ' 1 • \ i
> ; < o r n mt u. Vi* i K i J r
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to the gro'' x end . > '  < >•> ilech et al , 1977;
lydt et al , 19»4) . In the resting * , , we won Id expect 
a dynamic equilibrium to persist between the free and. 
bound forms of : entous act in with the
a- , iiditig y r , - s. Hence, these morpf * , ,
c‘ ■ , rear to be tightly coir r a < , c h a n g e s  in the
no! vmer izat ion " 1 act in with a change in the
• n.er in which, file,- . is tire organized in ftr * ol
(Scl: r i, 1982). In ' ' -> f , i polymer - a , ,n,
ide has been shown to cause
phosphory/ 1 at ion of no.,. a mu. . 1 oil pro.^o'
CFechht m  and 1 - a- ' Calmodulin-dependent
protein kinase pre c> w  > ols the phosphor3
r 1 - 7 11 , ■ in the presence of micromolar
of (-01 > ,• its • dt -,.er , * <ond,
; 1 1 fact, tc ' ' / with the observ' • ' n that
113 . ext«
alf.I98l), is suggest ive of contractile forces being exertec
; ' o f  r J- , - ' , , 'I r  d  o  - .
c via the
eg 3 in the
x i n  s 1-.11 o' m ( * » b n  } ' r. 'opods (Southwick and
Stossel ' ' * .
- ‘‘ u ; m i ,> 1 . i a< I,*- ■, a I t ,• induce ' ! a < in the
"'3 “*>■<’' 1 x ; .r > microtubules, protei ■> ,> - a,. .1 ht -■ 
ui * o.-c in nearly all eukary < , '< ctxb '■ if 1 u:
r»gf •, y., , of ub tiles are on- 'o up of limit 1 , f f »*in» ’> .* ji
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it' ' •' ' ' ; !i.t! c< ■ »fv:- -1 cell shape,
n <! ' i ■ i and mitosis. Their 3 e> .- i ' ,come' ggt has
suggest ed as indirect1y ev1denced f rom ear 1 y
studies using mici 1 », r agg. ' " ,v .'imts such as
> id v inblast inc. (u'elson and tnden < , t;
Ramsey and Harris, J /' ,, Chemotaxis, polarity and
integrity of shape of locoiioting neutrophils were among
those observed to be depressed or :l, A visual
study, however, showed that colc<< > re > * sated 
neutrophils reacted chemotac • -cd', , gradient source
' : < » d A* u m s o n , < of, 11 *, showed irregular,
err*' j r i' ‘ r with wide - ' ;•
‘ 1 • , / e, , / , Mi W. rOOffC', . ' ' '3- up-
gradient , Therefore it seems that
microtubules are not an c r n y * 1 ,5' merit f
locomotion but may cc the locomotive
c ... * -»n ■ ! ’ '3 ' . bn u w i  .-.I has h 1
‘g g -Mg i I-/ by a study u - ? u ' *. r * 'o P mg. ?p g j
; - i 31. ' . , , rni i ,( (• , -3 ' 5 , / , t . t* " ) ilM he
t •« ’ - ,' , ' 1 r* . >: p *,rw '► 1 s »{■•}». -nded p < ** 3 J
!' * a chemc u t - i i g u. »< , in- - P ■ ■ ;
■ ■ microtubules
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1 4
Met >cyte locomotion
' \ l i / r • 'd: During the 19th century,
many ' u * - < : wei , s 5 -£ leukocyte,  adhesion to the
blood vessels and subsequently emigration into 
t issues in Inf lammat ion. Many of these 
reported events were no* * i o ' low! r ' he inje n c >s of 
bacteria or ' iiiicals, In 1887 Hess in* d - ed
these techniques by a > ' \ < z anthrax bacilli in a
; D'-ss chamber w e i beneath the skin of the
ted animal, He then observed various degrees of 
' ;yte acci * < m  in the chamber ■> . * <». ut 
recogn < - . 1 1  < I b e i n g  a res-' * * chemot act ic
my-'. '< ' the / - , A year ' »' 7 1 b< t , using a
r ! ' . y ' ' <, > , inserted ' f e  I i try tubes
containing substances to be tested into the
; - cornea -f ? ' ' 1 . • . , n  <> i *
* » - ' ' ' 1 i ' r leukocytes intc / 1 3 m, taw Lw was
uncei i <)iii -air''her t ^ * '*>•» * n was due to
random r ? ' ' 1 * > > i> ’ c m  m  ' mm . In a ■*' ing
the question, V"5 - * ■-d*  ^ m< *•- > i -• f be corne, im- i
injecting the test substances and was able to observe
d j! ect ly no,! i vo m  i < ' ? i * in to the ' * 1 * i t
contc i'h.i ’ i r He j,» «»» »> m~s r fc,.r r. •, » > m»j * injmotaxis was
the woi f i r r > > < in bringing u .ba vi-,, , ,y, <,
» si i.nuttMi <*< o lesion and the m m  ; rue. ;•; (H Hr Cm'
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; is one of the important requirements in the
e ‘ ' / of cell rn-.j.., i '.it. The importai * Leber’s
- ■ ngs was well r c and recognized l , >y by
Metchnikoff, the assistance of his co-worker, .he.
confirmed that dead or 1 > > , were capad?- of
' " w> ’ ■ oocytes - • * - /1 ing capi 1 lary tubes
'i •/ ', fi! .ieal cavity (Metchnikoff , bVco,
Between 1890 ana ‘ dk), there were many reports <m* -
'/ . results ei : ' -,, , m  the same technique of
injec* >:<>• lest substances into tissues
y  tubes (reviewed by McCutcheon, 1946; Harris,
19 34), Several workers tried - r ,• - ' <o; techniques
but were unsuccessful. > ■ n- " a, '< c, - , c  y
h ' ' \ < ' , i ■ n ’ ' 1 * ' ' i it 'V *ent approach by
o ’ ' ' , r - , into tra - * id* > «d. d.
d observi ' ", "'iwi1 » ’ » t > ' n*j vr <i * m  • ? <
\ ' ' " ' , 1 r . , { I ,,l O ! ti’
■ ' ' ■ ‘ ' 9 o i f , O • | il 1' M-li 17
responses even though it was technically difficult.
Great care is required since any slight trauma is likely 
to excite leukocyte emigration from the vessels. A 
< < o • ty Oil/ i >/ (', <■' * t r t o ;c 11 t , f i/as
’ (hf , / f / f o ' < f o / ! i u O ; Cl OO- il 9/ I O f I 1 ’
(Wilkinson, 19823), He was the first to observe
h o * // /O' , O' n o r  > * ,o m 9 ' rot ' « i i z c/3' « 0-0 o ? it 
/ • > ' ' h 1 ' o  ^ c* - ' f so non *09 ;h!m' , fv ' 3*L< *o
and, his col" ■ 1 (McCutcheon et al , ; 1  !o ;.on and
McCut cheon, 19 36 >   t he > - r d covers lip
method of Commandon to obtain some basic qua ive
' ' on leukocyte ligr , • rt w f >. ,> i , < ainera
Comparison between random and chemotactic 
a ' n was poss < - ' ' ':ng t.' * 'Chnique. Cells
were fou ’ ' respond to a chemot act ic gras tmn -r a
( ~ i / ' m  ' '  a.' leter but few ’ ’ responded as;
t' C increased. T:ir ,. _ , nematography was;
useful in Lew studies on leukocyte locomotion
dr, '<<, > behaviou ' f 1 i , in the absence of a
chemotactic gradient with sequ s of changes
/ , ' ■ * ' ! , < 1 / -i rat neutro] *
w t/ first to €' , i : o i the typical locom''""
morphology - ’ r ' 1 1 , Ct / , i 'in rings at both
anterior
; " ,t" n /; >da f , ■ f 1 . c . / \ }j u' . > i * *
of f i * , < m o - , ; j ' - - ■ ' j-'.s sini] r  / w ' ?
Rebuck and Crowley devised a technique known as the; skin
((, f,'1 »■ r , tf.Mi-,, ' * i ' v ' j;, ' , /,! ' t ' , / */ ; y  * .“r
o / * *' i ■ / i • • * r ! *'./•' i *v s  with a
drill before
,;,|L, I', ■ r , i f { ' i </ i i ‘ ! / r - r ' r ' t ' , /as
. , ,r •>{ ■<! H I "  > l ' C " - * I : M on 05 O ! r !
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chemotaxis. Substances were separated from 
' < : I micropore with a p > < , ot enabled
the cells to squeeze through the filter during active 
in ' t . n , Cells v - cu ; * sett le on top of the
, ! '' r and chemotactic factor wa _ ed underneath
•v I i owi r - f - , diffuse through _ ' - a r c rence setting
up a gradient C Boy den, 6 0  , < - c r ' ui a
new era in s ng leukocyte locomotion in vitro.
Ce 11 1ocomotion is a comp1ex phenomenon very much
. i y the eiivi.roni/, ' 1 < changes. To assay the
phenomenon accun - • rr.» a u o  , qiicuward task >•/ Hit
di ' - > » ' <> < ' < ’<, rent contexts.
\ >n about a particular aspect of ' -o |
aioT* '• * "t nay be obtained only 'by ' v  b /’; 'g more than one
assay/. Me I ■ j «■ , i for st. i » *: >,»- o . can be
i i into two major groups. ' m i >• ■ ' :mp 
includes ’> ' " ;r ays in which a lor go ;
/ i '' ! - ' - ve in ' , " :e or abse' * -
s - ffn r or 1 , e • » ' 1 . * i '< no interval the
i. of the
e ' ' u / ' r . l, i‘ 'no : in ■ r, - < n i : v » - . m
o are the agarose and micropore ’ < > at, iys f .
.oi group focusses on -.-a n the o et>i ,
toehe ,u - /-ft <3 - .ch live m o ' * 61. visually. Time-lapse
' i h '< r r * i.o , ,/g . , « r o u  ir <' i ' * j g 1 m d o u . - 1 \
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a- ' - , * or fibrin inv ,i assay are the methods
o , wi category. " ' d * i t ai
be accomplished throughout the 
wr , experiment ' time period o, this of
assays.
M i c r o p p r . e _ X L .T! - * ;/<ple assay initially
introduced by Boyden is still among the most popular
assays , ' <t V  (Boyden, 1962). A porou ‘ ( f
pore i ; ' ■ ■re - i r e ,  , , permit cells to crawl
through * ' i ely, but i c > * rrough passively, is
used - » , ' l - r > compartm* a r e  ' - e placed in
the upper compart merit; ■' ! - ,, i u; ^  < L is in the
lower region. M o  o the at tract ant wi < se
!•» '0 ; o poi 7 t th * 1 ; '• t-><</•--"' ; o< . dient, thus
' j ' o > ,  's' ; f u ' ' ] by m i r' r ' " 1 trough the
partition ", , /- o Afto - : • -p. ; ' *■ i -< i »k
filter is fixed and stained. Three possible ways can be 
applied in evaluating the locomotion of these cells.
l :•< j*' f * ' 'O' , to dete i , ; the 'J • , >i
it hod warn
i i ) st o '• o' , i ' s s , r ! . -i ' ., find Hill, r, , ,
a .ond and Hirsch,
' / / , j o > • \ a ' a < ’ P ■ ' i 1 of f » ' 1 (me such
I j , r < !* • c  I C  ,s n> i 1 !- O'l' I C ’.'fO r ' > , j I ' M  V I  ) m ! o
d ' 1 ,'.ce through the 1 i H r  without - o >o ? i r:
,1 / ! , mc - . , , - n _ i a ,, i , <;!> t * i <i; s'o » u i - * » 1 '
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racked clown past the leading front of 
is then racked back up to the leading plane 
where the » , , ' two or more * -*! - . are * c - '
together in the se , A micrometer reading is
taken >n before the fine adjustment is
~acked up to the top surf a o tin ■ . to
re>^ -i i a second reading. To - » ‘ mce between the two
as a i ' • , i - 't J- - oy t he
lew ; ' t o; if-' * - „ * least five readings are
a J » < 7 nt } from each , 1 t , * is
^f,c ' . urate and reproo d h method as it is less
' nt on - 1 - ' - c ' ' i on the
L ! ^ , Another advantage a i  ^c ' < > - is that
it can be used for ’ chequer board1 studie ond and
f ; i ' 1 : > ) ' ' - " »• i series h Fioexs is set
up with the ’ ' ' *: < cd to » « ■ - d ,< , a i v . ,
i ' < ' < , and * - ' : c s.i p ,-i ' a , )F J i >u
> , , f  / ■ • i ' ' • i n  a  • s ■ i' 1 1 ' -' . ‘ * r  4»
v,f ‘ >*,<< ,(i i i<■< - cox ' ,8 . a ' its bv! i «> wt k  F-. * u a
gradient, I
d 1 sc iace.flien t s tdian would ice expected from oDserveci
displacements in the: absence of a gradient, this gives 
j hiFFdvcMF >"es of the method
include its js in the
propo:* t (.m 3 < < . > f i., po is * j , mi that ar* * u h r  f «>
t ... ,., a major drawback assay i .* i'm 1 it
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'W . ' i' .! observ - u of the paths of
the me , The second method to evaluate cell
locomotion is by determining the number of cells which 
have reached an point, The oldest and easiest
version of this method is to count the on the
lower surface of the filter even though it is inaccu
lower surface nay hare
dr , ' oi j , To c iract such a problem, an
* ’!* r , » .5 h-*' ! ran recommended involving the
use of a sect c ' , -no ^ • ' lie non-adherc * » < -
' ? J 1 or - ' ’ . f • 1 1 1 i : o be done
at a chosen y c a, ,1 in the , <' beyond it . This
- ( f . ' .. t _ , 1 ' » ' ' c s  due to
detachment.
Determining the 1 ' ' number 1 '
the former way of counting
ent &t . ,    and
forms the the last * i - ■ ?
mo : i on
ce £ 1 © 1 cl ai id how
they
is ti.lie w
and the
human
cl
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' y >. ; assay is si - '• / ; , * i immunodiffusion tests
in which three ' ie « » '-«-e bored into , - ose on
a . * ' ' ' Chemoai :• i: Jt >,u control
! two outer wells while the 
center well is filled with cell si. . With time
the chemotact 1 > r, j ,e - , • through the gel
c> , .ting the *. the central well. In response
to * ; ( wl c  ■ jc, n- ,, -ce between tb , , n- xse and
As a result of the act ivity an egg-shaped 
p cittern of cell distribution is established, with the 
pointed end facing the well containing the at tract ant. 
formed, Essentially this method measures the locomotion 
of a cell population but has the advantage of being used 
as a visual assay, permitting motile behaviour of a
Vi s  issays
> < < *»• ,l,o v ; • f ,i ’ * ms i
r a p  f p  , ,' ' ,, , ' i ' b y  • O  ' ) i i 1' < i f  c > ,cif t } ;»
c A ertheless» the > , ,  ^• uos re n  •.
•' rf o < ‘ i - at - - - c .' , - a p..* -r m, , , i , t a
, i / -re* " 1 J o'", ( , f 1 , o i ■ {' m 4 ' ' *
* , i\ > i ». ' ' < Km o / - . the
, s . , m  > - i p . "  ( 5 i , - * * '  t i e  f ■ h r ;  o ? p - o r f c i i t t  t u  < >  r e v
based upon the change in shape of cells in suspension
when stimulated by an agonist. An unst i i i i t i i a f  ed
n> -hi »pf * i ? i carefully » ,< < , * ' h ho 4 oi 'vr > e n
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mo- ,'i ' ogy nit morphological pola, n , » but adopts a
non-spherical or polarised morphology in the presence of 
a stimulus (Heist on and f 1985), Various
parameters such as 1.3 course of ' ' - , r *• , degrees
f and p, -. ' - < 1  < d <: cl I ■. \ ,r
'9 - f) measured. Iren though the a: ' '' ,, ivl.de
further inf on, " . - n beyond ' > omc» c 0 1 'o,
a factors can be screened for
any stimi-' ' / ' . Another adva ' - ' » j e assay
is that ' ' ' ' s * _ o sessment '-d the i mined  ^1. >
locomotor r r ' ' ' se to ' , ■ "3
■antage a . as > is that certain compounds such, 
as .! - ' 'hi, a microtubule- ' \ > ,'< ' >-g agent, induce
po 1 ar i sat i on but t hey are not c 1 as id as
chemoa
factors which, inb 1 ’ otic
' i it'MS 'i ' 1 •'!' I ' , ■ ,>. , f , - mV < ' , r
U. t jo, . >i r . * . lb tod c ;g use of a
it 1 * , . f,« . 1 > ; , 9 l  f'l i-d, I V ! / / . No
■ « Mt; '(/ s' ml, n * », o,t ' •» si" » f ' 5 is needed in
< * - o  , * - , , t f • 1 f >' 1 , >; the r > r.» 1 h
source excerpt to orient themselves to the gradient, The
r !( (i lr , . ' « » ~n-r C U t  1 '' *' t( *H I W' ) p j ' -< » / " S
by a narrow bi j ;■ ' ’> hour ,u . use- 1 an b»1
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' I w ' ' , < i - ',t con.'" i ' chemoattr-
or d with a stimulant and the other with a
, so lut ion, C , < are allowed to adhere to a
' ' - 1 ti- < i them Inverted over the ' /r secured
by , ' s 1 " ' * - -s. Morpt» ; ' ' -
h o t gradient Is observed hence p r o w  'v r 
rapid means of idea ' / if any given , f < tant is a 
true <!>',■ t ,.ct1 * 4 '> ;
Time-lajpse_ cinematographyi To analyse the movement
a w  « erved micros' ',,o w  / a filmed record is
esse if ■ > . It is import <’ ' j * . dk the motion of a
cell » »- { < " ,> by eye s l .> 1 > for a long
time considering the usual slow speed of a
mo' - > neutrophil, 2 0 micrometer per minute. , ov r
cb r . ' v 'C' ' can f« < . ' i > , < > - • >•& , * s' , * i . - : rse
interval r w  ' - ' n sin , . w  ** i p , m
f ' ' "f * Ms 1 if , c'i . ' 1 ! O' ' * O V , . MlU
1 ' P m  [" -us- two reo - *, ,/* ' i - , s > *
With to I ' l • s ' ' i ' I ' << / ' ’ g of
s ' ,, 1 m    .:. ' i -' ii' f f ,s c ston 1 i <- i ,
’ i, v * . " " has the adv s < f/ ' : ; . o. . << o * > >d - '
i,,- » 11 pi I pc ' ’j ' images. A microscope
•" s ' t 4 j>. u ,, < s r  ' md a s" - ca stage of 37° C w H h a 
ci," a* -c '.s- .,,, { j b . ’» ' ia' ,f ' f' the
- ", , w . >,i i. i m  -. - <i s w  * , I d1' ; ' ! J , • i t j ci
f. .<.< * u . i n g pin ci r~c -— nt rant -g « * of low r, c  ( / o c -mo 
because a large field with enough cells is needed for
43
' ■' pur poses, Higher iia, 1 - . ms with
contrast optics are used to st shape changes
■' a 1 , i 'ie ciing, analysing cell tracks
was done by projecting tne film onto a drawing paper
a  and Wilkin:' , < ’ / ; r ' * c ci Hast on, 3 31 „ ,
recent 1 y , a n i croa r r ^ t - >
(Dow et al, 1987),
, c '' r f' is post i '* ' " - ci > '.n on
beha’v > ' - > conses J neutrophils to chemot: act ic
by t 1 110 * ' 63 C 1 116 i ' ' ,‘>7 Oil 2“
o: - < '1 r < o' as ser>t , ,* c sum in coated
3? ire < , i o. and Wilkinson,
- 7 ,, The s 'r . 1 is coated with o „ , , w!c u  
should not act as a stimulant, uce adhesiveness
l r , * f the neutr », t - is to locomote on. t>t ' o
s!su . hi assay has , shown to be lief < r -
/ / , , , co - ' : k < • , ‘ ' -op, ,
' « C , < ' f ! , > ; • , ' ■ , ' . / i . i , », j V , , . ' '<
"",'ds an attract ,0
; The use of collagen and. > o * ' > ,«
',(n,h< of cell locomotion ; ' ' r < < .reasingly
popular
o f j, - i - . ! ' ■ ; . 1 iJ '■ o-. tant , the
bui • ,> •-'« will <m' t' * .* 1 the transparent 3-
r * 1*!' j? Uo?f" < * o «' us ct! f r 1 o gel| • their
path, ■ !h 1 > , , M  t » , k '34) , Type 1
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hich can be prepared froi/ < r ' ;■ < 1 tendon
(E1 sda 1 €3 and Bard , rms a ge I w i t h i n f ew in i nut es
being restored to > < { , pH and , r •
b < in , ; • are prepared from
thrombin a; , , - ogen, Chemoat tract ants are i - ' ! f
incorporated into or layered on top of the gels in
. „ desired gradients before ' the cell 
suspension on the surface. An te period is
> f i > J> r the ■ - ' : • to invade the gel matrix
s ' ' ' * , ; j ‘ • . Gel invasion assays
can be adapted for assessing net population movement 
r her by i ' wading front method or co . i eg the 'of is 
? hi 'Migh tin * . j < 1 trig the gel with
1 , , s - , del assays can also be used to study
cor' ■ ' ' ' i ' . There are, however, technical pr A! '-;is
O; be enco t - when employing pr- » y, , . It is
- '  1 1 I h s -' - ' m ■ ! d r  ; - as t,„,,
and c« *’ r ' < s not eas < J ' re is any
> > • , \ o i ' r i - - 1 , ' >• > ( , S' i * on
t h « J  ' ' fi* B "  i i  , has Peon achieved.
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Section 5
Chemi1uminescence
Chemiluminescence is the production of light by 
chemical reactions involving the formation of
electronically excited states. _    . ' .*
The first report of chemiluminescence was made by 
Albrecht in 1928 (Stross and Branch, 1938) who was 
described to have observed bright chemiluminescence when 
luminol, a cyclic hydrazide, was oxidised. Oxidation of 
luminol can be carried out in protic media such as water 
or in aprotic solvent such as dimethyl sulfoxide. The 
pthalate ion produced almost quantitatively during 
luminol oxidation is found in an electronically excited 
state and is responsible for the observed emission.
Chemi1urninescence by phagocyt ic cel Is: The generat ion of 
chemically reactive molecules as a result of the 
respiratory burst in PMN , is an essential step in host 
defense against microbial invaders. Chemiluminescence of 
PMNL is a phenomenon related to the activation of the 
respiratory burst as originally reported by a group of 
investigators demonstrating light emission at the onset 
of phagocytosis (Allen et a l , 1972; Cheson et al , 1976). 
The response is influenced by a number of factors such 
as temperature, ions and media (Andersen and Amirault, 
1979) and can be amplified by the addition of 5-amino- 
2 ,3 - d i h y d r o - l ,4-phthalazinedione or luminol (Allen and
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Loose, 1976). Before the introduction of luminol, the 
mechanism of light emission from the phagocytes was 
shown to involve both superoxide anion CO"2 ) and the 
enzyme myeloperoxidase (Rosen and Klebanoff, 1976). As a 
result of adding luminol chemiluminescence production 
was found to be totally dependent upon the MPO-H2 O2 
system (DeChatelet et a l , 1982). Their studies showed
that the presence of MPO in extracellular fluid is 
insufficient to obtain a normal chemiluminescence 
response from MPO-deficient PMNL indicative of the 
light emission reaction taking place both intra- and 
extrace1lularly. In luminol-enhanced chemiluminescence 
systems,the reaction may be limited by the diffusion of 
luminol into the cells and not by the generation of 
oxidative metabolite.
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i 6
membrane receptors
Interact ion between j rytes and other cells or
me' 1 is of central importance in a wide
spectrum of granulocytic functions which contribute to
’ i / -_u infect ions. Me 1 : n of
lenced by the nature, of these
intera .s / « ton and Born, >> . Adhesive
' ' iS of granulocytes vr . j , j or endothel ium or
r : ' »' * d 12 ' ' '   s have been shown to be
■ - - » ' ’ 1 by membrane receptors.
' - Mac-1 s , r ' f * j t ' i ^oteins
/ "4 ' ' sion-p 1 1 “ ' ^ ceptors
' » . ' ance in ' V > , h < > I
i functions (Springer et
- - were discovered ' m f ,.»» ! > '
' - ‘d ‘ ns . i !.: c, ' r r c - ; ' > •’ a - y , ? , , :
? ' ; * .a- cs;! i , ; / " ( i-i. ii!” :*d !>ii *s the
»' * * ' , i, 'b ;•*>'. *" ' ties witn microbes opsonised with
components C3bi  ^! ! '' , * - j , >id
adherence of leukocytes ar endothelium
(Luscinskas ( 5 o > r ' ’»i>* ico* 'C^  , , >>,,> c r , ’ /
f?*' ' / ' H • .'nergi- - < i h ,t a u -oc>r
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' ' of leukocyte adhesic/ t / o  \iicy
In early / ' a group of patients manifesting 
widespread bacterial infections, defective neutrophil 
f - < and •" t ■,ed se. - » r e umblleal cord was
identified (Ahre . , ■ » r , c. _ , , A year later it w a s
proposed that the defective neutro functions in
those patients were secondary to an abnorm r in
' - (Crowley et al , 1980). Subsequent 1 y other
' - rst i ■ .»; ors reported siuii lar findings - I < i 'C 
with feAti cie * / ocytosis t-d ! o i a: ai pus at
b - , u inf6' . i» 
leukocytes; to extravasate and trieir retent ion in the 
vasculature, due to their inability to adhere to
;undotheiial cells as observed in vitro,
Charac* ' - ' > m u of the prc •, "3 mi ' die
a  a "  ' h a v e  c  - < < y  J* t h  5 - M l
3' n • • >, - '' ' a , ’ It c«, , d ' /  m  ' <
monoclonal antibodies! for t*- s n '• ' '<Ut.b
the common 'e able to
r * * a a a u i o < ency in i s i
three -a , , '.eta c> sf ' a * r ‘ ' '•« b "hocytes (Springer 
et al, both
i>. , " < - • ' . d v a • * tee expression '•*
' (f. • * nun i' * Id-" * ' c , < g. f"*» a defect of Jnb
j , u  < n  a  , f , - .  a j i f a  i d .  , j ; - n  j ;  a ; - \ , - ,  { \ , , t
M i n  t < ■ O  , ' w  a I  u  f ' ! ,  U ) C  ( }  ( f ! I ! , . I ' M ' l d  11/  h ' - <
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abnc 1 ( . i 1 ' \ chains
( • , , < ! ,) ,
Almost all I have been observed to
manifest profound a b n o r m a f  of neut*- , adherence 
r ' ' 1 ' and adhesion-dependent functions including
chemotaxis, orie w - o and aggregation. The re » - > ry
s< 1 ' - 1 ' ' .> ' »' ' _ ? '' - e to poco o!
opsonized pa and antibody-dependent cellular
c noted to be abnormal , On the other
hand adh»-- < j ■ . i r functions like cell
polar! , receptor ' binding of FMLP, and
intrac* A, micro, , r _ bty are reported to be
t r ’ \ ' i d , ' 1 j 1 ' 'C f ' i tl i ,esence of normal IgG,
Fc, CR1 J receptors on 7 f ' ' ' < (r
, .nulocytes (Springer and Anderson,
S t n  ' , > / < ' ' >». a
'1' 1 » -s ri »r , ‘ ' 5 ’ ? i r  ^ ans-
, , *1 , ' - i * f < tied ' ' 'Mo ‘
h' ' r ■ r f * ' ' * ^cursor > * t ■, (Kurzinger ci al ,
, ' ; 'O i r /' o A Miller et al, !> o > , . The
members of the family . each con ;  .• non-
covalently ,*od ' > , < tv ^utide chains
with the absence (Kurzinger and
S, / » , 1,982; Sanchez-Madrid et al , A A f he
t, s a : c- !m o s -' .1 s are not onlv present on c iit_ * >'it
surface t <d 1 * - i/<l <J i 4 * ; < , >o !es. Alpha chains
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integrin superfamily have molecular w of
.'0 : ; 1 , , ' , n , /, and 150 I ^ o  o, and
they are home n  -is to each other. The beta cha • ( << , 
is a. 95 I'O poiyp- ! ■-e <■,> 11 " no resem><» , * :e to the 
ha ' - • 1 .: ' ' -1 the three p m ' e, ns.
M < - * .jhri , both chains reveal extensive
homology other integrin receptors thus confirming
if''- memberships in the supergene family ot integrins 
(Hynes, 1 . The glycoproteins require u
i 'on , > ‘ - i' ,'o.is between the two
ig with warm temperature and an intact 
u. ' os - ; , . .ous cytoskeleton for t m  , '• 1 - net ional
abi1i t i es. 
BIosynthesis
-synth < • < * h> ') »lei ! 1 has been studied in
humans and mouse ’ ' * * - m f ; \ n \ > ■ m  * on- m  t
and Spr ■ ? , 1983; b i> . <«. ' ? » >o ' r 8/ m  t<
m ? o ! J ! O', ‘ - e , <  ,urr ■ ' m  * m 5 '» ■ <’ i 1
endop 1 asm i c ret i ci: 
where carl 
increase in mo]
probably/ in the 
t ed t o t he 
o u t ;  . o < h i ‘ i
occurs. The r »* m  t
molecules are t h e n  surface or to
intracellular .storage sites (Todd et al , 1984; Bainton
et ■ al , 1987; Miller et al , 1987b). Inf 1 ammatory
flH O, j 1 i; / <»I P ; p  / ' ‘ > !,, f / > (i , ; i; Hi >, j , S i ‘ i « (J —
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fold increase if.
U ;  a  - . ci- v n o - e i j  s u v i ' a c e  ( S p r i n g e r  e t  a  .1 ; . . . i s a t :  t r i t e r s ^
Increased surface expression is not impeded by 
protein synthesis , < j. j . < g o„ < ~ , antly
of great impo - , . , ; » o , t 5 . » ' mess
and , >i > > ■ ; r - ’ f - t • . the r rules from the ‘ f
.. to the ' ' ) , srface 1 e readily .switched on
b amatory stiinuli.
C h a r a c , 1 1 ' <> > "> ’  - f  p r c  r > r s  / . 1 t a f a m i l y
The first mol ecu lei found to from
a > cocyte adhesion c r  o * r-ncy • - < a */ >
(CR3, Mac 1, Mo 1, C3bi receptor) that f ions as an 
opsc?, * ' . - ; - i ' a, es the to ding of iC3b-coated
part i c 1 es wh i ch i s y phagocyt os; i s of the
entity (Beeler et al 1982; Wright et al » 1983). The
receptor ; ' m. ' > surfface-; m < -• t low. r . - e
precursor
composed of two non-covalently linked polypeptides which 
n '  t . ,  f n  . ' i . c ;  } . w  , i requires nign
car to interact 
verstein,
1982; Wright and Jong, 1986). The binding capacity is
i 1igands
, , 5, } , .i . j, ' {. t s , , . ( * - ? i yep • «s5<arvp> as the
site of recognition for the molecule and also for many
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al , ; D f Souza. et al , (,/ . Recent work has
Identified additional ligands for this receptor
€3 surface
*5 , r -mania and promoting the internalization of the
intracellular parasite (Russell and Wright, ffr,; 
Surfaces coated with fibrinogen can also be recognized 
by C ' . <, ence of neut , - c . ,
and subsequent - < * n a ' , /fc ‘ ' » c , 1988).
■ t e  receptor has 'been shown to r &  T> ze an
uni den* , 1 * c ’ polypeptide on the sin ion. .1 unstim _ <* ed 
human , / vein end- 1 ; , > (Harlan et a i ,
1987) .
Mom antibodies against the second receptor
.2 the v,r ' were used , block T-cell an-Mf/'ued
* ' , * . St" , 3 have : < « i ed 3 ? 1 vmnhorvte
function- s
which are r:
n4r s * , t f , > ; i f , ! j ^  ^ | 3 f , <
seen to inhibit cytolysis by binding to LFA-1 molecules 
on the
* ' ■ ' 3.*. < ''',o r s' r ;v '.w -   ) t r  r r l o r  ' ;i t o x i c
but f n« i 11 t ■ adli.esion
cured ai on c, , ,, oto,'». c , such as strengthen* I uv.
‘t ;' i \ \tt> >t\ s •'• * •• (,i . * /.11 , , ‘ , d »r11. , i, : > < © a
y,' t 'I ' n :i» i - c  u j / if ,<>f, 4 r, s i ! i 1 >, * ' n a b a
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, , «*, , 'tj' ‘ > - ' r r, ' , I ' s  o n
* , ' l  "  ' ■ c i e d  i n ’ "  - , * , ,  u n t i l  M a r l i n  a n d
The pr 3, - 5  ®  o / * ' 11-1 inserted xa^u
, f / ' ' membranes *rrds> cells hearing LFA-1 but not
those ; out the receptors, c*' acture determiner to ,js of
ICAM-1 has < n that it belongs to the inn ; ,, * -
superfami ly '' o > ? • no, ; j :i sequeii * * t Arg-Gly~Glu
inst' ’ of ' »>' RGB sequence (Simmons i » ! 3 ;
5 ' '33 * . ICAM-l serves as the Jcoifid
"or > j 3 on endothei ium sin - 1 f '' ,
Lt-jJidCw-i e stow-"' ’y 7 o ' ; en.dot.hci . 5 cells
that express; the molecule on r surfaces.
I ! /  1 1 z i t '' ,!'' 11f' 4 ' j t C I f f ' '  ' I / , ; 1 > ( ! ; 3 *  j i ' 1 ' '  f f I
' ' ’ i s < i t  W 1 r i  , , • i , f , o f , < ' , S. , ! ,'.3 < i " , 11; I *i o
structurally ident ica1 to the beta—chains of the f irst
« a  ' fftf»i ' s iI 3  1' f : , ;i ! ; ' i c  l I 3  3 j ' ; 3 3 ; 1 i L v  'S c  * a I .
? ?* <*’ - f 3 ? i 1 5 ( 3 « 3  / i f3  , I c h 3/ ; i r { 7 , • * ; <_ *
c  s: 3 c  , • * |>*< - f ; 3 , c  ‘ o * 3  3  p c-o- < "  , < * «
»« * r /1 r , f 3 1 3-< >3 i i - >; !,t * S 11 * 1»c i ■<■ * | < i j f 3  'l i > ’ . f f d ' >  ^ P  e
- • ; i f  3 c <  1 ' O r  ’ - f i 1 11 f c  , * 3 - p  ' i  *3 3 | o 3 h
3 3  : i ,<3 f ! ' ’ ' h n v i ’ < mos« 33 i sj ( < « f ; MiOG’i c f  i h -
!f‘ ' * 1 < > > 1 Ofih i 'f 1 ,1U « 3  , , 30<'jf 3 7 > f 3  o  - , 3 i - :  . S / C 3
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' >o \  1 i - C/, !r ,ece ptor activity and is
s i in i i ar t o t he xieut r opfa i 1 recept or £ or i C3b
(Myones et al,
A ’ for 0)11/'CD 18
B the above-mentioned ligands, CD11/CD18
n , » 'M' ", have been discovered to ' role in
- ' h- < 1 - , inbi . .es thus reveal ing their
widen r < , ' mctional cha ' , 1' " .
es against CR3 par < ! - id the, binding
of pa :-* \ ■ ' -es such as zymosan (Ross ' . ' f , 1985a),
S ' , ’ i / o ' C o c c u s  (Ross et a l  . 11' >■,, and L e i s h m a n i a
till ' - 1 , 1985) on to phagocytic ' ' i in the
of « 'O.* ( e * ‘i- < , !, ' ' ; r ■'
i, it was pi' s < ■ ' 1 s ' 1 - ,t ' ' . j- -1 d ; . < * I ,
with the particles without involving C3bi, This idea is 
supported, froot the observatIons of leukocyte adhesion
de f i c i ency ( LAD ) pat i ent s ce 11 s exh i b i t i tig. ' def ect 1 ve
f 1 , < > , < d h< r f x an *.j' * p ' > / / c? ' ( > '4 ),-*< m< ' - >,
" V T i H f f  j    -?<•- '  - O   a ...r o  .... i r - r ;   { ~ ; y / r -, - -f  j  -  i u  i  i i p  i  C e l  t,  BC.1
f"'< ' '<>• j pfi-H'i•* i '.j ; r. \ , ) u t }  i \ shut . f i '• capacity to
t 1 >r > * ' Cvr y, Id r f * t ; .il'O d< ) > r >  <' M3
' hi I l'<t i wrd Vn old , I dd - c hi ' i> c. ya ism n  rece<*i
"'Of;, P' ,t ; ! H , s f ! J S w 1 V/< -I s cle ' i I*i I r 1 '
UiOH' ■ b >1; i I < <rb i 5,1 1 i o', ’ ii> i i r v m 'a b > ' t it < * f j ji,r
o' i 'li , A i nd ' m , ! * , a i l l  ohcr 'M'd ; I h»v t>' ie of the
55
receptors is present indicating the capability of 
individual receptors to bind to the organism separately.
The ability of phagocytes to recognize a carbohydrate 
structure on the microbes and ingest them without 
opsonization may serve to limit the multiplication of 
these organisms in early stages of infection before the 
onset of adaptive immunity.
Recognit ion   of bacterial..... 1 i popo 1 y sacchar i des :
Macrophages bind __ E.coli by recognizing the most 
prevalent molecule on the surface of the bacterium, LPS,
9nd two distinct biriding sites for LPS on the CR3I molecule
have been identified(Wright and Jong, 1986). This claim has
been recently substantiated by Wright and his co-workers 
when they blocked the binding of C3bi with anti-CR3 but 
not that of LPS (Wright et al , 1989) . Although binding
sites for LPS and C3bi are separate, they seem to be 
functionally linked. The binding site for LPS on the 
CD18 family appears to be less affected by the identity 
of the alpha chain since all 3 members exhibit 
equivalent binding capabilities to LPS. Even though 
precise structural features of the LPS binding site are 
yet to be defined, it is agreed that members of CD18 
family of receptors on PMN are required for recognition 
of bacterial LPS. The presence of dual binding sites may
be a common property of receptors related to the CD18
f am i1y .
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Adhesio n o f l e u k o c y t e s t o e n dothelium: Increased
adherence of circulating neutrophils to the endothelial
ce 11 1 ining ^  of the microvasculate is an essential step 
In the early events of inf 1ammation, and precedes^ 
neutrophi 1 migrat ion t.hrough the vessel. _wa.il.. towards thesiteof in j_ury 
(Movat,1985). For nearly a century, chemotactic factors have 
been regarded as key participants in the process of
leukocyte diapedesis demonstrated both in vivo and in 
vitro. With the discovery of leukocyte surface adhesive 
glycoproteins, the mechanism of neutrophil adherence has 
been better understood (Tonnesen, 1989). Documented 
observations on the adhesive interaction between
endothelial cells and leukocytes may indeed be directly 
i nduced by phys iologically relevant chemot act i c st i mu1i.
The major subject though is the confirmation of the key 
role played by the glycoprotein family in this 
interactive process. In the study conducted by Tonnesen
(1989) ?.leukocvtes_ of paL ients wit.h  LAD showed markedly
dimini shed adherence- to eridot. he i i a 1 ceils in response to 
chemotactic stimulation so did normal cells challenged 
with MAbs specific for beta subunit. Margination*thought 
to be a reversible spontaneous interaction of 
unstimulated neutrophils with vascular endothelium,
_ seems to occur independently of the receptor
family as .indie at ed v the non-inhibitory effect of 
antibodies on non—stimulated adherence of normal cells. 
Surface expression of the adhesive glycoproteins is
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obviously essential for neutrophils in enhancing 
adherence to the endothelium before diapedesis in the 
presence of a variety of inflammatory mediators (Smith 
et al , 1988). In addition to the expression of CD11/CD18 
complex of glycoproteins for localised adhesion of blood 
leukocytes to vessel walls at sites of inflammation, a 
cont r i but i on of endothe1i a 1-1eukocyte adhes i on mo1ecu1 e- 
1 (ELAM-1) to the mechanism of leukocyte adhesion has 
been reported (Bevilacqua et a l , 1987b; Luscinkas et a l , 
1989). Results from these in vitro studies suggest that 
PMN adhesion to activated endothelial cells involves two 
separate cellular mechanisms: a leukocyte-dependent
mechanism involving CD11/CD18 and an endothelial- 
dependent mechanism involving ELAM-1.
Regulation
The act of mediating adhesive interactions by the 
CD11/CD18 family is under strict physiological control. 
Normal circulating neutrophils do not stick to the 
vascular endothelium but tend to do so with dependence 
on the receptors after challenging with C5a. An example 
of regulation involves the binding of C3bi-coated 
particles to CDllb/CD18 on neutrophils after introducing 
a stimulus that will induce a 2-to-lA fold increase in 
expression of this glycoprotein family on the cell 
surface (Wright and Meyer, 1986). Current evidence 
indicates the resulting upregulation i s d n e  , ' t o  mobi1ization
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of preformed molecules from the Intracellular storage 
sites perhaps the specific granules and/or the 
gelatinase-containing organelles to the plasma membrane 
(Petrequin et al , 1987; Bainton et al , 1987). At the
same time evidence is slowly accumulating which throws doubt 
upon the concept of stimu1us-induced upregulation and 
increased surface expression are required for the 
enhanced adherence. There is a proposal that subsequent 
biochemical or conformational modifications, an 
interaction with another membrane component or possibly 
an alteration of density distribution of glycoproteins 
within the membrane may be required to produce the 
actual adhesive site once the molecules have been 
projected on to the cell surface (Detmers et a l , 1987).
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Section 7 
Lipopolysaccharides
Lipopolysaccharide is a macromolecular substance 
firmly bound to the surface of gram-negative bacteria 
forming an integral part of the outer membrane unit 
(Inouye, 1979). The molecule seems to elicit a variety 
of the clinical manifestations of the diseases caused by 
gram-negative bacteria in humans (Emond et al, 1978).
Unlike many bacterial exotoxins, LPS does not have 
enzymatic activity that disrupts normal host cell 
physiology. Rather LPS is thought to activate host 
cells to release abnormal amounts of endogenous 
mediators such as IL-1 and TNF which are able to alter 
physiologic homeostasis in ways that may be toxic or 
beneficial to the infected animal (Beutler et al , 1985; 
Durum et a l , 1985).
A distinction between endotoxin and
1ipopolysaccharide is needed to understand the role of 
each molecule in the context of causing diseases. 
Endotoxin consists of an outer membrane macromolecular 
complex of lipid, protein, and polysaccharide (Hitchcock 
et al , 1986). LPS is a molecule of covalently bound
lipid and carbohydrate separated from the bacterial cell 
wall and from protein and other constituents (Westphal 
et al , 1983). LPS possesses all the biological
act i v i t i es of endot ox i n .
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Structure
Chemically LPS consists of 2 parts of contrasting 
chemical and physical properties: a hydrophilic
polysaccharide and a hydrophobic lipid, lipid A (Orskov 
et a l , 1977). The polysaccharide is further subdivided 
into the 0-specific polysaccharide and the core
oligosaccharide. The former is built up of repeating 
oligosaccharide units whose structure and composition
vary for different LPS while the latter is more 
conservative in its structural make-up (Nghiem et a l , 
1982). Hydrophobic lipid A is the most high 1 y conserved part 
of LPS being similar among the gram-negative bacteria.
For structura1 and biological invest igat ions,
mutant strains, the so-called R (rough) mutants have 
been of great value. These mutants have a genetic defect 
in the biosynthesis of complete LPS lacking in 0 chains 
or 0 chains and part of the core (M&kel&nd Stocker,
1984). The most defective types of LPS which are
synthesized by Re mutants (sometimes referred as deep 
rough or heptoseless LPS) only contain KDO (unique 2- 
keto 3-deoxy-octulosonate) linked to lipid A. Apparently 
Re LPS is the minimum requirement to maintain integrity 
of the gram-negative outer membrane. LPS with intact 0- 
antigen are denoted as smooth form.
Isolation and purity
When studying the biological properties of LPS 
purity is an important prerequisite since the presence 
of other bacterial components , will affect
these properties (Hitchcock and Morrison, 1984). Nucleic 
acid, proteins, phospholipids and glyeans are the 
commonest contaminants in LPS. The most widely applied 
method of isolating LPS has been the phenol-water 
procedure (Westphal and Jann, 1965). For many years this
method was employed to isolate the S- and R-forms of
LPS; comparing with other techniques these extracts were 
characterized by the lowest degree of contaminants 
Although relatively pure, these isolates did contain a 
low but significant quantity of contaminants (1-3%
protein) whose complete removal proved enormously 
difficult suggestive of strong linkage with LPS (Galanos 
et al , 1969). With the advance of isolation and
purification methodology, a considerable improvement in 
the purity of LPS has been achieved. The introduction of 
phenol-chloroform-petroleum ether (PCP) extraction 
procedures made the isolation of R-form LPS possible 
which is uncommonly free of the commonest contaminants 
reducing them to less than 0.1%. Hence the term LPS 
should be reserved for purified bacterial extracts which 
are reasonably free of detectable contaminants 
particularly protein.
Solubility in water
The presence of hydrophilic polysaccharides and 
hydrophobic lipid A endows LPS molecule with amphipathic 
properties. Solubility of LPS in water depends on the 
relative proportion of these two regions; increasing 
with higher proportion of hydophilic region (Galanos et 
al , 1977). S-forras, rich in polysaccharides, exhibit
greater solubility than the R-forms. Within the R-forms, 
solubility decreases going from Ra to Re indicating that 
the number of core sugars parallels a corresponding 
decrease in solubility. LPS does often shows great 
differences in solubility which is unexplained by the 
polysaccharide contents. R-form preparations isolated by 
the PCP method are generally more soluble than the 
corresponding phenol-water extracts, even in some cases 
better than phenol-water extracts of S-form. The 
presence of negatively charged phosphate and carboxyl 
groups plays an important role in solubility properties 
of LPS especially for the R-form and free lipid A. 
Divalent cations (Mg2 + and Ca2+), needed to neutralize 
these negatively charged groups, have a marked effect, on 
the solubility of R-forms causing them to aggregate and 
precipitate from aqueous solutions.
Relationship of LPS structure to biological activity
There has been an appreciation that discrete 
structural components of the endotoxin molecule are
responsible for the biologic activity. Studies employing 
endotoxins from Salmonella mutant strains provided 
evidence that LPS is responsible for many of the 
biological properties of endotoxins (Kim and Watson, 
1967). Furthermore the lipid A moiety of LPS plays a 
prominent role in the expression of endotoxicity, as 
demonstrated in studies using LPS derived from core­
defective mutants and free lipid A. In addition to using 
endotoxins from bacterial mutants to establish 
structure-function relationships, selected portions of 
the molecule modified by physicochemical procedures 
were also utilized (Neter et al , 1956). Subsequently the 
studies involved the use of the cationic antibiotic 
polymyxin B to modify LPS activity through 
stoichiometric binding to the lipid A region (Morrison 
and Jacobs, 1976). Procedures to modify LPS structural 
chemistry have contributed significantly to the 
knowledge of LPS biological activities in relation to 
its structure.
Interaction with host mediation systems
Bacterial endotoxins exert an impressive array of 
biological effects on the susceptible host by virtue of 
their capacity to interact with a number of mediation 
systems of the host (reviewed by Morrison and Ulevitch, 
1978). The precise role in mediating certain 
pathophysiologic events associated with gram-negative
sepsis in humans remains unresolved. Immune responses to 
endotoxins may occur via the humoral system resulting in 
the production of specific antibody. Such antibody could 
promote clearance of the endotoxin by the 
reticuloendothelial system or sensitize an endotoxin- 
containing microbe to complement mediated lysis or 
phagocytosis. Alternative1y a ce11u 1ar mechanism may be 
involved, with the production of activated cells that 
would aid in eliminating the microorganisms.
Effects of endotoxins on neutrophiIs
Neutrophils represent an important target for 
bacterial endotoxins. In addition to their ability to 
alter blood levels of circulating neutrophils (as 
reflected in neutropenia or leukocytosis), bacterial 
endotoxins are capable of influencing the locomotory, 
met abolie- and bact er i c i da1 propert i es of neut roph i1s . 
Endotoxin-neutrophi1 interactions appear to be highly 
complex with both direct and indirect consequences. 
Studies demonstrating that a concentration of endotoxin 
of less than 1 microgram per milliliter is sufficient to 
modify neutrophil functions are consistent with the 
hypothesis that endotoxin may mediate at least some of 
the effects on neutrophil behaviour observed in septic 
patients (Dahinden et a l , 1983; Haslett et al, 1985).
Significant variations among LPS chemotypes cause important 
variat ions in neutrophil functions (Pugliese et a l , 1988).
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EB.dp.!t9 XJn !?iB.ding to the neutroph_i 1_.: An init ial binding
interaction is required between the endotoxin molecule 
and the leukocyte membrane for a direct alteration of 
neutrophil functions. Only a few studies have addressed 
the nature of this interaction in a detailed manner 
either in respect to the receptors involved, the number, 
of binding sites or the mechanism of binding. In 1955 
Braude et al observed that the initial rapid clearance 
of labelled endotoxin injected intravenously into 
rabbits was accompanied by marked leukopenia. Their work 
was later pursued by other investigators attempting to 
evaluate the binding capacity of neutrophils to 
endotoxins but with complications emanating from factors 
that might influence the interaction such as the natural 
form in which endotoxin is presented to the cells. In 
late 1988 some light was shed on the endotoxin receptors 
on the cell surface of neutrophils (Wright et al , 1989). 
Members of the CD18 adhesion family of receptors were 
discovered to be essential for recognition of bacterial 
LPS and eventually binding on to the phagocytes.
Effects on adherence and aggregat ion: Intravenous
administration of endotoxin produces an early and 
pronounced decline in the count of peripheral blood 
neutrophils because of a drift of these cells to the 
marginal pool and eventual sequestration in capillary 
beds. During this period significant changes in the 
adhesive and chemotactic properties of peripheral blood
neutrophils have been observed. There is evidence, 
suggesting that certain inflammatory mediators (LTB*, 
C5a, and FMLP) induce increased neutrophil adherence to 
endothelium via an effect on neutrophils (Tonnesen et 
al . 1984).Other authors indicate that mediators like LPS may
act to enhance neutrophil adhesion on the endothelium 
either directly or indirectly after exposing LPS to both 
neutrophils and endothelial cells (Pohlman et al , 1986;
Schleimer and Rutledge, 1986; Thomas et al , 1988).
Besides stimulating adhesiveness, aggregation of 
neutrophils in vivo was also reported after injecting 
bacterial endotoxins into rabbits (Berthrong and Cluff, 
1953; Goodman et a l , 1979). Induction of cellular
aggregation in vivo occurs via an indirect mechanism 
possibly complement dependent.
E f f ect s on neutrpphi1 mot i1ity: LPS elicits a marked
acute inflammatory reaction characterized by intense 
neutrophil infiltration when localised within tissues. 
It appears to be the primary mediator of neutrophil 
migration elicited by gram-negative bacteria since 
treatment with agents that inactivate LPS diminishes 
this response significantly (Issekutz and Bhimji, 1982). 
Even though LPS is not a chemoattractant it is a potent 
inducer of neutrophil infiltration with a minute amount 
as low as 10~3M sufficient enough to elicit a detectable 
response (Colditz and Movat, 1984). Following this study 
a project was embarked upon to determine if any release
of cytokines was involved in the activity of LPS 
(Cybulsky et al , 1988). To answer the question, they
applied tachyphylaxis experiments, local desensitization 
of tissues to an inflammatory agent, to establish a 
potential role for cytokines generated in situ by LPS. 
Significant heterologous tachyphylaxis was observed 
between IL-1 and LPS implicating the potential role of 
IL-1 as a mediator of LPS-induced neutrophil emigration. 
Chemotactic responsiveness was also studied and found to 
be diminished after exposure to bacterial endotoxins 
(Haslett et al , 1985). The reduction in neutrophil
directed and random locomotion has led to a proposal 
that endotoxins are capable of "cross-deactivating” 
these cells to multiple chemotaxins by rendering them 
hyperadhesive (Dahinden et al, 1983).
Effects on lysosomal degranula ..Lon: - _
Extracellular release of enzymes from neutrophil storage 
granules can be induced by inflammatory stimuli or trace 
concentrations of LPS (Haslett et a l , 1985). Recently it 
has been observed that LPS enhanced FMLP-induced 
neutrophil secretion of elastase as well as MPO and 
vitamin Bi2 -binding protein (Fittschen et al , 1988). LPS 
alone does not result in release of LTEU by neutrophils 
but priming them with picogram quantities of LPS 
increases the production and release of LTB4 in the 
presence of a second stimulus (Doerfler et a l , 1989).
The results thus far suggest that LPS might affect host
defense and tissue injury by potentiating effects of 
other stimulants on neutrophil release of granule 
components.
Effects on oxidat ive and bac t er i_cj_ daj capacity : Sever a 1
investigators have evaluated the potential influence of 
endotoxin on neutrophil bactericidal activity in general 
and on oxidative capacity in particular. Guthrie et al 
(1984) examined the effect of bacterial endotoxin in 
modifying the oxidative metabolic response and found
that LPS did not appear to act as a stimulus in
releasing 0~ 2 nor did its presence increase the release 
in combination with a primary stimulus (Guthrie et al , 
1984). However, ]pre~ Incubat ion of the cells with LPS 
resulted in a significance enhancement of the 0 ~ 2 
release; the priming effect was obtained in the absence 
of serum in order to study the direct interaction
between LPS and neutrophils. Cohn and Morse were among 
the first to assess bactericidal capacity of neutrophils 
in the presence of endotoxins (Cohn and Morse, 1960). 
Enhanced killing was noted when fresh serum was added 
but no appreciable killing occurred without the serum, an 
indication of some serum constituents that mediate the 
phagocytic ability of these cells. Proctor on the other 
hand observed a depression in subsequent killing of 
bacteria after pre-exposing the cells to endotoxins 
(Proctor, 1979). Oxidative metabolic activity of
neutrophils was indirectly promoted but subsequent
capacity to mount an oxidative response following 
challenge with opsonized bacteria was impaired. These 
controversial results were later partially explained by 
a demonstration that neutrophils adhering to plastic 
dishes underwent significant increases in oxidative 
metabolic activity following endotoxin challenge, 
whereas those maintained in suspension failed to do so 
(Dahinden and Fehr, 1983). Surface contact therefore may 
be an important determinant of neutrophil responsiveness 
to certain stimuli including LPS.
Ef f ect on neut rophi1 product ion: Bact er i a 1 LPS i nduce
dramatic haematologic and haemodynamic changes following 
intravenous administration of these toxic components 
into animal species including man (Territo and Golde, 
1976). These changes are reminiscent of those clinical 
symptoms observed in gram-negative septic patients. One 
of the earliest observable haemotologic aberrations 
after LPS injection is a transient disappearance of 
circulating neutrophils or neutropenia. Neutrophilia or 
an increase in neutrophil production ensues immediately 
following the neutropenic state as a result of a 
proliferative response and release of mature cells from 
the bone marrow due to endotoxin challenge.
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Section 8
Diabetes mellitus
In the untreated state diabetes mellitus is 
recognized by chronic elevation of glucose concentration 
in blood (hyperglycemia). It is a heterologous primary 
disorder of carbohydrate metabolism with multiple 
etiologic factors that generally involve absolute or 
relative insulin deficiency or insulin resistance or 
both.The sever ity of its symptoms is largely determined by 
the degree to which insulin action is deficient. The 
currently accepted classification and criteria for 
diagnosis of diabetes are based on the 1979 report of the 
National Diabetes Data Group (NDDG, 1979).
Diabetes can be separated into 2 general disease 
syndromes:
(1) type I or insulin-dependent diabetes mellitus (IDDM) 
is present in patients with little or no endogenous 
i nsu1i n secret ory capab ility. With ext reme hyperg1ycem i a 
developing, they are entirely dependent on exogenous 
insulin therapy for immediate survival. This form of 
diabetes usually but not always develops in early 
childhood. Older terms for this syndrome are ketosis 
prone, brittle diabetes or juvenile onset.
(2) type II or non-insu1 in-dependent diabetes mellitus 
(NIDDM) manifests in patients who retain significant
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endogenous insulin secretory capacity. Although 
treatment with insulin may be necessary to control 
hyperglycemia, patients do not develop ketosis in 
absence of insulin therapy and are not very dependent on 
exogenous insulin for survival. Previous terms for NIDDM 
include maturity or adult onset, nonketotic and stable 
diabetes.
In addition to the major categories of diabetes,
large number of secondary forms have been identified. 
They exist when some other primary pathophysiologic 
states are strongly associated with the diabetic state. 
In general these cases are unusual and comprise only a 
small proportion of the total diabetic incidents. Any
disease process that limits insulin secretion or impairs 
insulin action can cause secondary diabetes.
Pa thogenesis
A strong genetic component is said to be involved 
in the etiology of IDDM. A major association with HLA 
antigen particularly DR3, DR4 as well as HLA DQ has been
suggested (Wolf et a l , 1983; Henson et a l , 1986;
Michelson and Lernmark, 1987). There are also several 
lines of evidence suggesting a role for viruses (Yoon et 
al , 1979; Rubenstein et al , 1982). Circulating
autoimmune antibodies binding to cytoplasmic antigens of 
islet cells and B cell surfaces are detectable in 
patients blood implicating their part in initiating the
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disease state (McCuish et a l , 1974; Betterle et a l ,
1987).
Abnormalities of insulin and to a lesser extent 
glucagon secretions and actions are central to the 
pathogenesis of NIDDM (Lang et al , 1981; Leslie et al ,
1986). Insulin deficiency, resistance, and accelerated 
hepatic glucose production existing in NIDDM are 
considered to be contributing to hyperglycemia in the 
patients (Donner et a l , 1985; Reaven et a l , 1985;
Swislocki et a l , 1987).
Host defense mechanisms in diabetes mel1itus
Patients with diabetes are considered to be more 
susceptible to infections which seem to be more severe 
and difficult to control than in non-diabetics (Rayfield 
et a l , 1982). Various steps involved in host response to 
invading microbes such as PMN chemotaxis, adherence to 
endothelium, phagocytosis, intracellular killing, and 
cel1-mediated immunity have been found to be depressed 
in some diabetic patients (Mowat and Baum, 1971; Bagdade 
et al, 1974; Tan et a l , 1975, Tater et al, 1987;
Andersen et al , 1988). It is still unclear if these
defects actually contribute to enhanced susceptibility 
to infections in diabetic subjects. A combination of 
defects in a patient with poorly controlled diabetes may 
well be synergistic and together those defects can
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either heighten susceptibility or augment severity once 
infection is initiated.
Neutrophil function
One of the earliest studies to examine the nature 
of lowered bacterial resistance in diabetics was 
conducted by Marble and co-workers (Marble et a l , 1938). 
Using whole blood from 27 diabetic patients and 23 
normal control subjects, they documented similar 
phagocytic, bacteriostatic and bactericidal power 
against selected strains of streptococci among these 
samples. They explained the negative results on the 
basis of well controlled disease state without 
presenting any data to evaluate the degree of diabetic 
control and studies of other organisms that might be of 
clinical relevance to the patients. To understand the 
role of neutrophils in diabetics, a study of metabolic 
aspects of the cell was undertaken (Esmann, 1983). PMNLs 
from severely diabetic patients exhibited a decreased 
rate of glycolysis due to decreased activity of 
phosphofructokinase. A decrease in total activity of 
glycogen synthetase and impaired activation of this 
enzyme led to a decrease in glycogen synthesis thereby 
reducing the glycogen content of the cell. It is 
hypothesized that such enzymatic impairment is crucial 
in diabetic patients and can be restored upon insulin 
treatment.
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Chemotaxis
Perillie and colleagues studied the local exudative 
response to inflammation in the skin of diabetic
patients using the Rebuck glass coverslip technique 
(Peril lie et al , 1962). During the first 3 hours the
neutrophil response was virtually absent in patients 
with acidosis (uremic or diabetic) in comparison with 
non-d i abet i c and we11 cont rolled d i abet i c sub j ect s . 
Local cellular responses were markedly increased with 
improvement of acidosis thus concluding that acidosis 
resulted in reduced capacity to resist invasion and
spread of bacterial organisms. Kjersem et al (1988) 
made a direct study of the correlation between blood 
sugar level and neutrophil motility. PMN migration 
measured both in vivo (skin-chamber) and in vitro 
(modified Boyden chamber) was shown to be decreased in 
diabetics during normo- as well as hyperglycemic states. 
Short-term changes in metabolic control seem to be
without effect on chemotactic abnormality. Poor PMN 
movement has been described not only in diabetic
patients but also in their non-diabetic first degree 
relatives suggestive of a heritable defect rather than 
one induced by metabolic upset (Molenaar et a l , 1976).
Phagocytos is
In vitro phagocytosis examined in 38 nonacidotic 
and 7 acidotic diabetic patients showed that only the
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latter manifested decreased phagocytic activity and the 
defect disappeared upon correction of acidosis (Bybee 
and Rogers, 1964). Recent experimental evidence however 
showed that phagocytosis in diabetic patients was 
comparable to that of control cells unless the control 
cells were incubated with the patients sera which tended
to reduce the activity (Tater et al , 1987). ,_______-
Kjersem et al in 1988 observed that serum independent 
phagocytosis was significantly increased during normo- 
and hyperglycemia but a reduction was noted from normo- 
to hyperglycemia. Serum dependent phagocytosis of 
opsonized LPS particles however was no different in 
patients and controls during normoglycemia.
Intracel1ular ki11ing
Nolan et al (1978) separately assayed engulfment 
and intracellular killing of S. aureus in an in vitro 
system using diabetic PMN. The cells treated with 
insulin or oral hypoglycemic agents displayed decreased 
bacterial killing as compared to the controls. When the 
patients were retested after improved blood glucose- 
control, 6 out of 7 patients showed improvement in
intracellular killing. Later oxidative killing of 
Candida albicans in vitro under elevated glucose and 
beta-hydroxybutyrate concentrations both independently 
and in combination was studied (Wilson and Reeves, 
1986). Their data suggest that oxidative killing by
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neutrophils from IDDM patients is inhibited by high 
concentrations of glucose and ketones be it separately 
or in combination. Killing by non-oxidative means was 
nevertheless unaffected by the in vitro metabolic 
disturbances .
Adhesion
Diabetic neutrophils manifested diminished 
adherence to nylon fiber columns (Bagdade et al , 1978)
and later were shown to have a similar physiological
impairment when bovine aortic endothelium was employed
as a substratum for adhesion 
(Anderson et a l , 1988). No correlation bet ween met abolie
control and adherence to the endothelium was suspected
but instead the impaired release of fibronectin by
neutrophils was suggested to be the explanation for
defective adhesion. They found that diabetic plasma
augments adherence of diabetic neutrophils to
endothelium implicating a plasma factor as acting
specifically on endothelium rendering the substrate
hyperadhes i v e .
Accumulated data allow a formulation of a model 
which may account for the infectious complications of 
diabetes. Diabetic PMNs have defective adherence to 
endothelium resulting in a poor tissue inflammatory 
response although in the intravascular space the plasma 
may serve to correct the defective property. There is a
speculation that 2 factors, defective neutrophil
cicil 10 s i o n  ci i i \„l
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endothelial cell hypoadhesiveness, together may act to 
prevent PMN exudation from the vascular space and hence 
results in a suboptimal neutrophil response in 
inflammation.
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Section 9 
Purpose of study
The ability of PMNs to migrate towards a site of 
inflammation is an area in cell biology that has long
been of interest to cellular immunologists. The work in 
this thesis is intended to contribute further to the 
knowledge of the mechanism by which these cells 
traverse the blood vessel wall towards the site of 
injury particularly in the presence of endotoxins. The 
project to be described will mainly focus on the 
locomotory responses of PMN when challenged with LPS and 
the effects of certain antagonists on these responses. 
Antagonists used included polymyxin B, steroidal and
non-steroidal anti-inflammatory drugs. Monoclonal 
antibodies towards CD18 glycoproteins were used to 
observe the blocking effect on neutrophil shape change 
due to LPS and eventually to establish whether this 
family of receptors plays a role in providing a receptor 
site for LPS on the cell surface which controls the 
locomotor response to LPS. To assay the locomotory 
responses of PMN, recent techniques in studying cell
locomotion were implemented namely the polarisation 
assay, the micropore filter assay, the visual assay and 
the gel invasion assay.
Once data had been obtained from normal healthy 
individuals, the system was tested on cells from
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patients. PMN from diabetic subjects were chosen for 
this study since PMN functions in these patients have 
been reported to be defective (see previous section). 
Besides investigating the locomotive function, metabolic 
activity of these cells in comparison with the normal 
cells was evaluated in the presence of LPS using a 
chem i1urn i nescence assay.
CHAPTER 
M A T E R I A L S  A N D
2
METHODS
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Siliconization of glass slides
Siliconized cavity glass slides were used to study 
the PMNL activity in suspension observed on a time-lapse 
video system. The slides were initially cleaned by 
dipping them in stericol solution and washed with 
running water. They were then air dried and cooled 
before siliconizing them. To coat with silicone, the 
slides were immersed in repelcote (Hopkin and Williams, 
Chadwell Heath, England) a 2 % solution of water
repellent consisting of dimethyl-dichlorosilane in 
1,1,1-trichloroethane, for 1 minute and then air dried 
for another 60 minutes. This was done at room 
temperature inside a fume hood. After drying, the slides 
were rinsed with distilled water to remove any traces of 
hydrochloric acid formed during hydrolysis of repelcote. 
Finally the slides were dried in a hot air oven and then 
autoclaved for sterilization.
Preparation of standard buffer
For a standard buffer, one molar MOPS (3-(N- 
morpholino) propanesulfonic acid) (Sigma, Poole, Dorset) 
was prepared by dissolving 20.93 gm in 90 ml of 
distilled water with a magnetic stirrer. The pH of the 
buffer was adjusted to 7. U using the pH meter by slow 
addition of 16N sodium hydroxide (BDH Chemicals Ltd, 
Poole, England) with constant stirring. The final volume
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was adjusted to 100 ml at the desired pH value followed 
by filter sterilization. The latter was done by 
filtering through 0.2 pm pore sized filters (Flow- Pore 
D26, Flow Labs Ltd., Rickmansworth, Herts, England), and 
the solutions were aliquoted into 20 ml sterile 
universal bottles and stored at 4° C before used.
Preparation of media
Hanks balanced salt solution (HBSS) (Flow Labs 
Ltd., Rickmansworth, Herts) was prepared by diluting a 
ten-times strength HBSS solution (10 ml volume) with 89 
ml of sterile distilled water and 1 ml of 1M MOPS. This 
medium was labelled as HBSS/M0PS after adjusting the pH 
to 7.2 with IN NaOH. HBSS phenol red free solution was 
used as a prepared isotonic solution (Flow Labs) and 
buffered by the addition of 1 ml 1M MOPS to 99 ml HBSS. 
Human serum albumin (HSA) (Hoechst, England) was 
dissolved in HBSS/M0PS or phenol red free HBSS/MOPS 
(prf-HBSS/MOPS) at a concentration of 10 mg/ml.
Preparation of fixative
Glutaraldehyde (Grade II, 25 % aqueous solution,
Sigma, Poole, Dorset) was added to HBSS/MOPS to give a 
2.5 % v/v solution. The pH was adjusted to 7.4 by adding 
IN NaOH. The fixative used to fix cells throughout the 
project where appropriate was designated as glutd/HBSS- 
M0PS.
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Preparation of test reagents
N-f ormy1-L-met h i ony1-L-1eucy1-L-pheny1a 1an i ne 
CFMLP), leukotriene B4 (LTB4 ), luminol, phorbol 12- 
myristate 13-acetate (PMA), zymosan and dimethyl 
sulphoxide (DMSO grade I) were purchased from Sigma. 
FMLP, LTB4, luminol and PMA were prepared as stock 
solutions of 10“2M in DMSO and stored at -20° C. Fresh 
FMLP solution at desired concentrations were made up in 
HBSS/MOPS when needed. LTB4 was used in thin layer 
chromatography as prepared. Luminol and PMA were diluted 
at appropriate concentrations in prf-HBSS/MOPS before 
used in chemiluminescent assay.
Non-steroidal antiinflammatory drugs BW755C (Burroughs 
Wellcome) and Revlon 5901 (ICI). were given by Dr. A.Rossi 
(Pharmacology Dept., Glasgow University) while 
indomethacin and dexamethasone were obtained from Sigma.
The drugs were dissolved in DMSO at a concentration of 
10“ 2 M .
Peptides possessing the triplet RGD sequence were 
purchased from Sigma: Gly-Arg-Gly-Asp-Ser, Gly-Arg-Gly-
Asp-Pro-Lys, Arg-Gly-Asp and Arg-G’ly-Asp-Ser. These 
peptides were dissolved in HBSS/MOPS at a concentration 
of 10“2M. Monoclonal antibodies against CD11/CD18 
glycoproteins, adhesion related surface receptors of
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leukocytes, were generously given by Prof. A. McMichael 
and Dr. D. Mason (University of Oxford) and Dr. N. Hogg 
(Imperial Cancer Research Fund, London). The antibodies 
(listed in table 1) were dialysed against HBSS/MOPS for 
24 hours to remove azide and eventually stored in a -20° 
C freezer at 1 /ig/jul concentration.
Platelet activating factor, PAF Ci6 (1-0-Hexadecyl- 
2-acetyl-sn-glycero-3-phosphocholine), was obtained from 
BCL, Sussex, England. The factor was dissolved in 
HBSS/MOPS at 10_2M. Glucose, anhydrous monosaccharide 
sugar, was supplied by BDH Chemicals, Dorset, England.
Lipopolysaccharides of Shigella flexneri (Ra, R c , 
Sla and Sic) were prepared by Dr. Simmons (Dept. 
Bacteriology and Immunology, Western Infirmary) while 
1ipopolysaccharides of Salmonella minnesota (Re and Sm) 
were purchased from Sigma. These 1ipopolysaccharides 
(LPS) were from rough strain mutants (designation 'R') 
and smooth strains (designated as ’S ’) of the bacteria. 
Figure 2 shows the exact positions of these LPS 
chemotypes. The LPS were mixed in a 56° C sterile 
distilled water at a final concentration of 1 mg/ml and 
kept at 4° C. Lipid A from Salmonella minnesota was 
purchased from Sigma and prepared similarly to LPS. 
Freeze-dried polymyxin B sulphate (Aerosporin, Wellcome
84a
Ant i-CDlla Anti-CDllb Anti-CDllc Anti-CD18 Donor
711 649 256 706 McM i chae1
714 650 277 710 »»
715 651 300 713 I!
717 652 721 719 If
720 653 727 725 If
723 654 728 I
724 656 It
657 «
44 3.9 Hogg
2LPM19C KB23 Mason
KB90 it
Table 1. Antibody codes. Monoclonal antibodies used to 
block LPS-induced PMN polarization.
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Foundation Ltd., England) was dissolved in HBSS/MOPS at 
a concentration of 1 mg/ml.
Fresh human serum
Blood samples from normal and patient volunteers 
were transferred into sterile bijou containers and left 
undisturbed for 30 minutes at room temperature for 
clotting. The clot was centrifuged at 500 X g for 5 
minutes and the clear serum was saved in a plastic tube.
Isolation of neutrophil leukocytes
Human blood was collected from normal donors by 
venepuncture and was mixed with preservative-free 
heparin (Evans Medical Ltd., Liverpool) at 10 units/ml 
in sterile plastic universals (Sterilin Ltd., 
Teddington, England). Patient's blood samples were 
generally transported in a sterile lithium heparinised 
plastic tube. The patients involved in the study were of 
type 1 (insulin-dependent) and type 2 (non-insulin- 
dependent) diabetics. Their ages ranged from 20 to 40 
years and the duration of the diabetes was between 1 and 
28 years. All of the subjects were microproteinuria 
negative and had no infections during the study while 
approximately half had background diabetic retinopathy. 
The blood was then layered onto lymphocyte separation 
medium, an aqueous solution of Ficoll and sodium 
metrizoate with a density of 1.077 gm/mi at 20° C (Flow
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Labs Ltd., Rickmansworth, Herts), in a ratio of 2 ml of 
separation mixture to 3 ml of blood. The content was 
then centrifuged for 30 minutes at 400 X g. All 
centrifugations were carried out at room temperature and 
sterile conical base plastic centrifuge tubes were used 
throughout the experiments (Sterilin Ltd., Teddington, 
England). The supernatant including the mononuclear cell 
layer was removed and the mixture of erythrocytes and 
granulocytes was resuspended in HBSS/MOPS. This 
suspension was mixed with 6% dextran solution (Dextraven 
110, CP Pharmaceuticals Ltd., Wrexham, UK) in a 
proportion of 1 ml dextran to 3 ml of cell suspension, 
left for 40 minutes at room temperature and the 
leukocyte-rich supernatant was then decanted. 
Erythrocyte contamination is conventionally removed by 
the use of aggregating agents such as high molecular 
weight dextran (Skoog and Beck, 1956). These agents 
promote aggregation of erythrocytes in fluid medium 
consequently leading to more rapid sedimentation rate of 
the red blood cells. The leukocyte-rich supernatant was 
centrifuged for 10 minutes at 400 X g leaving the pellet 
comprising of granulocytes and some erythrocytes. 
Removal of residual erythrocytes contamination is of 
great importance in this project especially in 
chemiluminescence studies as red coloured solutions may 
quench light emission. Erythro-lysis of the leukocyte- 
rich pellet was performed by osmotic lysis in which the
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cells were briefly exposed to distilled water. The 
procedure effectively removes erythrocytes but must be 
done rapidly . ( < 30 seconds) to leave the
leukocytes intact. The suspension was transferred to 
another tube followed by adjustment of the solution to 
isotonicity with the addition of HBSS/MOPS and 
centrifuged at the above mentioned speed and time. The 
pellet was washed one more time before resuspending in 
HBSS/MOPS containing HSA and counted in an improved 
Neubauer haemocytometer. The yield ranged from 1.0-2.0 X 
107 cells/ 10 ml of blood giving a population of > 95% 
round neutrophils as judged by phase-contrast 
microscopy with a 40X objective.
Checking cel 1 viabi1ity
A 0.2% solution of trypan blue (BDH Chemicals Ltd., 
Poole, UK) was prepared in normal saline and was 
filtered to remove any undissolved dye. One hundred 
microliter of cell suspension at 106 cells/ml was mixed 
well with 100 pi of the dye solution and left for 1 
minute at room temperature. A drop of this mixture was 
placed on a microscope slide, mounted with a coverslip, 
examined under the 20X phase-objective of an inverted 
microscope (Nikon, MSD). Viable cells excluded the dye 
solution and were retractile whereas dead cells took up 
the dye and stained blue. Neutrophils isolated by the 
stated procedure always contained > 97% viable cells.
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Isolation of collagen
Type 1 collagen was prepared from rat tail tendons 
following the method of Elsdale and Bard (1972) with 
slight modifications . Tails were collected from rats 
weighing 230-250 grams. They were soaked in 70% ethanol 
for 5 minutes before removing the skin. Tendons were 
stripped and dipped in HBSS/MOPS containing 50 units/ml 
penicillin and 50 jug/ml streptomycin (Flow Labs Ltd., 
Rickmansworth, UK) for 5 minutes. The medium was removed 
and the tendons were soaked in 3% acetic acid (BDH 
Chemicals Ltd., Poole, UK) in a sterile conical flask 
and left overnight at 4° C. The content of the flask was 
thoroughly mixed for 1 hour with a magnetic stirrer and 
undissolved materials were removed by centrifugation at 
800 X g for 30 minutes. The clear tropocollagen solution 
was mixed with 20% wt/v sodium chloride at 1:2 to 
precipitate the collagen. It was then centrifuged at 600 
X g for 40 minutes when collagen precipitates 
accumulated at the top of the centrifuge tube and the 
undissolved materials were removed as a pellet. Collagen 
precipitates were collected and washed once with 
distilled water. They were dissolved again in 3% acetic 
acid and centrifuged twice at 800 X g for 20 minutes 
each time rejecting a portion of the solution at the 
bottom of the centrifuge tube. This treatment completely 
removed small undissolved materials from the collagen
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solution with an increase of optical quality. Collagen 
solution was dialysed against distilled water adjusted 
to pH 4 with hydrochloric acid. The concentration of 
collagen in solution was determined by comparing the 
optical density value at 234 nm (using matched cuvettes 
‘in a Pye Unicam Spectrophotometer, SP 1800) to a 
standard graph prepared with a freeze dried sample of 
the same collagen preparation. Aliquots of the collagen 
solution were dispensed into sterile plastic tubes and 
stored at -20° C until use.
Polarisation assay
The assay depends on obtaining a starting 
population of round unstimulated cells. Conical bottomed 
plastic tubes were used throughout as prolonged contact 
with glass causes adhesion and eventually release of 
endogenous chemotactic factors leading to a high 
background of polarised cells. After the process of cell 
separation, neutrophils were checked for their polarised 
morphology. Final cell preparations should be > 95%
spherical. Otherwise the preparation had to be 
discarded.
For the assays, following the method of Haston and 
Shields (1985), neutrophils were adjusted to 1 X 106 
cells/ml in HBSS/MOPS+HSA to which the substance to be 
tested was added. The tubes were incubated for the 
required time period at 37° C and then equal volumes of
2.5% glutd/HBSS-MOPS were added to each tube to fix the 
cells. After 10 minutes the fixed cells were washed 
twice in HBSS/MOPS and resuspended in the remaining 
medium (about 500 a*1). The fixed cells were examined by 
phase contrast microscopy with a X 40 objective (Vickers 
Microscope) and any cells deviating from spherical 
outline were scored as polarised. A total of 300 cells 
were counted in each preparation and the number of 
polarised cells was expressed as a percentage of the 
total cells enumerated. Neutrophils which were spherical 
in outline but with filamentous projections or small 
blebs were counted as negative or unpolarised.
Supernatant col lection
Neutrophils at 1 X 106/ml were incubated in sterile 
conical test tubes containing 10 pg/ml LPS for 90 
minutes at 37° C. The tubes were then centrifuged at 400 
X g for 8 minutes and the supernatant was transferred to 
another tube before being used. With this simple method, 
whatever factor(s) that are being released by the cells 
should be obtainable in the cell-free supernatant. The 
supernatant was usually used immediately in appropriate 
tests with a new batch of neutrophils or sometimes 
stored at 4° C overnight before use.
91
Preliminary investigation of released factor(s)
The supernatant obtained from preincubating 
neutrophils with LPS was dialysed against HBSS/MOPS for 
24 hours at 4°C. The dialysate and the solution outside 
the dialysing tubing were tested for the presence of 
factor(s) that stimulate locomotion as judged by the 
polarisation assay. The supernatant was also subjected 
to heat treatment at 56° C for 30 minutes or 100° C for 
3 minutes.
Hexane extraction and thin layer chromatography
An equal volume of supernatant and hexane was mixed 
in a separating funnel for the 1iquid-1iquid extraction 
process. The aqueous layer was eluted and mixed with 
another volume of hexane twice after which it was 
restored to physiological conditions and tested for the 
presence of any neutrophil polarising activity. The 
organic layer was collected, pooled together and 
concentrated using a rotary evaporator (Btlchi 1.011, 
Switzerland). Evaporation was conducted under pressure 
provided by a water pump. The evaporation flask was 
heated to a temperature of 50° C on a water bath and 
rotated during the process.
The concentrated organic layer was spotted on a 
thin layer chromatographic plate which had been coated 
with silica. The plate was then placed in a chamber 
containing 20% ethyl acetate and 80% petroleum ether for
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60 minutes at room temperature. Later the plate was air- 
dried, sprayed with concentrated hydrochloric acid and 
heated in a 250° C oven for 5 minutes. Before spraying, 
the plate was usually observed under ultraviolet light 
to spot the probable area where the substance had 
migrated. The concentrated sample was also tested for 
neutrophil polarising activity under physiological 
cond i t i ons.
Gel filtration and spectrophotometry
A column of Sephadex G-25 (superfine) (Pharmacia 
Fine Chemicals, Middlesex, UK) was prepared by allowing 
the dry powder at 5 mg/ml to swell in an excess of 
phenol red-free HBSS/MOPS for 1 hour at 90° C. The high 
temperature serves to accelerate the swelling process as 
well as to deaerate the buffer. The suspension was 
stirred gently with a glass rod. Once the gel had 
swollen, it was carefully poured into a 25 ml (1 cm in 
diameter) chromatography column. The column, with a 
stopcock plug at the bottom, was plugged with cotton 
wool to form a bed support for the gel suspension. All 
the gel required was poured in a single operation and 
was allowed to settle before opening the outlet. The 
outlet plug was released to allow the eluant to flow out 
with three volumes of eluent passing through the column 
in order to stabilize the bed. Each time the buffer was 
eluted out, the top portion of the column was carefully
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filled with eluant buffer thus preventing the column 
from drying and disturbing the packing process. After 
the third running, the sample was layered above the gel 
surface using a pasteur pipette and the column outlet 
was opened allowing the sample to drain into the bed. 
The eluant was collected in sterile plastic tubes at a 1 
ml volume each. The samples collected were then analysed 
for protein content by spectrophotometric determination 
before using it in polarisation assay. Matched cuvettes 
in a Pye Unicam Spectrophotometer SP 1800 were used to 
determine the absorbance of protein molecules at 280 nm 
wavelength.
Micropore filter assay
As mentioned in the introduction, the assay 
consists of an upper chamber suspended in a lower 
chamber. The upper chamber is a sawn-off tuberculin 
syringe barrel while the lower chamber is a machined 
multiwell plastic compartment placed in a box with holes 
bored in its lid. Cellulose ester filters (Millipore, 
Bedford, UK) with a thickness of 150 pm and pore size 3 
pm were glued to the lower end of the upper chamber with 
Uhu glue (Beecham Uhu, Middlesex, UK). The lower 
compartments were filled with 170 pi of test reagents 
and the upper chambers contained 1 X 106 neutrophils/ml 
in HBSS/M0PS+HSA in 100 pi. The filters were allowed to 
wet from the top before lowering into the lower chambers
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to ensure that the filters were presoaked with non- 
chemotactic medium. The tests were incubated at 37° C 
for 60 minutes undisturbed to allow cell locomotion.
At the end of the incubation period, the upper 
chambers were removed, inverted to empty out the fluid 
and were immersed in 70% ethanol to fix the cells 
present on and in the filters. As the glue melted the 
filters were detached from the barrel and transferred to 
Sterilin plastic dishes containing 25 compartments each 
of 1.8 cm2 using a forceps touching only the rim. Small 
holes were punched out at the bottom of each compartment 
allowing fluid to flow in and out freely. The filters 
were well identified by placing them in different 
compartments before commencing the staining step. The 
filters were stained in sequence by dipping them in 
distilled water for 1 minute, haematoxylin 1 minute, 
distilled water 1 minute, tap water 10 minutes, 70% 
ethanol 2 minutes, 95% ethanol 3 minutes and a mixture 
of 80% ethanol and 20% butanol for 5 minutes. Since 
xylene dissolves plastics, dipping the filters in xylene 
was carried out in glass bijou bottles. The filters were 
mounted top side up on glass slides covered with DPX and 
coverslips after the xylene had clarified the filters. 
To assess cell migration, the leading front method was 
used. Using the X 40 objective of a light microscope, 
the micrometer fine adjustment was racked down past the 
leading front of cells. It was then racked back up to
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the leading plane in which the nuclei of two or more 
cells were in focus together within a field, at which a 
micrometer reading was taken. The fine adjustment was 
racked up to the top of the filter and a second 
micrometer reading was noted. The difference between the 
two readings gave the measure of the migrated distance 
by the leading front of the cells. A mean was calculated 
after five readings were taken at different planes in 
each filter.
Preparation of collagen gel assay
Three-dimensional collagen matrices were prepared 
by adjusting the osmolarity and pH of the stock collagen 
solution, 2 mg/ml, to physiological levels (Shields et 
al , 1984). One milliter of 10X RPMI 1640 (Flow Labs
Ltd., Herts, UK), 200 jil MOPS (pH 7.4), 44 nl NaOH and 
8.8 ml of collagen solution were mixed rapidly in a 
sterile plastic tube (final collagen concentration in 
the gel was 1.76 mg/ml). The method to study human 
neutrophil migration towards gradient sources was 
adapted from Islam et al (1985) . Gels for the 
chemokinetic experiments were prepared by dispensing 0.5 
ml portion of the mixture into the wells of a tissue 
culture plate (Flow Labs) with 24 flat-bottomed wells 
(1.7 X 1.6 cm). Gels were allowed to become firm at room 
temperature within 15 minutes. The substance to be 
tested was layered onto the gel and left for 1 hour for
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even distribution. The remaining fluid was removed and 
cells in suspension containing the tested substance were 
overlaid on top of the gel. For controls, the substance 
was absent in both the gel and cell suspension. 
Neutrophils suspended were used at 106 cells/well in 1 
m 1 suspens i o n .
Gels for the chemotactic assays were prepared as 
follows: 0.4 ml of collagen was distributed and allowed 
to set in wells of tissue culture plate. The test
substance was layered on top of the gel for 1 hour after
which the remaining fluid was removed followed by 
layering of 0.3 ml collagen over the first gel and 
allowed to set. This was to form a layer through which the 
substance could diffuse to form a gradient. A suspension 
of neutrophils at 106 cells/ml in HBSS/MOPS + HSA was
added to the top of the collagen layer an hour later. A 
similar procedure was used for controls with the absence 
of test substances. The plates were immediately 
incubated in moist chambers at 37° C for the cells to 
invade the gel for various time periods. Collagen gels 
were fixed after the prescribed time with 2.5% 
g 1utd/HBSS-MOPS for 30 minutes at room temperature. The 
upper surface of the gel was washed 3X with HBSS/MOPS to 
remove non-invaded cells. A leading front method was 
used to quantify the infiltration of neutrophils into
the gels (Zigmond and Hirsch, 1973). Four randomly 
chosen fields on duplicate gels were counted for
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migrated neutrophils assessed by the calibrated 
micrometer of a Nikon inverted phase contrast microscope 
under X 200 magnification.
Visual assay of neutrophi1 shape change in suspension
The filming chamber used for visual assay of cells 
in suspension was a si 1 iconised cavity glass slide (76 X 
25 mm; BDH Ltd., Glasgow). Square coverslips (22 X 22 
mm) were washed in stericol, rinsed thoroughly in 
distilled water and finally blot dried with soft tissue. 
A sample of 100 pi of cells at 106 cells/ml in 
HBSS/MOPS+HSA preincubated at 37° G with 10 pg/ml LPS 
was transferred to the chamber after each incubating 
time period covered with a clean coverslip that had 
silicone vacuum grease ringed around it. The filming 
chamber was immediately placed on an Olympus phase- 
contrast microscope stage (BH-2) at a X40 magnification 
where the temperature was maintained at 37°C using a 
warm air curtain. After filming was done using a 
Panasonic video camera and a time lapse recorder 
(Panasonic NV-8050) recording at 48 t imes faster than real 
time, shape change was traced out from the screen on to a 
tracing paper by playing back the recorder and pausing 
for every 30 seconds to draw the outlines.
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Shape analysis of fixed cells
Glutaraldehyde-fixed cells after polarisation assay 
were mounted on slides and the outlines of the cells 
were drawn using a camera lucida attachment on a Wild 
M20 microscope with a bright field illumination and a 
X100 objective. The optical section that most nearly 
represented the shape that could be deduced by focusing 
up and down was drawn. With the assistance of Dr. J.M. 
Lackie from the Department of Cell Biology, Glasgow 
University, outlines of the cells were then traced on a 
digitizing tablet with the stylus set in a stream mode, 
a technique introduced to analyse cell behaviourCWiJkinson 
et al , 1988). The three shape parameters (elongation, 
dispersion, and extension) were stored for each cell and 
at least 50 cells were measured from each experiment. 
This analytical exercise was first used by Dunn and 
Brown (1986) . Extension is a measure of how much the
shape differs from a circle and has a value of zero if
the shape is circular. It is also the sum of elongation 
and dispersion. Dispersion is a measure of irregularity 
of contour and proved useful as an objective criterion 
to distinguish spherical from non-spherical cells. 
Elongation is a measure of how much the shape must be
compressed along its axis in order to minimize its
extension. Elongation can never take a value of less 
than zero or greater than extension. Comparisons between 
vaiues were made using Mann-Whitney U-tests.
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Chemiluminescence
Cells for 1uminometry were prepared as described 
previously but were finally resuspended in phenol red- 
free Cprf)- HBSS/MOPS +HSA. Opsonization was performed 
by suspending zymosan in prf-HBSS/MOPS containing serum 
at appropriate dilution and incubating at 37° C for 30 
minutes in a water bath. The suspension was centrifuged 
at 3000 X g for 10 minutes before washing the pellet 
twice and finally resuspended in prf-HBSS/MOPS. Luminol, 
used to amplify chemiluminescence, which had been 
dissolved in DMSO at 10" 2 M as a stock solution was 
further diluted in prf-HBSS/MOPS to the required 
concentration prior to use.
The cell suspension, luminol in medium and test 
substances were pre-warmed at 37° C in a water bath for 
10 minutes before using them. The reaction mixture 
consisted of neutrophil suspension (1 0 6 cells/ml), 2 0 0  
til luminol at 10-4M and test substances mixed in a 3 ml 
disposable test tubes (LP3, Luckham Ltd., Sussex). It 
was placed in the light-proof chamber of the Luminometer 
1250 (LKB Wallac). The carousel was rotated to bring the 
sample in line with the photomultiplier tube to record 
the readings; the resulting light output in mV was 
recorded on the digital printout set at 1 0  second 
recording integrals. The temperature within the reaction 
tube was controlled by water passing from
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t hermost at i ca 1 1y cont ro 1 1ed c i rcu1at or t hrough a 
polished hollow metal sample holder thus maintaining the 
reaction mixture at 37° C. The gain control was set to 
give a reading of 10 mV using a built-in standard while 
a background ;subtract. ion , control zeroed the instrument 
prior to placing the sample in the chamber.
Photomiorography
Still photographs were taken using an Olympus 
microscope (BH-2) equipped with phase-contrast optics 
with X40 and X100 objectives. Photographs were taken on 
Kodak Panatomic X 35 mm films (ASA 32). The films were 
developed using HC110 developing solution and fixed with 
Unifix. For printing on Kodakgraph projection paper, 
Kodak Dektol developer and Uni fix were used.
Statistical analysis
Each experimental value was determined in 
triplicates or more or otherwise stated. The average 
values were used for statistics. Data were expressed as 
means ± standard deviation values. Differences between 
the controls and test samples were analysed by the two- 
tailed Student's t-test for paired data (significant P< 
0.05). Where appropriate, correlation coefficients were 
determined and the significance test was made using the 
t-test. Non-parainet r i c tests. Mann-ivni tnev U-tests , were 
used i 11 t. tie shape anaiys is of f ixed ce 11 s .
CHAPTER 3 
RESULTS AND DISCUSSION
102
Section 1 
POLARISATION ASSAY
Besides the widely known chemotactic factors, the 
presence of LPS causes polarization in a suspension of 
PMN (Haslett, 1985). In the first part of the project,
LPS from Shigella f lexneri and Salmonella minnesota were 
tested in the polarisation assay using several different 
LPS chemotypes to investigate the relationships that 
might exist between the structural complexity of LPS and 
the PMN shape change in the absence of serum. Figure 1 
shows the cell envelope of Gram-negative bacteria and a 
detailed structure of the envelope. The general 
structure of bacterial LPS with the different sites of 
mutation resulting in the chemotypic variations is shown 
in figure 2. Gram-negative bacteria appear to share a 
common pattern in the structure of their cell envelopes 
(Hammond et a l , 1984).
Dose response
After isolating PMN from the whole blood, the cells 
were incubated with varying concentrations of LPS of 
each chemotype at 37° C for 60 minutes and then fixed 
with 2% glutaraldehyde. The number of cells acquiring 
polarised morphology was enumerated and expressed as a 
percentage. The rough strain LPS (Ra and Rc of Shigella
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flexneri , and Re of Salmonella minnesota) of the 
bacterial species caused a greater percentage of shape 
change in neutrophils (Figure 3) than the smooth or 
wild type strains (Sm of Salmonella minnesota, Sla and 
S3a of Shigella flexneri'). The percent polarisation 
increased as the concentration of LPS increased and 
eventually plateaued out with an optimum at 1 0 4 ng/ml. 
Beyond this concentration there was no enhancement of 
polarisation. At the lower level of LPS concentrations, 
both the rough and smooth strains were able to elicit 
shape change down to 100 ng/ml. Within the rough strain 
chemotypes, the Re mutant of Salmonella minnesota 
induced more polarization (54%) than the two chemotypes 
of Shigella flexneri (30% - Ra, 37% - Rc) while among 
the smooth strains there was less variation (18-25% 
polarisat ion).
Time course
Using 104 ng/ml (10 /ig/ml) as the working 
concentration, LPS from Salmonella minnesota Re mutant 
was assayed for its effect on shape change at times 
between 0 to 110 minutes. Figure 4 shows that the 
proportion of polarized cells increased to a maximum at 
90 minutes. Prolonging the time of incubation up to 150 
minutes failed to increase the number of PMN polarising 
in response to the presence of LPS. Figure 5 shows a 
series of pictures of neutrophils at different times
104
after exposure to LPS. Some cells showed polarization 
after 15 minutes of exposure to LPS (Figure 5c) and this 
increased up to 60 minutes (Figure 5d-f). Cell viability 
remained intact in LPS up to 110 minutes judged from the 
the morphology and retractility of the cells under 
phase-contrast microscopy.
Effect of antibiotic
Polymyxin B sulfate has been frequently used to 
counteract the biological effects of LPS by forming a 
stable complex with the lipid A region of LPS molecule 
(Morrison and Jacobs, 1976). Hence, in this polarising 
assay polymyxin was added to neutralise any LPS effects 
on the neutrophils. Varying concentrations of polymyxin 
were mixed with the cells for 1 0 minutes before 
challenging with LPS for 90 minutes fixing the cells at 
the selected incubating period. Equivalent concentration 
of polymyxin to that of LPS (10 /ig/ml) did reduce the 
population of cells with non-spherical shape but 
statistically this was insignificant (Figure 6 ). Smaller 
concentrations were virtually ineffective in modulating 
the polarisation of PMN. Incubating LPS with polymyxin 
before adding the cells did not produce a similar result 
to that shown in figure 6 ; cells polarising as if there 
was no antibiotic present. Incubation of cells with 
polymyxin alone did not cause any shape change thus
105
excluding the possibility Qf the antibiotic contributing 
to the polarisation of PMN.
Discussion
The effect of LPS on neutrophil shape change has 
been reported (Haslett et al , 1985) but not examined in 
detail. Such neutrophil responses were therefore 
investigated employing different LPS chemotypes of 
bacterial species. Figure 3 suggest that LPS structure 
is important in affecting shape change of the 
neutrophils. As the number of sugar moieties decreased, 
a bigger polarising response was observed supporting the 
view that the molecular composition of LPS partially 
determines the polarisation effect. This relationship 
can be seen from figure 7 which depicts the polarising 
activity of PMN with respect to the specified chemotypic 
variation of LPS molecule. Thus these sugar moieties may 
prevent LPS from interacting with the neutrophils. This 
observation is similar to that of the phagocytic 
activity of PMNs towards a bacterium in which smooth 
strains of a bacterial species having complete 
polysaccharide chains are less effectively phagocytosed 
than mutants devoid of certain sugar molecules on the 
cell wall backbone (Hammond et al , 1984). It has been
documented that the mutant Re 595 endotoxin, which is 
devoid of all 0- and R-polysaccharides and backbone 
sugar he.pt.ose, does possess similar biological
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activities including immunogenicity, pyrogenicity, arid 
lethality to that of the smooth LPS though somewhat 
lower (Kim and Watson, 1967; Kasai and Nowotny, 1967).
It is quite evident then that O-polysaccharides as well 
as R-polysaccharides and heptose are either non­
functional in inducing the shape change of neutrophils
or inhibit shape change suggesting that the shape-change 
- response is associated with the 1 ipid portion! of the
molecule.
Unlike the shape change in response to chemotactic 
peptides that occurs rapidly (between 5 to 30 minutes), 
polarisation of PMN after the exposure to LPS was slow. 
Maximal response was attained only after 90 minutes of 
exposure. The slow response suggests an indirect effect 
of LPS which may prime the neutrophils to respond to 
some other factors. To define the requirement of the 
presence of LPS in inducing shape change, the 
neutrophils were pretreated with polymyxin B sulfate, an 
antibiotic which has been reported to diminish the 
biologic effects of endotoxin on neutrophil lysosomal 
enzyme release, metabolic changes associated with the 
release and reduction of nitroblue tetrazolium dye 
(Bannatyne et al , 1977; Corrigan et a l , 1974). The
neutralising effect of polymyxin on LPS-induced 
neutrophil shape change was tested. The number of 
poLarised PMN was minimally reduced (figure 6 ) and this 
was insignificant statistically. Polymyxin B sulfate has 
been shown to disrupt bacterial endotoxin (Koike et al ,
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1969). Earlier studies proposed that polymyxin competes 
for the same receptor sites as that of LPS on the target 
cell (Kunin, 1970; Kunin and Bugg, 1971). Later 
Morrison and Jacobs (1976) reported that polymyxin in 
fact interacted directly with the lipid A region of 
bacterial LPS. They have demonstrated the interaction to 
be stoichiometric. The ineffectiveness of polymyxin in 
causing significant blocking of cell polarisation could 
be due to the presence of a second (non-LPS) agonist or 
it may be part of the LPS other than lipid A that has 
different sites of action on the target cells thus 
promoting further polarisation. When lipid A was tested 
in the polarisation assay, the response was rapid 
(Figure 8 ) similar to that of FMLP (Haston and Shields, 
1985; Shields and Haston, 1985). The purity of the LPS 
samples should be considered as a possibility that may 
influence the biological activity. LPS samples from Dr. 
D.A.R. Simmons are known to be quite pure, and 
particularly are free of peptides and any proteins. 
However, the purity of commercially available LPS and
lipid A are unknown.
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Figure 3. Dose response curve. Neutrophil polarisation in response to 
LPS from S h ige lla  flexneri (Ra, Rc, S1a, S3a) and 
Salmonella minnesota (Re and Sm) at 37° C for 60 minutes. 
Designation R represents rough strain while S indicates 
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Figure 4. Time course of polarisation of neutrophils in response 
to LPS of mutant strain Salmonella minnesota Re 595 
(10 ug/ml ) incubated at 37° C. The values were 
obtained from 5 different experiments with the cell 
concentration of 106 cells/ml. Bars mean standard 
deviations.
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Figure 5. Photographic sequence of cells polarising in 
LPS. Neutrophils were incubated with 10 qg/'ml 
LPS at different times and then fixed. The 
fixed cells were photographed and later 
printed.(X40 magnifications)
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Figure 6. Effect of polymyxin on LPS-induced neutrophil 
polarisation using various polymyxin dosages.
Neutrophil, suspensions (106 cells/ml) were 
preincubated with polymyxin for 10 minutes at 37° C 
before challenging with LPS (10 ug/ml). The graph is based 
upon results from 3 different experiments with standard 
deviation bars.
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CHEMOTYPES OF LPS
Relationship of the chemotypes of LPS (104 ng/ml) to 
the polarisation of the neutrophils. The time taken was 
at 60 minutes. The different chemotypes were from 
Salmonella minnesota strains (Re and Sm) and Shigella 
flexneri strains (Rc, Ra, S1a, and S3a).
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Figure 8. Time course of polarisation of neutrophils in response to lipid 
A of Salmonella minnesota (10 ug/ml) incubated at 37° C.The 
values were from 3 different experiments with a celi concentration 
of 106 cells/ml. The bars stand for standard deviation values.
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Section 2
CELL-RELEASED FACTOR
The release by neutrophils of chemotactic factors 
which act on other neutrophils to cause phagocytosis and 
degranulation was investigated by several workers in 
response to a variety of stimuli (Phelps, 1969; Zigmond 
and Hirsch, 1973; Bentwood and Henson, 1980). The effect 
of LPS in inducing similar release of a cell-derived 
factor was studied by incubating neutrophils with 1 0  
jig/ml of Salmonella minnesota Re 595 LPS for 90 minutes, 
removing the supernatant and reincubating this fluid 
portion with a fresh batch of cells. Figure 9 shows that 
the response of the latter cells in assuming non- 
spherical shape was rapid (within 5 minutes of 
incubation) which is unlike the response to LPS alone 
and the maximum percentage of polarised cells, 29.5%, 
was attained after 10 minutes of incubation. Beyond this 
time period, the percentage of cells changing shape 
declined at first but after 30 minutes the number of 
polarised cells began to increase again slowly. The 
second phase assumed a similar pattern to that of 
polarisation using LPS directly. The supernatant 
collected was diluted X10 and X100 and then incubated 
with a new batch of cells for 1 0 minutes to obtain the 
maximal polarising activity. As the concentration of
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supernatant decreased, the percentage of polarised cells 
was simultaneously reduced (Figure 10). The effect of 
cell density during the priming phase with LPS upon 
release of a supernatant factor was also studied by 
adding such supernatant to a fresh batch of neutrophils.
As can be seen in figure 11, the lower the number of 
cells used to harvest the factor, the less the activity 
of the factor based on the results of the short-term 
polarisation assay. This suggests release of a cellular 
product whose total activity is dependent on cell 
concent rat i o n .
Discussion
Induction of polarization of neutrophils by LPS 
follows a time-course that is not typical of chemotactic 
factors. The latter produce polarization within 5 to 15 
minutes (Shields and Haston, 1985) whereas LPS works 
very slowly. Therefore the expectation is that a 
chemotactic-type factor may have been released by cells 
on exposure to LPS. Supernatants prepared by pre­
incubating neutrophils with LPS were shown to cause a 
rapid shape change in fresh neutrophils within 5 minutes 
compared to the longer time taken when ceils were 
exposed to LPS directly. The indication then is that
.after a certain period of exposure to LPS, the cells started to
release a factor detectable in sufficient quantity U) Cduse
the leukocytes to exhibit polarised morphology. On diluting
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out the supernatant, fewer cells were polarized. To 
support the view of the role played by the released 
factor further, cell density was varied to manipulate 
the amount of cell-released factor. A significant 
reduction was observed in the polarisation of PMN when 
cell concentration was 1 0 4 cells/ml in comparison to 
that of 1 0 6 cells/ml, an indication of lesser amount of 
factor produced. It is possible that polymyxin (section 
1 of the results and discussion) was unable to cause any 
reduction in total cell shape change at the later stage 
of incubation partially due to the increased presence of 
a new agonist, insensitive to polymyxin, that induced 
non-spher i ca 1 morpho1ogy.
An observation that needs further attention during 
the time course in short-term polarisation was the 
change in the percentage of cells polarising after 30 
minutes. Instead of declining or levelling, the graph 
shows a slow increment in the percent polarisation. A 
possible explanation for this effect was the presence of 
free LPS in the supernatant. Polymyxin B sulfate which 
was again preincubated with PMN before challenging the 
cells with the supernatant was observed to result in a 
small reduction in the number of polarised cells 
(results not depicted graphically). Thuseven with asmall 
amount of LPS as had been documented earlier, cells 
would still respond towards its presence amounting to 
the increase of polarised cell even though the effect is
Ill
not comparable to that of direct incubation of cells to 
LPS. The neutralising action of polymyxin on LPS 
consequently seemed to be relatively ineffective at 
longer time period as evident by the small difference in 
short-term polarisation assay of supernatant to that 
system with polymyxin present.
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Figure 9. Time course of polarisation of neutrophils in
supernatant in comparison with polarisation using LPS 
directly. The supernatant was obtained from 
preincubating PMN (106 cells/ml) in LPS (10 ug/ml) 
for 90 minutes at 37° C. New batch of PMN (106 
cells/ml) was added to tubes containing the supernatant 
or fresh LPS samples and incubated at 37° C. Five 
different experiments were used to plot the graph. The 
bars stand for standard deviation values.
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FigurelO. The effect of diluting supernatant in short term 
polarisation assay. Supernatant was recovered from 
preincubating neutrophils (106 cells/ml) in 10 ug/ml 
LPS at 37° C for 90 minutes. New batch of cells was 
then added to the supernatant and incubated at 37° C for 
10 minutes for polarisation assay. The data were taken 
from 3 different experiments with standard deviation 
values represented by the bars.
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Figure 11. The effect of cell density on the release of polarising 
factor. Three different concentrations of neutrophils 
( 1 0 ®, 10®, and 104 cells/ml) were initially 
preincubated with 10 ug/ml of LPS for 90 minute at 37° 
C after which the supernatants were saved and tested on 
new batch of neutrophils (10® cells/ml) in polarisation 
assay at 37° C. The data presented were from 5 
experiments. Bars are standard deviation values.
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Section 3
MICROPORE FILTER ASSAY
Testing the supernatant in short-term polarisation 
assay does not directly test the locomotory ability of 
the cells promoted by the cell-released factor. Another 
approach was used to test that the factor released by 
the neutrophils in the presence of LPS not only induces 
shape change but also induces locomotion and chemotaxis. 
The micropore filter assay was used for this purpose.
To test if the supernatant collected after 
incubating PMN at 106 cells/ml with 10 fig/ml of LPS for 
90 minutes contained chemotactic activity as well as the 
capacity for stimulation of cell locomotion, different 
concentrations of the supernatant were placed above and 
below the filters. Both absolute concentration and the 
concentration gradient were varied using a checkerboard 
assay (Zigmond and Hirsch, 1973) as shown in table 2 in 
which migration towards a given substance at different 
concentrations was tested by placing the cells in 
chambers of positive gradients, negative gradients or in 
the absence of a gradient. In table 2, cells in the 
chambers along the diagonal from the upper left position 
to the lower right were migrating in the absence of any 
concentration gradient. Moving down the diagonal the 
absolute concentration of the supernatant to which the
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cells were exposed increased and so did the migrated 
distance. Raising the concentration of the attractant 
influenced the cell migration to a certain extent 
reaching a maximum mean of 86.1 jum before eventually 
decreasing. Above the diagonal from the upper left to 
lower right the cells were migrating from a low 
concentration to a higher concentration of the 
supernatant, a situation of positive gradient. Below 
this diagonal they are moving through a high 
concentration to a lower one, a negative gradient. The 
experimental values above the diagonal are in general 
higher than the corresponding values on and below it, an 
outcome that would be expected to have resulted from a 
chemotactic effect of the supernatant but not a 
confirmatory evidence. Confirmation on this effect could 
be derived by determining the migrated distance of the 
cells assuming that they responded only to the various 
absolute concentrations and not to the concentration 
differences. It is then necessary to compare the 
expected or calculated values with that of the observed 
experimental values. In order to achieve this 
confirmatory test mathematical calculations outlined in 
the paper of Zigmond and Hirsch (1973) were followed 
using a programmable computer and diskette to obtain the values.
Cells migrating in the positive gradients had higher 
experimental figures (without parentheses) than those 
ca1cu1ated (in parent heses) wh i1e neut roph i1s i ocomot i ng
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in negative gradients had higher calculated values than 
that of the experimental origin. These differences 
between the two figures, calculated and experimental, 
demonstrate the response of the cells towards the 
absolute concentrations as well as the chemotactic 
response to the concentration gradients of the 
attractant in the supernatant.
Discussion
Shape changes of inflammatory cells induced by 
agonists are not always associated with locomotion 
(Keller and Zimmermann, 1987; Wilkinson et al , 1988).
Methods to analyse leukocyte locomotion directly are 
heeded. The micropore filter assay has enabled cell 
biologists to differentiate motile behaviour of PMN 
towards substances that may be chemotactic or otherwise.
If cells migrate from zero concentration of a 
chemotactic substance to a higher concentration, this is 
not alone a sufficient proof of chemotaxis.
These cells might just, be responding towards the • 
ambient absolute 'concentration of attractant. . , The
checkerboard assay was therefore adopted to distinguish 
chemotaxis from chemokinesis. Comparison between the 
calculated values and the experimental values suggested 
that the supernatant had exerted chemotactic influence; 
in general cells moved further in a positive gradient
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and less far in a negative gradient. It has been shown 
that the calculations employed in the checkerboard assay 
do approximate to a real result that can be obtained in 
the absence of any chemotactic effects (Wilkinson and 
Allan, 1978). The supernatant in question thus fulfilled 
the criteria required of a chemotactic factor as 
analysed by the checkerboard system.
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Table 2.
Percentage of supernatant below filter
0 10 30 70 100
57.5V 79.9 83.6 95.0 86.9
+ \ + + + +
\3.70 N3.61 3.58 2.90 2.88
\ ( 6 1 ) (67) (73) (76)
v. 73.2V 81.6 90.1 97.3
V^ + V + + +
V  1 .47 \2.12 1.92 2.00
N. (75) (78) (80)
68 .Vv 79.7V 87.3 91.2
+ V. + V + +
3.26 \  2.69 \2.61 2.82
(78) V. V. (81) (83)
66.1 74?V. 86.iV 84.7
+ + N. + V^ +
3.56 3.28 V 2.98 V 3.80
(83) (84) \  (85)
64.3 70.7 80?V. 81 .IV
+ + + \ + v^
4.58 3.13 3.11 v 2.21
(84) (84) (82)
Migration of neutrophils in concentration 
gradients of supernatant in micropore filter 
assay at 37° C for 60 minutes (measuring units in 
pm). Values in brackets represent the 
calculated values with n=5. The observed values are 
shown as distance of migration ± standard deviation 
values.
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Section 4
COLLAGEN GEL ASSAY
Another assay that can provide a better insight 
into cell locomotion is the collagen gel assay. The 
three-dimensional matrices of the gel give a much closer 
physiological setting for ceil locomotion than the 
filter assay. Figure 12 shows a time course for invasion 
of collagen gels by the neutrophils in the presence and 
absence of the LPS-induced supernatant factor following 
the methodology outlined by Islam et al C1985)/fhe cells, in 
a uniform concentration ot the supernatant, responded well 
and migrated deep into the gels in comparison to ceils
in a gradient of the supernatant.The former condition was 
achieved by overlaying neutrophils in supernatant on top 
of collagen gel incorporated with similar concentration 
of supernatant present in the cell suspension. For the 
latter condition, collagen gel was impregnated with the 
supernatant and later overlaid by another portion of gel 
without the supernatant so as to form a gradient source.
A suspension of neutrophils was layered on top of the 
second gel layer to allow the cells migrating in 
response to the gradient. As the time allowed to invade 
the gels increased, the distance travelled increased 
eventhough not in a linear fashion. Over three hours of 
invasion, the depth of the migration increased very
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slowly. Distinct morphological characteristics were 
noted for the migrated cells in contrast to that of the 
initial preparative stage of the cells on top of the gel 
(Figure 13) . Extensive polarised morphology was assumed 
as the cells penetrated deep into the gel.
Discuss1on
Collagen is a more physiological substratum than 
glass or tissue culture plates thus making it an ideal 
choice for the study of cell locomotive behaviour. 
Besides using the micropore filter assay to investigate 
if the supernatant did have the chemotactic factor, a 
similar kind of assay was used in the collagen gel 
assay.    . ' r..
The displacement of the cells in gradients was
1 ower than in the chemokinet ic condit ion (in uniform
concent rat ions). This difference might be because in B 
(Figure 12) a lower concentration of the supernatant 
reached the cells. The behaviour of neutrophils in 
collagen is not fully understood but the medium permits 
clear morphological changes to be observed when a single 
cell moves through a physiological environment mimicking 
that of a normal tissue.
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Figure 12. Collagen gel assay. PMN at 106 cells/ml was layered on 
top of the gel in the presence of or without supernatant at 
37° C. The supernatant was obtained by preincubating 
PMN (106 cells/ml)with LPS (10 ug/ml) for 90 
minutes at 37° C. Data plotted were from 5 different 
experiments. Bars are standard deviations of the means. 
Results from condition A are expressed graphically as 
curve A with the control as curve D. Results from
condition B (2 layers of collagen with a gradient through 
the top layer) are represented by curve B with the 
control as curve C.
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figure 13. Photographs of PMN in collagen assay. Picture 
A (X10 magnification) shows cells on top of 
the gel while picture B (X100 magnification) 
focuses on cells migrating inside the gel.
118
Section 5
VISUAL STUDIES
The polarisation assay measures deviation from the 
spherical to non-spherical shape at one point in time. 
The actual movements of the cells are not observed. A 
visual assay using a video camera helps to give more 
detail of the actual behavioural response of these cells 
and measuring morphological parameters of the activated 
cells is an additional method to quantify the degree of 
shape change.
Shape change in suspension
Neutrophils that were preincubated with or without 
LPS for various times were quickly transferred to a 
filming chamber and their movements were videotaped. 
Individual cells were singled out to record the shape 
changes in suspension for different time periods of LPS 
exposure when the videotape was played back. The 
tracings of the shape changes in suspension of the 
neutrophils show that the front-tail polarity of 
individual cells did not remain constant in direction, 
but changed with time ( F i g u r e  14). The cells frequently 
elongated and then rounded up before eventually settling 
down on the slide. Greater number of movements were 
quite obvious after the ceils have being exposed to the 
LPS for over 30 minutes with a faster speed of changing
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shapes. The observations indicated that the cells were 
activated by an agonist since the majority of these cells 
remained spherical when observed in the absence of a 
st imulus.
Shape analysis
To define shape change induced by the presence of 
LPS more precisely, analytical assessment was done 
following the method of Dunn and Brown (1986). 
Neutrophils, LPS-induced and FMLP-induced, polarising at 
different time periods were fixed and the outlines 
traced before analysing them with a computerised 
programme. All cells with a dispersion value greater 
than or equal to 0.02 were selected as non-spherical for 
further calculations (Wilkinson et al , 1988). Figure 15 
shows representative samples of the shapes incubated at 
different times with LPS or FMLP. Tracings of the shapes 
of cells in LPS displayed a progression in the 
morphological changes from the start of the incubation 
period up to 90 minutes. These ceils were much more 
elongated and all of the selected cells had a dispersion 
value of greater than 0.02 after 90 minutes. Cells in 
FMLP had acquired a high elongation value even after 30 
minutes though the biggest median value for elongation 
was after the 90 minutes mark. The deviation from 
spherical morphology as measured by the dispersion value 
was however evident for the total cell samples as early
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as 10 minutes (Table 3). Using Mann-Whitney U-tests, the 
difference in shape change within the LPS-induced group 
was evaluated (Table 4). Statistical analysis was also 
done to compare if the shape change induced by LPS was 
similar to that of the classical morphological change 
due to FMLP. Significant differences were observed 
between the groups (Table 4) . Up to 60 minutes FMLP 
induced greater shape-change than LPS. However, at 60 
minutes and 90 minutes no significant difference was 
found in the shape change between these two groups.
Discussion
Studying shape change induced by a stimulant by a 
visual method proved to be valuable in distinguishing 
between the classical shape change due to a known 
chemotactic stimulus and that of a non-specific inducer 
such as phorbol esters (Wilkinson et al , 1988).
Videotaping shape changes in suspension gave much more 
information about the detailed activity of the ceils 
than studyingfixed cells in polarisation assay. PMN were 
observed to continuously and vigorously change in shape 
after a longer period of time exposed to LPS before they 
finally settled down on to the surfaces. Even though 
broad veils protruding were not well presented, 
protrusions and retractions of cellular membrane from 
more than a single point were vividly recognised. 
Constrictions of the cell body were demonstrated by the
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motile cells. Rapid morphological changes noted at later 
times may be related to the presence of a second agonist 
that seemed to be responsible for the locomotory 
behaviour since in the absence of LPS the cells 
frequently assumed rounded shapes with small shape 
changes in suspension.
Analysing the shape change using shape parameters 
(elongation, extension and dispersion) allowed a 
comparison of the LPS-induced polarisation with that 
due to FMLP. Long exposures (60 to 90 minutes) showed no 
significant difference in elongation from the results 
for FMLP. This is consistent with the presence of an 
agonist that induced a similar effect to that of the 
known chemotactic factor FMLP. The significant 
difference between the two stimuli at earlier stages (up 
to 60 minutes) may be due to the fact that LPS has no 
direct effect in polarizing cells but causes delayed 
release of a cell-polarizing factor. During this 
preparative period those cells that were able to respond 
well were therefore activated by LPS but had not yet 
released the polarizing factor.
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Figure 14. Live cells using videotape. PMN incubated at 
different times with LPS were observed in 
filming chamber and videotaped. Motions of the 
cells in suspension were traced out at 30 
seconds intervals (Roman numericals). Times of 
incubation: Cell A- 30 min, Cell B- 45 min, 
Cell C- 60 min, Cell D- 90 min, Cell E- 120
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Figure 15. Fixed cells using camera lucida.
Representative samples of shape changes of PMN 
in the presence of LPS or FMLP at different 
periods of incubation were outlined after 
fixing them. Cells in LPS are shown as (Al) 10
min, (A2) 15 min, (A3) 30 min, (A4) 60 min and
(A5) 90 min. PMN in FMLP are drawn as (Bl) 10
min, (B2) 15 min, (B3) 30 min, (B4) 60 min and
(B5) 90 min.
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Median values
n (%) Extension D i spers i on Elongat i on
PMN in LPS for:
0 min 1 (2) - - -
10 min 16 (32) 0.394 0.034 0.365
15 min 23 (46) 0.666 0.071 0.612
30 min 44 (88) 0.653 0.060 0.577
60 min 49 (98) 0.864 0.098 0.744
90 min 50 (100) 0.874 0.092 0.755
PMN in FMLP 
for:
10 min 49 (98) 0.730 0.069 0.658
15 min 50 (100) 0.737 0.063 0.673
30 min 50 (100) 0.919 0.073 0.843
60 min 50 (100) 0.866 0.087 0.782
90 min 50 (100) 0.920 0.076 0.851
Table 3. Measures of shapes of neutrophils. The cells were
either incubated in LPS (10 jug/ral) or FMLP (10-8 M) 
at the stated times before being fixed and later 
statistically analysed using Mann-Whitney U-test.
’ n* is the number of polarized cells (out of 50)
(%) is the percentage of polarized cells 
Cells with dispersion < 0.02 were excluded.
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Sample Extension Dispersion Elongat ion Signif icance
10 vs 60 4.85 5.43 4.29 P< 0.001
10 vs 90 5.11 5.15 4.56 P< 0.001
15 vs 60 4.41 5.34 4.18 P< 0.001
15 vs 90 4.59 4.89 4.26 P< 0.001
30 vs 60 3.88 4.12 3.32 P< 0.001
30 vs 90 3.93 3.63 3.45 P< 0.001
L10 vs F10 3.41 4.05 3.32 P< 0.001
L15 vs F15 4.50 3.40 4.58 P< 0.001
L30 vs F30 4.07 4.10 3.88 P< 0.001
Tab1e 4. St at i st i ca1 analysis of shape changes. Using Mann-
Whitney U test difference of PMN morphological 
alterations after treatment with LPS or FMLP was 
analyzed. The first half of the table depicts 
comparison between each period of PMN incubations 
in LPS (sample= time versus time). The second half 
of the data compares shape changes between cells 
incubated in LPS (L) and those in FMLP (F). 
Unlisted are those which were insignificant in the 
shape change differences.
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Section 6
EFFECT OF ANTI-INFLAMMATORY DRUGS
Anti-inflammatory drugs have been utilised to
block the release of certain factors by inflammatory
cells by interfering with arachidonic acid metabolic
pathways. These drugs were tested on the polarisation
system to determine if PMN shape change in the presence
of LPS could be blocked and if so this may suggest that
metabolites from the arachidonic acid pathway may be
involved in the shape change of the cells. One steroidal
(dexamethasone) and three non-steroidal (BW 755C, Revlon
5901A and indomethacin) anti-inflammatory drugs were 
tested.Dexamethasone indirectiy.by st imuiat ing synthesis 
and release of_ 1 ipocort. in . b 1 ocks the act ion of ~ ~a membrane
bound enzyme called phospholipase A2 needed to switch on
arachidonic acid metabolic pathways (Flower and
Blackwell, 1979). BW 755C is reported to possess the
capacity of inhibiting the lipoxygenase and
eye1oxygenase pathways in the ceil membrane (Higgs et
al , 1979). The former pathway is responsible for the
release of leukotrienes while the latter leads to the
production of prostaglandins. Revlon on the other hand
is a specific lipoxygenase inhibitor thereby interfering
with the release of the potent chemotactic agent
leukotriene B4 (Rossi, 1987), while indomethacin is a
cycloxygenase inhibitor (Lands, 1981).
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Indomethacin, dexamethasone, BW 755C and Revlon 
5901A at a concentration of 10 pg/ml each were 
preincubated with 106 PMN/ml for 10 minutes at 37° C 
prior to exposing the cells to 10 pg/ml of LPS. The 
stated dosage was chosen after three different doses (5, 
10 and 15 ixg/ml) were tried which resulted in a better 
inhibition at 10 pg/ml. The blockading effect was 
analysed between 15 to 90 minutes of incubation time. 
Factor production was eventually tested by preincubating 
the cells with the respective drugs for 10 minutes and 
then adding LPS, allowing incubation to proceed for 
another 90 minutes before finally saving the supernatant 
to be tested on the new batch of cells in short-term 
polarisation assays.
Indomethacin and dexamethasone were observed to 
have failed in preventing either the shape change or the 
production of the factor. However, BW 755C and Revlon 
5901A were able to lessen the number of cells polarising 
significantly only at a 60 minutes time period (Figure 
16). As for the factor release, a significant difference 
was seen for both drugs in comparison to that of the 
.control system having no drugs (Figure 17) when 
supernatants were tested on a fresh batch of 
neutrophils. Excess NSAID in the supernatant may have a 
residual effect on the new batch of cells responding 
towards the factor in the medium. Therefore, the new 
batch of cells was initially preincubated with NSAID
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before being challenged with the supernatant. Such 
experiments showed the absence of any reduction in the 
polarisation of the cells hence ruling out the effect of 
the drugs in inhibiting these cells from responding 
towards the unknown agonist (results not shown). All the 
drugs tested were found not to be cytotoxic at the 
concentration level used and did not by themselves 
activate the cells to assume the polarised shape.
Discussion
One of the ways by which PMN release chemotactic 
factors is via arachidonic acid metabolism. NSAID have 
been tried to block arachidonic acid metabolism and 
apparently reduce or stop the releasing of the 
chemotactic factors. Conventional drugs like 
indomethacin and dexamethasone do not reduce shape 
change activity but the new generation of NSAID 
exemplified by BW 755C and Revlon 5901A may work well in 
preventing the release of cellular factors. Both drugs 
were observed to caused a marked reduction of polarised 
cells after 60 minutes of incubation. The chemotactic 
type activity of the supernatant was consequently 
affected hence providing a partial clue to the possible 
involvement of arachidonic acid metabolites in this 
system.
Results from the in vitro and in vivo studies of 
NSAID on neutrophils have demonstrated that cellular
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reponses such as lysosomal release induced by FMLP, 
concanavalin A and PMA were inhibited by the drugs 
(Abramson et a l , 1984). Even though these findings
implied that the modulation of neutrophil functions was 
dependent on leukotrienes synthesis inhibition, however 
there are diverse effects observed among the 
cycloxygenase inhibitors in the inhibition of neutrophil 
functions such as inhibition of superoxide anion 
production (Kaplan et al , 1984; Minta and Williams,
1985). Similar drug effects were observed on the 
polarising capacity of neutrophils in the presence of 
LPS thereby indicating that anti-inflammatory effects of 
NSAID may not be attributed solely to their ability to 
inhibit prostaglandin synthesis but rather may extend to 
other metabolic effects on neutrophils such as 
1eukot r i ene synt hes i s .
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Figure 16. The effects of non-steroidal anti-inflammatory drugs on 
LPS-induced neutrophil polarisation assay. The cells at 
106 cells/ml were exposed to the drugs (10 ug/ml) for 
10 minutes at 37° C followed by the addition of LPS at 
10 ug/ml. Five experiments were done for each drug 
used. (Bars are standard deviation values.)
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Figure 17. Polarising factor production in the presence of non­
steroidal anti-inflammatory drugs represented by the 
polarisation assay of the supernatant obtained from 
preincubating PMN (10® cells/ml) with 10 ug/ml of 
drugs for 90 minutes at 37° C. New batch of cells at 10® 
cells/ml was used in the polarisation assay. (n= 4)
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SUP REV+LPS
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Section 7
PRELIMINARY CHARACTERISATION OF THE CELL-RELEASED FACTOR
Further studies of the cell-released factor in the 
supernatant was needed to characterize the polarising 
inducer of the neutrophil that may be vital in the 
inflammatory processes.
Heat treatment
The supernatant saved was heated at 56° C for 30 
minutes and 100° C for 3 minutes after which it was 
tested for the presence of the polarising inducer on the 
cells. Under both conditions the polarising activity of 
the PMN was unaffected suggesting that the cel 1-released 
factor was heat stable.
Dialysis of cell-released factor
Through dialysis, a rough estimate of the molecular 
size of the factor could be obtained. The supernatant 
was dialysed against HBSS/MOPS+HSA for 48 hours changing 
the medium every 24 hours. After dialysis, the dialysate 
was incubated with fresh PMN for short-term polarisation 
assay. Polarisation of the cells was noted in the 
dialysate while the medium outside the dialysing tubing 
failed to induce any shape change to the leukocytes. 
From this observation the factor might be a large 
molecule, not small enough to diffuse out of the
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dialysing bag or a small molecule firmly bound to a 
large molecule thus preventing dialysis.
Hexane extraction
Equal volumes of the supernatant and hexane were 
mixed in a separating funnel to allow any organic 
compound in the supernatant to be isolated from the 
aqueous portion of the supernatant. The aqueous layer 
was eluted out and mixed with another volume of hexane 
before eventually saving it to be used in the 
polarisation assay. After separation from the hexane 
layer and concentrating the aqueous layer, a time course 
of polarisation assay was done using the latter. Minimal 
activity was detectable (12.33% ± 2.05) after 60 minutes 
of incubation with the hexane/buffer system as the 
control giving the usual background polarising activity 
of around 2% while the unextracted supernatant recorded 
37.33% ± 2.5 polarisation at the same time. It was
therefore possible that the factor may not be composed 
of just a single molecular entity but a mixture or 
combination of more than one compounds, one of which 
separates into the aqueous layer and one into the hexane 
layer. Alternatively, activity may have been destroyed 
dur i ng t he ext ract i o n .
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Thin layer chromatography (TLC)
The organic layer separated after hexane extraction 
was pooled together, concentrated under pressure in a 
rotary evaporator and eventually spotted on a TLC plate. 
Known samples of LPS, lipid A and LTB4 were also spotted 
on similar TLC plate as controls. Migrated spots of the 
tested material were observed under ultraviolet light 
before spraying the plate with a chemical detector and 
heating in an oven. Two black charred migrated spots
were apparent from the spotted point of the organic 
layer but none was observed from the controls (Figure 
18). The extraction procedure thus suggested that the 
factor was different from the known control but the
technique did not give detailed information about its 
nature.
Sephadex G-25 gel filtration
To obtain preliminary information about the 
molecular weight of the active material , gel filtration 
was performed using Sephadex G-25 to separate large (> 
5000 molecular weight) from small molecules. The eluted 
fluid was first analysed for protein content by a
spectrophotometric method at 280 nm and later used in 
the polarisation assay. As depicted in figure 19, high 
molecular weight compound having the polarising activity 
was isolated from the eluant. However, polarisation of 
the cells was also detectable in the low molecular
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weight region signifying a heterogeneity in the 
polarising activity with different activity at different 
molecular weight levels. Using the linear relationship 
between Kav and log molecular weight (Determann, 1968), 
the calculated molecular weight of the small molecule is 
approximately 1200. K av represents the fraction of the 
stationary gel volume which is available for diffusion 
of a given solute species; Ka v = Ve - V0 / Vt - V0 . Ve is 
the elution volume of a given solute, Vt is the total 
volume of the packed column bed and V0 is the void 
volume which is the elution volume of molecules only 
distributed in the mobile phase because of their large 
s i zes.
Discussion
Neutrophils in the presence of LPS seem to release 
a factor or factors that are capable of inducing shape 
change. This cel 1-released factor was further studied to 
understand its nature. Heating the supernatant at two 
different temperatures did not abolish the polarising 
capacity of the factor implying that the active 
component of the factor is heat stable. By dialysing the 
supernatant, the active component of the factor was 
retained within the tubing indicating that the factor 
may be a large size molecule or a small molecule bound 
to a macromolecule.
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Hexane extraction was done as a preparative stage 
in separating the active component of the released 
factor using TLC. The aqueous layer separated by the 
technique was found to have a diminished PMN polarising 
activity. It is therefore likely that most of the active 
compound was extracted out of the supernatant and 
remained in the organic layer. Concentrating this 
organic portion by rotary evaporator allowed an adequate 
sample application on TLC plate. Spots of the migrated 
compound detectable by spraying with concentrated acid 
revealed the presence of an unknown material different 
from the known controls of LPS, LTB4 and lipid A based 
on the upward migration of the materials on the TLC 
plate. Such an isolation procedure nevertheless 
restricted the used of the separated product in a 
polarisation assay since the product had been chemically 
modified after being sprayed and heated in the hot oven. 
Gel filtration provided the means of separating and 
purifying any mixed compounds to be used in polarisation 
assay. Separation took place according to the molecular 
size; large molecules that were unable to be retained by 
the gel beads were eluted first from the bed while 
smaller molecules were retarded since they were able to 
penetrate into the beads. Two different bands of 
molecular sizes were found again supporting the view of 
at least a low molecular weight compound is involved in 
the shape change activity. Small fraction, which is
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hydrophobic on phase separation, has aimost no 
absorbance at 280 nm and is quite likely to be a lipid, 
especially as lipoxygenase inhibitors reduce its 
formation. The activity detectable at high molecular 
weight elution is suggestive of the presence of a 
protein-like compound released by the cells, but unlike 
a protein it is not destroyed at 100° C. However, by 
looking at the physical properties studied the two 
different compounds may be bound to one another thus not 
portraying any kind of individual molecular 
characteristics. Results from the experiments conducted 
so far present the view that LPS may not just modulate 
the biological functions of the neutrophils in 
inflammation but also may involve the recruitment of 
these inflammatory cells by causing the cells to release 
a factor that would attract other neutrophils to the 
site of inflammation.
rFigure 18. Thin layer chromatography. Silica plate shows 
the migrated spot. (A) of the material 
extracted from the supernatant by hexane 
extraction. The spots were revealed by 
spraying acid and then heated in a hot air 
oven. Absence of migrated spots from (B) LPS, 
(C) Lipid A and (D) LTB*.
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Figure 19. Gel filtration of supernatant on G-25 Sephadex 
superfine and short term polarisation assay of the 
filtrate. The supernatant obtained after preincubating 
neutrophils in LPS for 90 minutes at 37° C was run 
down the gel column and the filtrate collected 
was incubated with a new batch of cells for 10 minutes at 
the same temperature.
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Figure 20. Graph of K w  against log of molecular weight.
Using the values from gel filtration assay (mentioned In text) 
approximate molecular weight of the compound was determined 
based on the linear relationship of log molecular weight and 
constant K av
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Section 8
RECEPTOR STUDIES
Human phagocytes express a family of cell surface 
glycoproteins known as LFA-1 (CDlla/CD18), CR3 
(CDllb/CD18), and pl50,95 (CDllc/CD18). It has been 
documented that these receptors do bind LPS (Wright and 
Jong, 1986). Neutrophils from patients lacking in the 
CD18 family of receptors exhibited the inability to bind 
to bacterial LPS (Wright et al, 1989). They also 
discovered that CR3 has a separate binding site that 
recognizes LPS. It is of interest therefore to test if 
these receptors do participate in the response of the 
cells to change shape when encountered with LPS.
Dose response
Cells were preincubated with varying concentrations 
of CD18 antibodies for 10 minutes at 37° C after which 
10 /ig/ml of LPS was added prolonging the incubation 
period for another 60 minutes. Upregulation of the 
receptors was reported to be maximal after approximately 
10 minutes at 37° C (Springer and Anderson, 1986). In 
figure 21, representatives of the three families of 
antibodies showed different capacities of inhibiting 
LPS-induced polarisation of PMN. The inhibitory effect 
increased as the amount of antibodies increased reaching 
a maximum inhibition at 5 /ug/ml concentration: 33%- CR3
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(2LPM19C), 23%- LFA-1 (717), 22%- pl50,95 (3.9). Above
this concentration the effects were maintained at 
similar level. Monoclonal antibodies against CDllb/CD18 
however presented a better inhibitory effect than that 
of the other two members of the family. Even though the 
inhibition was relatively small, at a concentration of 
0.1 jtig/ml these antibodies showed detectable inhibition 
of polarisation of the neutrophils.
Time course
For a time course assay, 10 fig/ml of each 
monoclonal antibody against the CD18 family of receptors 
was pre-incubated with PMN for 10 minutes and then the 
PMN were incubated with LPS for the prescribed time 
period. After 15 minutes of LPS incubation, all three 
antibodies gave an inhibitory effect of > 70% (Figure
22). As time of incubation with LPS was extended, less 
inhibition was seen particularly after 90 minutes when 
anti-LFA-1 anti-pi50,95 showed no inhibition but anti- 
CR3 st i11 possessed s 1i ght i nh i b i t ory act i v i t y .
Specificity of the monoclonals
To ensure that the antibodies were acting 
specifically towards release of LPS-induced factor by 
the cells, PMN were challenged first with antibody, then 
with an irrelevant chemotactic factor. FMLP at 10-8 M, 
whose receptors were unrelated to the CD11/CD18 family .
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Polarisation due to FMLP was unaffected after 30 minutes 
of incubation in the presence of the antibodies (90%- 
control; 90%- anti-CR3; 92%- anti-LFA-1; 89%- anti-
pl50,95). Another possible reason for the inhibition was 
that the inhibitory effect of these monoclonals on LPS- 
induced polarisation was due to low affinity binding of 
excess antibodies to irrelevant (non-CDll/CD18) cell 
surface structures. This was tested by washing the cells 
after the first preincubation stage (10 minutes at 37°
C) to remove any unbound antibodies before eventually 
continuing the polarization assay using LPS. The results 
were not altered by this manoeuvre giving a clear signal 
of the specificity those antibodies acted upon.
Assessment of different , monoc1ona1 antibodies
Different batches of antibodies with similar
specificities do not always exhibit the same kind of 
actions on a particular system. Likewise in this project 
different batches of the antibodies were assessed in 
their blocking capacities towards LPS-induced PMN
polarisation. As would be expected from tables 5a, 5b 
and 5c antibodies against the CDllb/CD18 receptors
displayed inhibitory effects that ranged from 0% to 40% 
while the range for ant i-CDlla/CD18 was from 0% to 30%. 
Only one particular batch of anti-CDllc/CD18 was able to 
reduce the polarising activity by 20% whereas most of 
the monoclonals from this group had no effect at all.
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The involvement of CDlla/CD18 receptors in the LPS- 
induced polarisation is somewhat greater than the other 
two members of the family.
Effect on the factor product ion
Reduction in the percentage of polarised cells, 
presumably by blocking the LPS receptor, would mean that 
the release of the LPS-induced factor was consequently 
affected. Testing the supernatant, from cells 
preincubated with antibodies, then LPS (90 minutes) in 
short-term polarisation assays on fresh cells showed a 
significant reduction of the percentage of polarised 
cells by 37% for anti-CR3, 14% for anti-pl50,95 and 20% 
for anti-LFA-1 (Figure 23). Serial dilutions of the 
supernatant resulted in reduced activity. Some cell- 
released factor was therefore released despite the 
blockage by these antibodies at the earlier stage of 
exposing PMN to LPS.
Blocking with three antibodies together
A combination of antibodies against all three 
proteins together would be expected to produce a greater 
inhibition than each one tested separately. The bar 
graph of figure 24 indicates that even after 90 minutes 
of incubation time, the combined antibodies had a higher 
inhibitory action (up to 34%) than the antibody free 
control.
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Blocking with RGB peptides
Since a member of the CD11/CD18 family of receptors 
has been found to recognize polypeptide ligands bearing 
the amino acid sequence Arg-Gly-Asp, the triplet RGD- 
sequence (Wright et al , 1987), it would be of interest
to observe if peptides containing the RGD-sequence would 
exhibit similar activity to that of the antibodies in 
i nh i b i t i ng t he po1ar i sat i on of neut roph i1s . Four
different peptides were chosen to study their effects on 
cell polarisation namely: Gly-Arg-Gly-Asp-Ser (RGD1),
Gly-Arg-Gly-Asp-Pro-Lys (RGD2, a fibronectin analogue), 
Arg-Gly-Asp (RGD3) and Arg-Gly-Asp-Ser (RGD4). These
peptides were used in a similar assay to that for
assaying the monoclonal antibodies. Pentapeptide 
containing cell attachment domains of fibronectin (RGD1) 
and fibronectin analogue (RGD2) specifically displayed a 
significantly high inhibitory effect on LPS-induced 
polarisation of PMN, 40% and 30% respectively, as 
depicted in figure 25. Interestingly peptides 
accommodating just the RGD sequence (RGD3 and RGD4) were 
relatively ineffective in suppressing the activities 
observed compared to the pentapeptide and the
fibronectin analogue proving that the presence of the 
triplet amino acid sequence may not solely be 
responsible for the blocking of morphological changes in 
the cells.
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Discussion
Recently members of the CD11/CD18 complex of 
leukocyte receptors, formerly known as CR3 family 
receptors, have become of considerable interest in 
inflammation research. The receptors were shown to be 
important in mediating adhesion of PMN to endothelial 
cell lining during inflammation and also found to 
function in the recognition of several other particles 
besides the surface-bound complement C3bi (Ross et al , 
1985a; Wright and Jong, 1986; Bullock and Wright, 1987; 
Dana et a l , 1986). Recently Wright et al (1989) observed 
that the CD11/CD18 receptors expressed the binding site 
for LPS which is distinctly different from the binding 
site for C3bi. Among the three members of the CD11/CD18 
glycoproteins used in the assays, antibodies against 
CDllb/CD18 displayed greater effect in inhibiting the 
polarisation activity. This was in accordance with the 
findings that CDllb/CD18 functional abilities are mainly 
associated with PMN cellular functions while CDlla/CD18 
and CDllc/CD18 are generally linked to cytotoxic effects 
of other inflammatory cells (Wright and Detmers, 1988). 
Other monoclonal antibodies within the same family group 
showed variable effects in blocking LPS-induced 
polarisation of neutrophils. Eight out of twelve of the 
CDlTb/CD18 antibodies tested were capable of modulating 
the response; 4 out of 7 of the CDlla/CD18 group were
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able to cause any significant blocking while only 1 out 
of 8 of the CDllc group was able to show significant 
blocking capacity.
A decline in the inhibitory effect for the 
antibodies at the later stage of incubation could be 
attributed to the aspect of interaction of antibodies 
since it may be that binding of the antibodies to cell 
surface molecules is reversible. Thus instead of 
completely blocking a molecule's function, the 
antibodies may hinder the effect. Antibodies could also 
be endocytosed by the cells at this stage. Difference in 
the degree of inhibition between the 3 monoclonal 
antibodies could be that the interaction by the anti- 
CR3 to PMN is much more efficient than the other 2 
members of the group. The specific action of the 
antibodies towards the receptors that are required for 
LPS to interact with on the target cells need to be 
assessed so as to exclude the non-specific actions of 
the antibodies. Such antibodies specificities were 
obvious when FMLP, a known chemoattractant with specific 
receptors (Koo et al , 1982), was introduced to observe
any blocking effect by the antibodies in which the cell 
responses directed towards FMLP was left undisturbed. 
Excessive amount of unbound antibodies which may have 
contributed to a non-specific blocking effect towards 
cellular polarisation was shown not to have been 
involved. This assessment was based on the polarization
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assay conducted after the antibodies which had been 
preincubated earlier with the cells to block the 
antigens were washed off. Both aforementioned 
specificity tests affirmed the exact binding target of 
these antibodies towards the receptor sites required 
for the recognition of LPS molecules. Effective binding 
of the antibodies towards cell surface receptors, 
probably blocking access of LPS interacting, would
thereby down modulate the production of the released 
factor. Reduced percentage of polarized PMN noted in the 
polarization assay on the supernatant was an evidence of 
such interference. Nevertheless, blocking actions
brought about by the antibodies were incomplete since 
polarization of PMN was still present when the
supernatant was serially diluted. Interaction of LPS 
with the cell membrane of PMN looks to be importantly 
required for the release of the shape change inducer.
Three monoclonal antibodies together suppressed 
shape change more efficiently than individual
antibodies. Here all the three sites seemed to be 
blocked simultaneously thus reducing the probability of 
LPS to interact with the receptor sites. Similar 
observations were reported by Wright and Jong (1986) in 
macrophages in which profound inhibition of LPS binding 
was only seen when all three family members were 
involved. Data published also indicate that CR3 
recognizes a RGD-containing sequence molecule (Wright et
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al , 1987). Addition of RGD-containing peptides to the
assay system would be expected to affect the polarising 
activity. As shown in figure 25, strong inhibitory 
actions were presented by those peptides particularly 
associated with fibronectin. New evidence indicates high 
structural homology between the 13 subunits of the CD18 
complex with adhesion-promoting proteins such as 
fibronectin receptors that recognize the RGD sequence 
(Kishimoto, 1987b; Law et al , 1987). Hence, the
information obtained supports the role of recognizing an 
RGD sequence in the LPS-induced PMN polarization. 
Separate binding sites for two different ligands within 
a single receptor but functionally linked could account 
for such reaction as observed by Wright et al (1989). 
Another possibilty that could explain the contrasting 
observation may be linked to a newly discovered receptor 
that has ligand binding specifically for the RGD 
sequence expressed by human neutrophils (Gresham et al , 
1989). This signal- transducing molecule could be 
interrelated with the activation of PMN induced by the 
presence of LPS. Cumulative results implicate the role 
of CD11/CD18 family of receptors on PMN in recognising 
bacterial LPS that would consequently induce traditional 
locomotive morphology for the leukocytes.
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Figure 21. Dose response curve of monoclonal antibodies in the 
blocking activity of LPS-induced polarisation assay. The 
antibodies against CD11 / CD18 glycoproteins were added 
to suspensions of neutrophils (106 cells/ml) and 
incubated for 10 minutes at 37° C before finally adding 
10 ug/ml LPS continuing the incubation period for 
another 60 minutes. The experiments were done in 
triplicate. Bars represent standard deviation values. 
Antibodies codes : 2LPM19C (anti*CR3), 717 (anti-
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Figure 22. Time course in the blocking activity of LPS-induced 
neutrophil polarisation by the CD 11/CD 18 monoclonal 
antibodies. Monoclonal antibodies (10 ug/ml) were 
incubated with PMN for 10 minutes at 37° prior to 
adding LPS (10 ug/ml). The experiments were done in 
triplicate. Antibodies codes: 2LPM19C (anti-CR3), 717 
(anti-LFA-1), 3.9 (anti-p150,95)
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Antibody
code Specificity
648 (44) CDllb
649 (VIM12) CDllb
650 (52.94) CD11?
651 (TM15) CDllb
652 (KiM5) CDllb
653 (M522) CDllb
654 (LM2/1.6,.11) CDllb
655 (M3D11) CDllb
656 (M01) CDllb
657 (B2.12) CDllb
2LPM19C CDllb
Mol CDllb
Percent 
inhibition of
LPS-i nduced Types
neutrophil of
polarisation chains
38.6 a
28.8 a
30.0
37.1 a
None a
37.1 a
17.2 a 
None
None a
None a
39.7 a 
18.4
Table 5a. Assessment of blocking activity of individual 
monoclonal antibodies against CR3 on neutrophil 
polarisation. The antibodies CIO /Ltg/ml) were 
preincubated with neutrophils (106 cells/ml) for 
10 minutes and then mixed with 10 jtig/ml LPS for 60 
minutes at 37° C.
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Ant ibody 
code Speci ficity
Percent 
inhibition of 
LPS-induced 
neutrophi1 
polarisat ion
Types
of
chains
706 (60.3) CD18 None 13
710 (CLB.54) CD18 None 13
713 (M232) CD18 None 13
719 (TS1) CD18 None 13
725 (IB4) CD18 None B
711 (CIMT) CDlla 5.1 a
714 (LeoLFA-1) CDlla? None
715 (25.3.1) CDlla 2.4 a
717 (2F12) CDlla 28.9 a
720 (22.1.1.17) CDlla 19.4 a
723 (6.1.2) CDlla None a
724 (CLB-LFA-1) CDlla None Oi
Table 5b. Assessment of blocking activity of individual 
monoclonal antibodies against the common beta 
chain (CD18) and LFA-1 (CDlla) of the adhesion 
promoting receptors on neutrophil polarisation 
following similar procedures to that of anti-CR3 
ant ibodies.
140e
Percent 
inhibition of 
LPS-induced Types
Ant i body neut roph i1 of
code Specificity polarisation chains
726 (3.9) CDllc 21.4 a
256 (BU15) CDllc None
277 (KB23) CDllc None
300 (Ki-Ml) CDllc None
721 (SHCL-3) CDllc None a
727 (L29) CDllc None a
728 (3KB43) CDllc None a
729 (KB23) CDllc None a
730 (KB90) CDllc None a
Table 5c. Assessment of blocking activity of individual
monoclonal antibodies against pl50,95 (CDllc) on 
neutrophil polarisation. Similar methods were used 
as that of the previous antibodies.
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Figure 23. Effect of diluting supernatant in the presence of 
'monoclonal antibodies on neutrophil polarisation assay. 
The supernatant was obtained by preincubating PMN 
(1 0 6 cells/ml) in 10 ug/ml of antibodies for 10 
minutes at 37° C and then adding 10 ug/ml LPS 
continuing incubation for 90 minutes at the same 
temperature. This supernatant was then incubated with a 
new batch of PMN (106 cells/ml) for 10 minutes at 
37° C. The values depicted were from 3 different 
experiments. Bar are the standard deviations of the 
means. Antibodies codes: 2LPM19C (anti-CR3) , 717 
(anti-LFA-1), 3.9 (anti-p150,95)
% 
PO
LA
RI
ZE
D 
CE
LL
S
140g
Figure
60 -j
50- 
40 -
30- 
20 -  
10 -
30 60
TIME (minutes)
□
□
LPS alone 
3MAb+LPS 
Anti-CR3+LPS 
Anti-p15095+LPS 
Anti-LFA-1 +LPS 
Control HBSS 
Control 3MAb 
Control Anti-CR3 
Control anti-p16095 
Control anti-LFA-1.
90
24. Blocking activity on LPS-induced neutrophil 
polarisation of three monoclonal antibodies together in 
comparison to each individual blocking capacity. Three 
antibodies combining together (10 ug/ml each) were 
preincubated with PMN for 10 minutes at 37° C before 
exposing the cells to LPS (10 ug/ml). Individual 
antibodies was treated similarly to that of the combined 
antibodies (n=3). Bars represent standard deviation 
values. Antibodies codes: 2LPM19C (anti-CR3), 717 
(anti-LFA-1), 3.9 (anti-p150,95)
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Figure 25. Blocking assay of LPS-induced PMN polarisation using 
RGD-containing peptides. The cells (10^ cells/ml) 
were exposed to the peptides (10 ug/ml) for 10 minutes 
at 37° C followed by the addition of LPS (10 ug/ml). The 
mixture was further incubated for 60 minutes at similar 
temperature. Results from five different experiments 
were used to plot the chart along with the standard 
deviation values shown by the bars. RGD1= Gly-Arg- 
G ly-Asp-Ser; RGD2= Gly-Arg-Gly-Asp-Pro-Lys 
(fibronectin analogue); RGD3= Arg-Gly-Asp; RGD4= 
Arg-Gly-Asp-Ser.
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Section 9
POLARISATION ASSAY ON DIABETIC CELLS
Thus far the project has shown that LPS-induced 
polarisation of PMN may be inhibited by blocking the 
cel 1-surface receptor sites for the LPS molecules. The 
methodology applied could be considered as simulating a 
defective neutrophil function. Hence, the assay system 
was tested on cells which are known to be defective in 
vivo. Diabetics PMN are believed to be among those that 
have a depressed functional capacity as cited in the 
introductory part of the thesis. In a study involving 
diabetic patients, three biochemical indicators are 
frequently included in analysing the experimental 
results: levels of blood glucose, glycosylated
haemoglobin and fructosamine. Raised blood glucose 
concentration above levels (normal range 3.2 - 5.3
mmol/lit) proposed by the Expert Committee of the World 
Health Organization forms an indicator in diagnosing 
diabetes mellitus (Report of WHO, 1985). Levels of 
glycosylated haemoglobin (normal range 5.7% - 8.2%) has 
been shown to reflect the degree of hyperglycaemia in 
diabetic patients thus presenting a satisfactory 
indicator of the metabolic control of the patients 
(Gonen et al , 1977; Graf et al , 1978; Paisey et al ,
1980). The fructosamine assay described by Johnson et al 
(1982) provides an index of giycaemia capable of
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distinguishing normal (range 1.1 - 1.6 mmol/lit) and
diabetic populations. Both elevated levels of
fructosamine and glycosylated haemoglobin in diabetics 
were found to be highly correlated in a positive manner 
by the above mentioned investigators with the blood 
glucose concentrations.
When PMN from diabetic patients of type 1 (insulin- 
dependent) and type 2 (non-insulin dependent) were 
incubated with 10 /Lig/ml LPS for 60 minutes, fewer cells
polarized than in the normal non-diabetic individuals
(Table 6a and Table 6b). On the average, the IDDM
patients had higher percent reduction of polarisation 
than the NIDDM patients (mean values 41% and 28.6%
respect i ve1y ). Three main clinical paramet ers,
glycosylated haemoglobin (HbAl), fructosamine and blood 
glucose levels, were considered in the study to observe 
if their levels were related to the reduction in the 
proportion of polarised cells. Levels of HbAl and
fructosamine in NIDDM and IDDM did not appear to be 
positively correlated with the reductive effect of LPS- 
induced PMN polarization (Figures 26 and 27; 
statistically non-significant (P > 0.05). In vitro
assay of the effect of glucose concentration on LPS- 
induced PMN polarizations was conducted since blood 
glucose level has been implicated as a contributor to 
the derangement of PMN functional capacities (Kjersem et
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al, 1988). Normal neutrophils were initially exposed to
glucose at different concentrations for 10 minutes at
37° C before being challenged with either 10 LPS
for a period of 60 minutes or 10“ 8 M FMLP for 30
minutes. As depicted in figure 28, at 3 mg/ml (16.7
mmol/lit) of glucose there was a significant reduction
of 23% in cell polarization with this inhibitive effect
raised up to 87% at 30 mg/ml. Unlike the result from
LPS, only at 20 mg/ml (110 mmol/I it) of glucose was
there a significant 19% reduction of FMLP-induced 
polarisation. However, this needs a control for the 
inhibitory ef fects of non-glucose-containing 
hyperosmo1ar so1ut i ons.
PAF modulation
Platelet activating factor (PAF), a pro- 
inflammatory lipid mediator produced by a variety of 
cells including platelets, basophils , monocytes and 
PMN, has been demonstrated to possess a stimulatory 
effect on human PMN functions such as exocytosis, 
migration and superoxide production (Shaw et al , 1981).
PAF not only directly activates PMN but in small 
quantities ’’primes" them as well eventually allowing PMN 
to respond to subsequent stimuli (Vercelloti et al , 
1988). Based on the reported observations of these 
workers, actions of PAF were therefore investigated in 
the polarization assays using both the normals and the 
diabetic cells. Both types of cells were preincubated 
with 10“8 M PAF for 10 minutes before adding LPS. Normal
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PMN exhibited an average of 44% increase in the number 
of polarised cells (Figure 29). Representatives of seven 
IDDM patient cells showed similar effects but with 
varying increases in the percent polarisation ranging 
from an increment of 55% to 103%. Even though PAF on its 
own does cause shape change, the percentage of these 
changes were within the control limit of < 10%. Any
cells with shape changes of > 10% at the beginning of 
the experiments were discarded.
Visual assay
The same method described earlier to measure shape 
changes of normal cells in suspension was used to study 
cells from diabetic patients. The illustrations in 
figure 30 of IDDM cells show no apparent morphological 
differences from the shapes of the normal PMN (Figure 
11). The frequency of shape-change though was much less 
for the diabetic cells than the normal counterparts.
Discussion
Diabetic neutrophils manifested diminished PMN 
functional capacities as the disease progresses. Hence, 
the projection is that diabetics PMN would be responding 
poorly too in the LPS-induced polarisation assay. The 
results from tables 6a and 6b clearly demonstrated the 
functional defects of the diabetic neutrophils to 
polarize as well as normal cells. Elevated levels of
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fructosamine and glycosylated haemoglobin did not appear 
to contribute to the poor response of LPS-induced PMN 
polarization as indicated by the correlation tests. 
Blood glucose levels that have long being thought to 
have a substantial effects on neutrophil functions in 
diabetes mellitus patients failed to show any positive 
correlation with this defect even though experimental 
data using glucose to interfere with the assay system 
gave a positive effect. Manoeuvring glucose 
concentration in vitro may not actually simulate the in 
vivo situation exactly. The in vitro studies using 
exogenous glucose simultaneously showed that FMLP has a 
different target site than LPS since the inhibitory 
effect was obtained at a much higher concentration using 
FMLP than using LPS. A similar inhibitory effect had
earlier being displayed when monoclonal antibodies 
against CD11/CD18 receptors were used in the assay. From 
the study it seems that the receptors needed for LPS 
binding on PMN may be poorly expressed or poorly
functional in the diabetic cells. The reason behind this 
def ect st i11 rema i ns unc1ear.
Besides having the ability to potentiate neutrophil 
responses to subsequent activation by an agonist, PAF 
was taken into consideration as a factor for assay 
following the work that showed PAF increased expression 
of membrane receptors for CR3 in human PMN (Shalit. et
al , 1988; Vercelloti et a i , 1988). Moreover, unlike
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other biological compounds that do increase expression 
of this family of receptors, PAF on its own did not 
cause shape change above that of the control level. 
Preincubat ing both the normal or diabetic PMN with PAF 
before challenging with LPS resulted in the increase of 
numbers of polarized cells. This marked enhancement of 
polarization is an indication of a stimulating or 
priming effect of PAF on neutrophils particularly in the 
case of diabetic cells. If membrane receptors do in fact 
play a role in the LPS-induced PMN polarization, then 
the action of PAF in enhancing the response could be 
partly due to the increased in cellular expression of 
CR3 receptors as documented by previous investigators 
(Shalit et a l , 1988; Vercelloti et a l , 1988). Another
possibility lies in the biochemical aspect of cellular 
activation in which PAF has been proposed as a priming 
stimulus via activating protein kinase C (Gay et al , 
1986). This phenomenon could have potentiated the 
polarizing response of the PMN for both normal and 
diabetic individuals. The locomotive apparatus in 
diabetic cells did not show any behavioural 
abnormalities judging from the motion of the patient 
cells in suspension with the aid of videotaping. Motile
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activity though was somewhat less which may indicate a 
low cellular activating process. The observations thus 
far reflect poor metabolic control as a result of 
impaired utilization of glucose to turn on the 
biochemistry of the cell (Esmann, 1963).
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Pat ient HbAl Fructosamine
Blood
glucose
Percent 
reduct ion 
of
polarisat ion
PI 10.1 3.6 17.4 20.0
P2 12.1 3.9 18.1 30.0
P3 10.3 4.3 17.2 28.0
P4 10.3 3.3 11.5 28.0
P5 8.1 3.4 12.9 15.4
P6 12.7 4.8 23.2 40.0
P7 12.5 3.4 13.7 20.0
P8 12.7 3.6 6.3 31.7
P9 7.6 2.8 10.3 32.3
P10 6.9 2.6 11.3 23.1
Pll 12.0 3.7 11.1 32.3
P12 5.4 2.3 5.1 33.3
P13 11.2 3.7 13.5 28.6
P14 11.5 4.1 15.5 26.7
P15 6.2 3.1 11.5 38.9
P16 13.5 5.0 19.7 27.8
P17 11.2 - 11.8 30
Table 6a. Polarisation assay on non-insulin dependent
diabetic cells. Patient cells were incubated with 
10 Mg/ml of LPS for 60 minutes along with a 
control normal cells. Percent polarisation was 
then converted into percentage of reduction. HbAl 
(glycosylated haemoglobin) is expressed in 
percent, fructosamine and blood glucose in mmol/ 
lit.
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Pat ient HbAl Fructosamine
Blood
glucose
Percent 
reduct ion 
of
polarisat ion
PI 9.7 3.9 12.3 36.7
P2 8.5 3.2 14.1 35.2
P3 9.8 3.8 23.6 39.0
P4 9.0 3.2 20.3 70.6
P5 8.3 2.9 7.2 64.8
P6 8.7 3.4 15.7 28.8
P7 - 3.9 20.3 42.3
P8 10.4 3.8 3.5 32.1
P9 9.5 - 19.8 37.5
P10 9.8 3.9 22.4 32.1
Pll 9.7 4.2 10.0 23.2
P12 8.2 3.1 15.3 48.0
P13 7.3 2.6 11.0 64.0
P14 16.2 4.0 23.0 35.7
P15 9.3 3.5 14.6 25.0
Table 6b. Polarisation assay on insulin dependent diabetic 
cells. The treatment of these cells was the same 
as that of non-insulin dependent diabetic 
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Figure 26. Comparison of the percent reduction in PMN polarisation with the 
level of glycosylated haemoglobin, fructosamine, and blood 
glucose of non-insulin dependent diabetics. (Correlation test, not 
significant. (P >0.05)
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Figure 27. Comparison of the percent reduction of PMN polarisation with 
the level of glycosylated haemoglobin , fructosamine , and blood 
glucose of insulin-dependent diabetics. (Correlation test, not 
significant.. P >0.05)
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Figure 28. Dose response effect of glucose on LPS-induced and 
FMLP-induced PMN polarisation. Neutrophils at 10® 
cells/ml were exposed to glucose for 10 minutes at 37° 
C before being challenged with LPS (10 ug/ml) for 60 
minutes or FMLP (10-8 M) for 30 minutes maintaining 
the same temperature. Data collected were from 4 
different experiments. Standard deviations of the means 
are depicted by the error bars.
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Figure 29. Polarisation assay of neutrophils in the presence of LPS 
and PAF for normal (N) and patients (P) cells. Cells 
(106/ml) were preincubated with 10*8 M PAF for 10 
minutes at 37° and then challenged with 10 ug/ml LPS for 
60 minutes at the same temperature.
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Figure 30. Live diabetic cells using videotape. PMN from 
IDDM patient were incubated at different times 
with LPS before observing in filming chamber 
and later videotaped. Motions of the cells in 
suspension were traced out at 30 seconds 
intervals (Roman numericals). Period of 
incubation: Cell A- 30 min, Cell B- 60 min, 
Cell C- 90 min and Cell D- 120 min.
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Section 10 
CHEMILUMINESCENCE ASSAY
Chemiluminescence is an energy product of phagocyte 
oxygenation activity. Measurement of this light emission 
enables monitoring of phagocyte oxygenation activity 
which may originate on contact with the particles to be 
ingested. The measurement requires a reasonable number 
of cel Is and a sensitive light detector. 
Chemiluminescence measurement can be increased even 
further by the addition of luminol which markedly 
amplifies the luminescence response (Harvath and 
Andersen, 1979).
Dose and time responses to a particulate stimulus
Zymosan at 4 mg/ml was opsonized with varying serum 
concentrations before mixing with PMN suspension as 
detailed by Easmon et al (1980). Using different 
concentrations of serum resulted in varied 
chemiluminescence peaking times and responses (results 
not presented graphically); 40% serum concentration was 
the most effective amount for the assay. The effect of 
opsonized particle concentration was evaluated too using 
different amounts of zymosan. As illustrated in figure 
31, light emission was greater if the opsonized particle 
concentration was increased up to 8 mg/ml but the peak 
response declined at 10 mg/ml.
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Dose and time responses to a soluble stimulus
Phorbol myristate acetate (PMA), a cocarcinogen 
extracted from croton oil, is known to cause marked 
cellular oxidative metabolism of resting neutrophils 
(DeChatelet et al , 1976). Thus it forms a useful
stimulus in the luminescent study of PMN. A stock 
solution of PMA (10-2 M) prepared in DMSO was further 
diluted to the desired strength suitable for 
stimulation. Similar procedural manipulations to that 
using opsonized zymosan were used. At 10"5 M a maximal 
peak response was achieved within a short period of time 
but above this concentration the DMSO was toxic to the 
cells preventing further investigation of the effects of 
higher PMA concentration on chemiluminescence response. 
Reducing the concentration of PMA resulted in a decline 
of the peak response and a later peak (Figure 32).
Discussion
The graphs in figures 31 and 32 depict the 
chemiluminescence patterns in response to both 
particulate and soluble stimuli. Further experiments 
showed that the peak response for PMA was generally much 
higher and occurred wi thin a shorter per iod of t ime than the
.response to opsonised zymosan. The declining
fallowing the peak response also
differed for both in that PMA showed a relatively rapid 
deceleration while opsonised zymosan had a gradual
decline. Contact of opsonised zymosan with the PMN 
cellular membrane results in an array of biological 
events: recognition via complement and IgG Fc receptors 
of the phagocyte, activation of cellular redox 
metabolism, phagocytosis, specific and azurophilic 
degranulation, and formation of phagolysosomes (Henson, 
1971; Bainton, 1973). When PMA is used as a stimulus, 
there is activation of redox metabolism without true 
phagocytosis and this has led to a suggestion that PMA 
activates the cell in the same manner as does 
phagocytosis (DeChatelet et al, 1976). Later, protein
kinase C was shown to be one of the key factor 
responsible in the activation of neutrophil function 
and that PMA is an exogenous activator of the same 
protein kinase (Wolfson et a l , 1985). One drawback in
the chemiluminescence study though is the variation in 
PMN response within normal individuals. Different 
batches of cells resulted in variations of the recorded 
values even though the pattern of response was preserved. 
Mean values for a normal standard curve are therefore 
impossible to tabulate.
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Figure 31. Dose and time responses to opsonized zymosan in the
neutrophil chemiluminescent assay. Normal PMN (106 " 
cells) were prewarmed in a 37° C water bath for 10 
minutes before the addition of opsonized zymosan and 
luminol (10'4 M). The content was then placed in the 
luminometer to record chemiluminescence.
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Figure 32. Dose and time responses to PMA in a chemiluminescent 
study. Normal PMN (106 cells/ml) were prewarmed in 
a 37° C waterbath for 10 minutes and then exposed to 
PMA in the presence of luminol (10*4 M) to record the 
chemiluminescence produced.
PMA
-EH 10 UM 
1 uM 
0.1 uM 
-o- 0.01 uM
11
151
Section 11 
CHEMILUMINESCENCE STUDY IN DIABETICS
Chemiluminescence provides a simple and sensitive 
means to assess the overall oxidative metabolic 
potentials of leukocytes. The quantitation of light from 
normal human neutrophils in response to a soluble and 
particulate stimulus is therefore useful before 
embarking on a comparative study on disease-state 
neutrophils such as that of diabetic cells.
Chemiluminescence using LPS with or without PAF
Normal or diabetic patient cells were mixed with 10 
fig/ml of LPS in a tube containing 10"4 M luminol and the 
response was recorded. In one experiment patient cells 
gave a very low peak read.ing of 45 mV after 72 minutes 
in comparison to normal cells peaking at 180 mV within 
58 minutes ( F i g u r e  33). The initial response from the 
patient cells was also quite slow. Samples from 
different normal donors took 30 to 60 minutes to reach 
peak values with few exceptions (Table 7a) while it took 
between 60 to 100 minutes for patient cells to produce 
the maximum response (Table 7b). There were wide 
variations but the trend was that generally the normals 
produced greater chemiluminescence than the diabetics as 
confirmed by t-test statistical analysis (significant at 
P< 0.05). The blood glucose levels in these patients did
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not seem to show any correlation with the low 
chemiluminescence response (Figure 34). In another set 
of experiments, both types of cells were preincubated 
with PAF at 10“8 M for 10 minutes before challenging 
with LPS and eventually used in a chemi luminescence 
assay. This was conducted since PAF has been reported 
to enhance neutrophils' oxidative responses to other 
stimuli (Ingraham et al , 1982; Dewald and Baggiolini,
1985; Gay et al , 1986). For normal cells there was a
slight decrease in the response but an increase for the 
diabetic cells. Different batch of cells from both 
sets of donors showed a similar picture as graphed in figure 33 
but with a wide variations in the responses (Tables 7a 
and 7b).
Chemi luminescence using LPS with PMA or opsonised 
zymosan
Normal PMN were preexposed to LPS for different 
times before introducing 8 mg/ml opsonised zymosan or 
10“4 M PMA into the reaction tube. Figure 35 shows that 
in the absence of LPS the peak chemi luminescence 
response using opsonised zymosan was higher than those 
with LPS. Preincubation with LPS for 30 minutes gave 
little change, but incubation for 60 and 90 minutes 
resulted in a depression of chemi1uminescence in 
response to opsonized zymosan. Using PMA as the 
stimulus, preexposure of the cells with LPS for
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different times produced the opposite result to that 
obtained using a particulate stimulus. At all three 
periods of preincubation, LPS increased the cellular 
response to PMA (Figure 36); within 4 to 5 minutes the 
peaking point was reached while it took 7 minutes for 
the control to peak at a lower reading. Cells preexposed 
for 30 minutes responded better than those exposed for 
60 and 90 minutes.
Assay on opsonised zymosan with or without agonist
The aforementioned procedural approach was used to 
compare the activity of the normal and diabetic cells.
In figure 37, the first three bars starting from the 
left at each time sequence represent results of the 
assay using normal cells in the presence of opsonised 
zymosan with or without PAF or LPS. With the progression 
of time, addition of PAF caused an increase in the peak 
response from 605 mV to 800 mV without the agonist. The 
value was 563 mV with 30 minutes of preexposing LPS to 
the cells without PAF. The following three bars 
represent readings from patient cells assuming a similar 
pattern of response to the normal leukocytes. Even 
though the activity was still lower than the normal 
control the time required to reach the peak level was 
not different from that of the control (Table 8). 
Correlation test shows that no relationship exists
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between blood glucose level and luminescence activity 
(Figure 38).
Assay on PMA with or without agonist
A very marked difference in the reponse was 
observed between diabetics and controls when PMA was 
tested (Figure 39). Preexposing PMN to LPS for 30 
minutes and PAF for 10 minutes boosted the light 
emmision from the normal and diabetic cells. Both types 
of cells responded more with the addition of LPS than 
PAF and again the patient cells showed no improvements 
in the readings in contrast to the normal donors (Table 
9). However, a correlation test done on the patient 
samples indicate a positive relationship between the 
level of blood glucose and the chemiluminescence 
response towards PMA (Figure 40).
Discussion
Neutrophils generating light after phagocytosis of 
opsonised bacteria was first demonstrated by Allen and 
co-workers in 1972. Later chemiluminescence techniques 
were successfully employed for the assessment of PMN 
oxygenation activities in phagocytosis and microbial 
killing (Horan et al , 1982). One of the particulate
stimuli that has been under discussion in inducing 
chemiluminescence in PMN is LPS. Conflicting results on 
whether bacterial LPS does induce light emission from
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human PMN have been reported (Wilson et a l , 1982;
Henricks et al , 1983; Kapp et al , 1987; Pugliese et al ,
1988). In this thesis by exposing the cells to LPS for 
over 90 minutes in a luminometer, chemiluminescence 
generation was detectable with the peak varying between 
45 to 60 minutes depending on the donor cells. Direct 
activation of luminescence by LPS was observed though a 
long period of incubation was required. Beyond the 60 
minutes mark, there was a slow decline in the activity. 
Such reactions were different using opsonized zymosan or 
PMA in both of which the response occurred within 10 
minutes. As in the polarisation assay which took more 
than 60 minutes to maximise, there seems to be a slow 
activation by the LPS for both types of activities.
LPS has also been demonstrated to enhance 
neutrophil oxidative capacity upon subsequent contact 
with other stimuli (Guthrie et al , 1984). The effect
known as priming may well be functioning when tested in 
chemiluminescence assay in which the reponse towards PMA 
was increased. Comparison of the priming effect was done 
with PAF which has been documented to prime neutrophils 
for enhanced release of superoxide anion (Worthen et al , 
1988). The priming effect exerted by PAF was evident in 
that subsequent exposure with opsonised particles and 
PMA potentiated light emission, a result that differed 
from LPS actions. With opsonized zymosan the increase 
was greater for PAF than LPS, while using PMA the effect
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induced by LPS was greater than PAF. Thus far the 
precise mechanism of LPS priming is unknown but the 
molecular basis of the enhanced activity has been 
investigated and related to changes in the NADPH oxidase 
and stimulus-response coupling (Forehand et a l , 1989).
As mentioned earlier chemiluminescence assays have 
been employed to assess the normal and abnormal 
functional capacity of PMN in the production of oxygen 
met abo1i t e s . Pat i ent ce11s from d i abet i c out pat i ent 
clinics were tested in the assay concurrently with 
normal controls. As expected and documented by other 
workers, light production using PMA and opsonised 
zymosan was impaired (Shah et al , 1983; Kjersem et al ,
1988). The response of patients’ cells to LPS was 
grossly impaired with a very slow and low activity. When
the priming effect of LPS and PAF was studied, both
exhibited similar results to that of normal cells:
enhancement with PAF and LPS on PMA activation; 
depression with LPS on opsonised zymosan but not with 
PAF. Relationships between level of blood glucose and
chemiluminescence response were negative except when PMA 
was used as the soluble stimulus (Figure 40). Small 
sample numbers could possibly result in a strong 
correlation between the two parameters.
The reason for the defective response in diabetics 
is still unclear but it seems that an intrinsic cellular 
defect of the PMN may be the key factor for the reduced
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activity. In vitro experiments like chemiluminescence 
indicate the inability of diabetic cells to mount a 
normal oxidative burst which may contribute to the 
decreased intracellular killing by these leukocytes.
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Figure 33. Chemiluminescent assay using LPS on normal and 
patients PMNs in the presence or absence of PAF. Ceils at 
106/ml were prewarmed in 37° C waterbath in the 
presence or absence of PAF (10'8 M) for 10 minutes 
after which they were exposed to LPS (10 ug/ml) to 
measure the chemiluminescence production. (NOR= 
normal cells ; PAT= patients cells)
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Donor
Peak
response
Chem i1um i nescence with: 
LPS
Peak Peak 
(mV) Time (min) response
LPS + PAF 
Peak 
(mV) Time
N1 131.2 62 118.1 55
N2 124.9 55 105.9 57
N3 98.2 57 83.6 50
N4 267.0 49 253.9 50
N5 170.0 32 158.5 40
N6 80.2 58 73.3 56
N7 . 143.8 67 157.1 70
N8 125.5 75 117.9 65
N9 63.9 96 61.4 90
N10 181.7 63 176.0 60
Nil 115.4 62 104.9 59
Table 7a. Chemiluminescence assay on normal cells induced by 
LPS at 10 /ug/ml in the absence or presence of PAF 
at 10-8 M.
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Chemiluminescence with:
LPS LPS + PAF
Donor Peak Peak Peak Peak
(BG) response (mV) Time (min) response (mV) Time (min)
PI 48.6 100 56.4 82
(14.4)
P2 47.2 80 62.1 62
(9.8)
P3 57.7 61 68.9 60
(10.3)
P4 40.8 90 60.5 75
(3.5)
P5 78.5 68 92.1 63
(15.3)
P6 46.2 70 59.9 65
(11.0)
P7 69.9 93 87.5 85
(12.0)
P8 34.4 60 45.6 52
(16.5)
P9 15.7 65 22.4 60
(5.1)
P10 99.7 72 125.6 67
(9.3)
Pll 42.4 83 61.9 70
(9.8)
Table 7b. Chemiluminescence assay on patient cells induced 
by LPS at 10 jug/ml in the absence or presence of 
PAF at 10“8 M. BG is the blood glucose level in 
mmol/lit. Comparison between normal (Table 7a) and 
patient cells using t-test shows a significant 
difference. P< 0.05
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Figure 34. Comparison of chemiluminescence response of PMN in the 
presence of LPS with the level of blood glucose of insulin- 
dependent diabetic patients. (Correlation test, not significant, _ P > 
0 .05)
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Figure 35. Chemiluminescent assay of the effect of opsonized 
zymosan on PMN preexposed to LPS. Normal PMN (106 
cells/ml) were prewarmed in 37° C waterbath for 10 
minutes before being exposed to LPS (10 ug/ml) for 0, 
30, 60 and 90 minutes. After each time interval 
opsonized zymosan at 8 mg/ml was added along with 
luminol to record chemiluminescence.
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Figure 36. Chemiluminescent assay of PMA on PMN preincubated 
with LPS at various time periods. Normal PMN (106 
cells/ml) were preincubated with 10 ug/ml LPS at 
various time periods after which PMA at 10'5 M was 
added at each interval .
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Figure 37. Chemiluminescent study of opsonized zymosan on 
normal and diabetics PMNs in the presence or absence of 
PAF or LPS. Cells at 106/ml were preincubated with 
PAF (10*8 M) for 10 minutes or LPS (10 ug/ml) for 
30 minutes in 37° C waterbath. Opsonized zymosan (oz) 
at 8 mg/ml was then added to each content in recording 
the chemiluminescent produced. (N= normal cells ; P= 
diabetics cells)
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Chem i1um i nescence with:
OZ OZ+PAF OZ+LPS
Peak Peak Peak Peak Peak Peak
Donor BG response time response time response time
PI 16.5 680.3 5 805 4 576.9 4
P2 5.1 545.4 6 575.7 4 487.9 . 4
P3 14.4 513 5 690 5 463.5 5
P4 12.2 745 5 833.6 5 657.2 4
P5 9.8 165.1 7 200 6 98.8 5
N1 783 7 912 5 662 6
N2 614 5 652 5 539 6
N3 548 6 709 6 484 5
N4 999 5 1082 5 793 5
N5 442 6 640 5 428 5
Table 8. Comparative study in chemiluminescence assay
between normal PMN (N) and diabetic PMN CP) using 
opsonized zymosan (OZ) at 8 mg/ml in the absence or 
presence of PAF (10-8 M) or LPS (10 *ig/ml). BG is 
the blood glucose in mmol/lit, response in mV, and 
time in minutes.
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Figure 38. Comparison of the chemiluminescence response of PMN in the 
presence of opsonized zymosan with the level of blood glucose of 
insulin-depenedent diabetic patients.
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Figure 39. Chemiluminescent assay using PMA with or without PAF 
or LPS for normal and diabetics neutrophils. Neutrophils 
(106 cells/ml) were preincubated with PAF (10-8 M) 
for 10 minutes or with LPS (10 ug/ml) for 30 minutes 
in 37° C waterbath and later mixed with PMA at 10'5 to 
record the chemiluminescence. (N= normal cells ; PT= 
diabetics cells)
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Chem i1um i nescence with:
PMA PMA+PAF PMA+LPS
Peak Peak Peak Peak Peak Peak
Donor BG response time response time response time
PI 12.4 357.2 6 534.1 3 612.0 4
P2 9.8 162.9 5 257.5 4 271.9 4
P3 14.0 510.4 5 581.4 4 711.0 4
P4 6.2 112.6 8 150.6 5 176.9 4
P5 10.2 162.7 7 214.7 5 220.3 4
N1 449.6 7 604.3 7 628.8 4
N2 587.8 8 655.0 7 705.5 5
N3 685.6 7 850.9 5 878.8 4
N4 336.0 5 574.6 4 605.0 4
N5 241.8 7 309.0 6 356.4 7
Table 9. Comparative study i n chem i1um i nescence assay
between normal PMN (N) and diabetic PMN CP) using 
PMA at 10“4 M in the absence or presence of PAF at 
10~8 M or LPS at 10 pg/ml. BG is the blood glucose 
in mmol/lit, response in mV, and time in minutes.
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Figure 40. Comparison of the chemiluminescence response of PMN in the 
presence of PMA with the ievei of blood glucose of insulin- 
dependent diabetic patients. (Correlation test, significant. _ 
P<0.05)
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CHAPTER A 
GENERAL DISCUSSION AND 
CONCLUSION
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Accumulation of neutrophils in tissues is a 
prominent feature of inflammation observed in a variety 
of pathological conditions such as cancer, trauma and 
infections. The phenomenon of tissue infiltration is 
well characterised in bacterial infections whereby 
neutrophils are attracted in large numbers to eliminate 
the invaders. In other conditions neutrophils are
recruited as scavengers of damaged tissues or unwanted 
extracellular deposits. Removal of foreign materials 
involves the production and releasing of bioactive 
compounds in particular required for the killing and 
digestion of microorganisms. However, these products 
also induce inflammation and tissue damage which 
norma11y appear aft er neut roph i1 accumu1at i o n .
In recent years several neutrophil chemoattractants 
have been isolated and well characterised each acting 
via unrelated receptors, suggesting that neutrophil
recruitment can result from the concerted actions of 
multiple stimuli. Several functional responses to 
chemotactic stimuli including shape change, adherence, 
directed migration, enzyme secretion and the respiratory 
burst are demonstrated in vitro after stimulation. Non- 
chemotactic stimuli like LPS nevertheless do elicit such 
cellular functions. This is of importance as the
neutrophil is one of the key elements in host resistance 
to bacterial infections. Current knowledge of the
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effects of LPS derived from the outer cell envelope of 
gram negative bacteria on neutrophil function has been 
cited in the introductory part of the thesis. The 
accumulated data from previous studies support the view 
that neutrophils represent an important target for 
bacterial LPS. Besides altering blood levels of 
circulating neutrophils as reflected in leukocytosis or 
neutropenia, LPS are capable of influencing the 
locomotory, metabolic and bactericidal properties of 
PMN.
Polarisat ion and locomotion
Even though many researchers have investigated the 
effects of bacterial LPS on neutrophil functions as 
summarised by Wilson (1985), none actually investigated 
the possibilty of neutrophils releasing a 
chemoattractant that may act on other neutrophils. What 
has been done in this project was to further resolve the 
question of what actually induced neutrophil shape 
change in the presence of LPS as discovered by Haslett 
and co-workers (1985). To assist such a study, the cell 
shape change assay or polarisation assay was implemented 
following the method of Haston and Shields (1985). The 
polarisation assay is quite useful for conveying 
information about the initial locomotory response but 
not about the locomotor events which follow 
polarisation. It permits the study of morphological
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changes of cells when encountering any kind of a 
stimulant. The polarised form assumed by the cells was 
shown to be similar to that of cells in locomotion 
(Zigmond et al , 1981) but the adhesion of cells to
surfaces may itself modify the spherical shape of PMN 
(Keller et al , 1979). Polarisation occurs independently 
of adhesion to the substratum (Keller and Cottier, 1981) 
thereby allowing in depth investigation of what induces 
shape change in suspension if the substance used is a 
non-chemotactic agent. Hence, with LPS the assay has 
been of great assistance in determining the cause of 
polarisat ion.
Before dealing with the unknown factor, the 
structure-function relationships of different LPS 
preparations should be discussed. Structural differences 
of different LPS preparations result in varied
biological effects on PMN. To see if the structure of 
LPS does play a role in inducing shape change, different 
chemotypes of the bacterial LPS were examined. Results 
obtained clearly show that different forms of the LPS 
give different activity in the PMN response. 
Contradictory results reported from investigators, as 
reviewed in the introductory part of the thesis, using 
LPS to modulate PMN responses could be due to the 
different LPS preparations used. The most effective 
form was that of Re mutant strains which have been shown 
successfully to elicit better biological responses in
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PMN such as the oxidative responses and inhibition of 
random migration than the other types (Kapp et al , 1987; 
Pugliese et al , 1988). The presence of the 0 core
antigen was found to depress nonopsonic recognition of 
bacteria by phagocytes strongly (Wright and Jong, 1986). 
Modification of the LPS structure affects the 
interaction of bacteria with receptors on the 
phagocytes. When analysed, the Re chemotype has the 
outer sugar moiety removed consequently exposing the 
intact lipid molecule of native endotoxin which was and 
is still considered by the majority of experts in the 
field to be the only source of the reactions elicited by 
endotoxins both for its toxicity and beneficial effects 
(Nowotny, 1987).
In doing assays with LPS, polymyxin B is often 
added to in vitro samples to ensure that LPS activity is 
removed. Many investigators reported that polymyxin B 
could reduce the activity of endotoxin both in vivo and 
in vitro (From et al , 1979; Cooperstock and Riegle,
1981). Later many more investigators have suggested that 
polymyxin, either free or bound to a gel support, can be 
used to ensure a solution free of endotoxins (Duff and 
Atkins, 1982; Dinarello et a l , 1984). Here in this work, 
inhibition by polymyxin B of LPS-induced polarisation of 
neutrophils was observed to be insignificant since the 
number of polarized PMN was minimally reduced. This 
ineffective inhibition could be due to the different
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batch of polymyxin used than that of the above mentioned 
investigators. Failure of polymyxin to block the 
polarising activity could also be due to the presence of 
non-LPS agonists that might not interact with the 
antibiotic thus inducing polarization of neutrophils.
Cel 1-released chemotactic factors from neutrophils 
have been reported by earlier workers (Phelps, 1969; 
Borel, 1970; Zigmond and Hirsch, 1973). To document any 
release of a factor in a suspension of PMN, the 
supernatant was saved and tried on new batch of cells. 
Shorter onset times in responding towards the fluid 
fraction in comparison to that of exposing LPS directly 
implicates the presence of a factor other than the LPS 
itself. Though it was premature to accept such activity 
as being from a chemotactic factor, the similarity in 
time course of polarization to that of cells activated 
in the presence of classical chemoattractants such as 
FMLP was evident. Additional cell locomotion assays were 
needed to confirm that the factor was indeed behaving 
as a chemoattractant. As mentioned in previous chapters, 
a micropore filter assay gives additional information 
about the relationship between polarised morphology and 
cell motility since not all non-spherical leukocytes are 
motile and a direct test of locomotion is needed 
(Keller et at, 1985). Using the leading-front assay, PMN 
migrated deeper in the presence of the cell-release 
supernatant. Checkerboard studies were done to show
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whether or not a directional response had been displayed 
by the cell population. The comparison of values between 
the experimental and the calculated figures as described 
by Zigmond and Hirsch (1973) point towards the existence 
of a chemotactic factor in the supernatant.
A collagen gel assay similar in principle to the 
micropore filter assay was simultaneously employed to 
study the response of leukocytes to a diffusing gradient 
of an attractant. The collagen gel assay has the 
advantage of not only allowing assessment of the 
locomotor capacity of cells in response to an attractant 
but also permitting direct observation of morphological 
changes of cells locomoting in a condition similar to 
what the cells experience in tissue matrices. Following 
the methodology developed by Islam and colleagues
(1985), the collagen gel assay like the filter assay 
suggests that cells migrate towards the supernatant. The 
polarisation assay and the locomotion assays thus 
confirm each other. Visual assays fortify evidence for a 
cel1-released factor. With a videotape recorder, cell 
movements _ in suspension after exposure to LPS were 
recorded and played back for analysis. Those polarised 
cells exhibiting crawling like movements in suspensions 
displayed good locomotion after settling down on the 
filming chamber, an observation similar to the findings 
of Keller et al (1983). The shapes of the polarised 
cells exposed to LPS were compared to those of cells
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incubated with FMLP. Classical locomotor morphology was 
similar at later stages of the incubation with FMLP or 
LPS meaning that whatever induced the shape changes in 
the presence of LPS behaved in the same way as the 
chemoattractant FMLP. All techniques used to study and 
analyse cell locomotion suggest the presence of a factor- 
released when cells were exposed to LPS for over 60 
minutes.
When human neutrophils are exposed to appropriate 
stimuli, a complex sequence of events follows such as 
the generations of stable prostaglandins and release of 
leukotriene B4 a known chemotactic factor (Goldstein et. 
a l , 1973; Samuelsson and Hammastrom, 1980). Since
neutrophils are the primary participants in the 
inflammatory processes, the study of the effects of 
steroidal and non-steroidal antiinflammatory drugs 
(NSAID) on the cells responses are useful. These drugs 
slow down or eliminate the destructive effects of 
inflammation. Inhibitory effects of NSAID on neutrophil 
activation by a variety of ligands have been published 
by many investigators (Simchowitz et a l , 1979; Kaplan et 
al , 1984; Minta and Williams, 1985). The involvement of
arachidonic acid metabolites as activators of the shape 
change in leukocytes in this research is a distinct 
possibility. Using four different drugs to modulate the 
neutrophil polarisation activity, differences were 
noted: dexamethasone and indomethacin failed to inhibit
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the polarisation activity while BW 755C and Revlon 5901A 
to a certain extent managed to block the release of a 
polarising factor.
Knowing that a stimulant must be present in the 
fluid fraction, it is of interest to pursue further 
studies to identify the substance. Straightforward 
determination of the physical properties of the factor 
suggests that the substance is composed of a low and 
high molecular weight molecules. Separating the two 
compounds needs a ,f iner and more accurat e i nstrument at i on . 
Based on the gel filtration result, the major activity 
in the supernatant consists of a high molecular weight 
compound. A low molecular weight compound of about 1200 
also contributed to the polarising activity of PMN. The 
fraction , hydrophobic on phase separation, could be 
derived from the arachidonic acid metabolism as evident 
by the interference of the released factor by the 
lipoxygenase inhibitors, BW 755C and Revlon 5901A. 
Characteristics of the fraction such as small size and 
heat stability infer that it may be a lipid molecule.
All the experiments conducted establish that a 
factor is released by the PMN after prolonged exposure 
to LPS and that the factor can stimulate PMN locomotion
in the absence of serum. The requirement for the 
production of the polarising activities was an
appropriate amount of LPS and the right cell 
concentration without any contamination from mononuclear 
cells. Activated mononuclear cells are likely to
influence neutrophil functions at the sites of
inflammation as well as in in vitro assays. Recently 
mononuclear cells cultured in the presence of LPS have 
been shown to l " ~ •. re 1 ease fact;ors capable of
activating neutrophils (Schroeder et a l , 1987; Walz et
al , 1987; Yoshimura_et al , 1987; Peveri et al , 1988).
Production of this factor, later known as neutrophil- 
activating peptide-1/ interleukin-8, nevertheless needed 
more than three hours of incubation before any 
significant effects on the PMN biological status could 
be detected. Neutrophils releasing a factor after 
incubation with the isolated product obtained after 
preincubating macrophages with LPS need consideration 
since reports have shown that neutrophils could be 
"primed” by certain agonists like LPS and PAF (Guthrie 
et a l , 1984; Vercelloti et al , 1988) thereafter
enhancing subsequent cellular activation by another 
agonist. Priming is a phenomenon in which cells after 
pretreatment with an agonist are activated, maybe 
through modification of intracellular signals, to 
respond at increased intensity towards different 
agonists. Any trace amount of LPS present in the
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supernatant could well be activating the PMN after the 
cells had made their first response to the released 
product. The activation of the cells then may arise from 
a combination of both factors secreted by the 
mononuclear cells and neutrophils. The polarising 
inducer in this project needs extensive characterisation 
using a more accurate methodology to identify the exact 
component of the substance. At present judging by the 
response of PMN, various endogenous chemicals could be 
released once PMN is being stimulated by LPS.
Receptor studies
Being a major target for the actions of bacterial 
1 ipopolysaccharides, it is assumed that the high 
sensitivity of the polymorphonuclear leukocytes to LPS 
derives from the receptors for LPS on the cell surface. 
Several investigators have shown that receptors for LPS 
might mediate the binding of bacteria to phagocytes 
(Tomita et al, 1981; Speert et al, 1984; Euteneur et a l , 
1986). The first reported finding on the receptor for 
bacterial LPS came from the work of Wright and Jong 
(1986) who were able to characterise the receptors 
responsible for the recognition of Escherichia coli. 
Further studies showed that LPS bind to CR3 (CD11/CD18) 
at distinct sites from that of C3bi (Wright et al , 
1989). What makes the issue interesting is that the 
receptors belong to the family of receptors for
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neutrophils adhesion to endothelial cells, the CD11/CD18 
family of receptors. The expression of the functional 
CD18 complex molecules appears to be essential for the 
migration of the inflammatory cells since patients with 
a defective gene for the CD18 fail to mobilise 
leukocytes to sites of inflammation (Anderson and 
Springer, 1987) and infusion of anti-CD18 monoclonal 
antibodies into animals blocked the emigration of 
leukocytes into peripheral sites in response to 
noninfectious stimuli (Arfors et al , 1987; Rosen and
Gordon, 1987). In vitro studies showed that CD18 
molecules are necessary for the initial binding of 
leukocytes to the endothelium (Lo et al , 1989; Tonnesen 
et a l , 1989).
With the available information, monoclonal 
antibodies against the CD11/CD18 family of glycoproteins 
were added to the polarisation assay system in the 
presence of LPS. The outcome of the tests indicates the 
existence of blocking effects of different degrees by 
the antibodies. More evidence of the blocking effects 
appeared when the supernatant tested in a short-term 
polarisation assay showed a reduction in the activity. 
Combination of the three monoclonal antibodies produced 
a greater blocking effect than the individual antibodies 
implying that all three members of the integrins may 
have participated in the recognition and consequently 
the binding of LPS molecules on the PMN cell surface.
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Unlike the work of Wright and Jong (1986) which showed a 
strong contribution of the B chain to the specificity of 
the binding of LPS to the macrophages, here it appears 
that the binding site of the CD18 family is highly 
affected by the identity of the a chain. This difference 
could be attributed to the types of cells used and the 
antibodies tested may be of different activities. The 
participation of the a subunit in the polarization assay 
could also be the reason why the degree of inhibition 
differs for each member of the family since each has 
their own unique a-chain.
Human neutrophils express a heterodimeric receptor 
(CDllb/CD18) that has ligand binding specificity for the 
Arg-Gly-Asp (RGD) sequence within many adhesive proteins 
(Haynes, 1987: Wright et al , 1987; Russell and Wright,
1988). When peptides containing the RGD sequence were 
used to competitively inhibit binding of LPS to PMN, 
strong inhibition was observed for the pentapeptide and 
fibronectin analog despite the fact that these peptides 
are structurally different from LPS. The two ligands 
then appears to interact with the same binding site on 
the CD18 molecules. In contrast, separate binding sites 
were used to recognize the two classes of ligands were 
reported by Wright and colleague (1989).
Even though the outcome of receptor studies differs 
from those obtained by earlier workers, the common view 
is that a receptor for LPS binding on PMN cell surface
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is required and -it_s__ structural identity is becoming 
clearer. The receptors related to the CD18 family seems 
to have the ability to recognize more than one ligand. 
This ability is not unique to the integrins (Roth, 1988; 
Mowbray and Koshland, 1987) and therefore being a member 
of this superfamily, the CD18 family is predicted to
possess such property.
Chemi1uminescence studies
The other aspect of the biological response brought 
about by the interaction of LPS with PMN is the 
oxidative metabolism of the cell which generally leads 
to production of light. Reports published on the 
induction of neutrophil chemiluminescence by bacterial 
LPS were conflicting as cited in the previous chapters 
of the thesis. One possible reason for the varied
results is the class of LPS used (smooth versus rough) 
as shown by Kapp et al (1987) who concluded that 
induction of PMN chemiluminescence by LPS is a property 
of R-form as S-form preparations are virtually devoid of 
this activity. Even though in this project only the 
rough form was used, the response was evident but after 
prolonged time of exposure. The period of exposure is 
therefore important since normal individuals show a 
range of 30 to 60 minutes of incubation time to attain 
the peak response while there are others who took longer
to reach at that same level . Class type of LPS and the
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time of exposure are two fundamental parameters that 
need considerable attention in doing the 
chem i1um i nescence st udy.
Besides exerting profound effects on the immune 
system, bacterial LPS have been shown to prime PMN such 
that the cells respond to subsequent stimulus with 
enhanced secretion of superoxide anion, acid hydrolases, 
elastase and PAF (Guthrie et al , 1984; Haslett et al ,
1985; Fitschen et al , 1988; Worthen et a l , 1988). In our 
chemiluminescence studies the priming produced different 
effects with different second stimuli (PMA or opsonized 
zymosan). One of the main variables that will affect the 
degree of priming is the time of exposure for it was 
noted that a longer period of exposure failed to 
potentiate the chemiluminescence activities on the 
soluble as well as the particulate stimuli. Previous 
workers obtained an optimal LPS priming after 60 minutes 
of incubation (Guthrie et al , 1984) but here 30 minutes 
of exposure was sufficient to produce a maximum priming 
effect. Subsequent stimulation by PMA was enhanced but 
not by the opsonized zymosan, an observation that 
requires further clarification. A clue to such a 
difference in the luminescence response may be gained 
from the work of Rosen et al (1989) . In their work on 
macrophages it was shown that while treatment with LPS 
alone induced low level phosphorylation of the 68K 
protein (a protein found to be equivalent to the major
substrate for protein kinase C) , it markedly increased 
the rate of subsequent PMA-dependent phosphorylation of 
this protein. This work was based on the observation 
that LPS potentiates protein kinase C-dependent signals 
in macrophages (Aderem et al , 1986). Though macrophages 
were employed in those studies, similar events would be 
expected to take place in other phagocytic cells 
including PMN. As a matter of fact a strong link between 
protein kinase C (PKC) and the activation of human 
neutrophils has been documented (Tauber, 1987). 
Opsonized zymosan stimulates superoxide anion release by 
a mechanism distinct from that of PMA. The response to a 
particulate stimulus is thought to be phospholipase A2 
mediated, calcium-dependent and independent of PKC while 
PMA bypasses these associated lipid metabolic activities 
directly stimulating the PKC (Maridonneau-Parini et al , 
1986).
The role of PAF as a regulator of human neutrophil 
superoxide anion generation in response to soluble and 
particulate stimuli was also examined. In vitro, PAF has 
a stimulatory effect on human PMN (Shaw et al , 1981;
Poitevin et al , 1984; Dewald and Baggiolini, 1986; Gay
et al , 1986; Shalit et al , 1988). The present study
suggests that PAF modulates neutrophil superoxide anion 
production in response to opsonized zymosan and PMA. 
Mechanisms through which PAF accomplishes enhancement, 
remains unclear. PAF may represent another primary
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oxidative stimulus acting through a priming effect 
similar to that of LPS via activating the PKC.
Studies in diabetic patients
Bacterial infections are more frequent and tend to
follow a more severe course in patients with diabetes
mellitus than in non-diabetics. Such observations have
led investigators to postulate that infections in
diabetics may be a consequence of neutrophil dysfunction
since the microorganisms causing infections are often
found to be of the same type isolated from patients with
impaired PMN functions (Wheat, 1980; Wilson, 1986). In
support of the hypothesis, neutrophil functions have
been shown to be impaired (reviewed in the introductory
part of the thesis) but the results from different 
laboratories are conflicting. "
■ ' .... Deriving from the reports cited previously,
neutrophils from diabetic patients would be speculated
to be responding poorly towards bacterial LPS. Low
polarisation activity noted from diabetic individuals of
both IDDM and NIDDM types may indicate a less active
involvement of the receptors in recognizing bacterial
LPS. If, on the contrary, the recognition site for LPS
is functioning normally it could mean that there is a
failure to secrete the polarising factor. Oxidative
bursts measured by chemiluminescence in the presence of
LPS were apparently lower than the normal donors.
Priming of the ceils with PAF improves the response of
I/O
these cells on contact with LPS. PAF can induce an 
increase in expression of the CDllb/CD18 receptors on 
human neutrophils (Shalit et a l , 1988). Taking account
of this stimulatory effect of PAF on human PMN, it is 
probable that cell receptors towards LPS are being 
functionally expressed to produce a potentiating effect. 
The possibility thus is that either diabetic cells do 
not express sufficient numbers of cell surface receptors 
or biochemical activation in response to a stimulus is 
impaired. Presence of a priming substance switches on 
the functional abilities of these cells to a limited 
extent. Glycosylated haemoglobin and fructosamine were 
observed to be positively correlated with the degree of 
diabetes (Gonen et a l , 1977; Graf et a l , 1978; Paisey et 
a l , 1980: Johnson et al , 1982). These biochemical
parameters along with the blood glucose level were hence 
implicated to contribute to the impaired neutrophil 
functions in diabetic cells. Results from the project do 
not show any significant correlation between 
glycosylated haemoglobin and fructosamine and the assays 
conducted. The glucose level may on the other hand 
contribute to the defective function of PMN as observed 
in the in vitro study on the effect of exposing normal 
cells to glucose at various concentrations. All the 
experimental evidences may help to answer the question 
of a defective nonspecific defense mechanisms in 
diabetic patients.
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Conclusion
Activation of the neutrophils in response to any 
stimulus may follow the general pathway of cellular 
signal transduction as proposed by Berridge and Irvine 
(1984). To explain what might have taken place in the 
response of PMN towards the presence of bacterial LPS, a 
diagrammatic presentation similar to the proposed 
response mechanism would be of a help (Figure 41) . A 
possibility in this case is that the ligand, LPS, binds 
to the CD11/CD18 receptors at the external cell surface 
and leads to the breakdown of PIP2 or 
phosphatidyl inositol 4,5-bisphosphate which in turn 
triggers the activation of PKC. The activated PKC then 
generates signals, among them is release of a soluble 
factor. The released-factor then interacts specifically 
with a recognition site dissimilar to the LPS binding 
site. A molecular modification of the cell membrane 
presumably of the same kind to the initial coupling 
response occurs subsequently inducing a signal 
responsible for the alteration of cell behaviour.
Expression of the CD11/CD18 surface receptors on 
human neutrophils which encounter LPS would definitely 
be of importance in the inflammatory sites. Recruitment 
of other neutrophils to the site of infection would be 
one of the defense mechanism of PMN exposed to bacterial 
LPS. On the part of diabetic cells, the low or poor
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biochemical aspects of cellular activation seem to be 
the key figure in these neutrophils displaying the 
abnormal phagocytic functions. Further investigations on 
the biochemical aspects of cellular activation may give 
a clue in correcting the defect in the patients’ cells 
hence reducing the risk of bacterial infections in those 
individuals.
Cl) (II)
(IV) (ill)
Figure 41. Diagrammatic presentation of PMN exposes to 
LPS.
(I) PMN with surface receptors CD11/CD18
( C)f£ ) in suspension with LPS molecules
(II) Binding of LPS molecules leading to the 
release of a factor ( Q  )
(III) Binding of the factor to specific sites
( W )
CIV) PMN polarising
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